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Voorwoord 
 
Zo, dat was het dan. Mijn werk in het labo levensmiddelenmicrobiologie is volbracht. Vier 
jaar geleden begon ik aan dit heus avontuur, en het is voorbij gevlogen. Ik sluit deze bijzondere 
periode graag af door even terug te blikken op mijn persoonlijke roller coaster van ups en 
downs, en door de mensen te bedanken die mij geholpen hebben om dit werk te voltooien. 
Naast het plezier om bij te dragen aan wetenschappelijk onderzoek, waren het voornamelijk 
de mensen uit mijn omgeving, die de afgelopen jaren zo mooi hebben gemaakt. Daarom is dit 
voorwoord aan hun gewijd.  
Voor de start van mijn doctoraat, toen ik de eerste keer met Chris kwam praten over mijn 
onderzoeksonderwerp, waren de plannen nog gericht op Bacillus sporen. Tijdens mijn studies 
vond ik bacteriële sporen helemaal niet interessant, maar Chris overtuigde mij al snel om er 
toch voor te gaan. Wanneer ik thuis de literatuur doornam, vond ik echter zoveel informatie 
over Bacillus sporenkieming dat ik het onderzoek dat wij voor ogen hadden, al minder 
uitdagend leek te vinden. Nadat ik mijn twijfelgevoelens met Chris besproken had, werd het 
plan verschoven naar Clostridium botulinum. Een anaeroob organisme dat een dodelijk toxine 
produceert, waar het labo nog niet eerder mee gewerkt had, en waar wereldwijd nog maar één 
mutant van was verwezenlijkt… “Oké, super, dat doen we!”. Aan enthousiasme en motivatie 
bij mij meestal geen gebrek. Echter de kunst van het relativeren, kalm blijven, geduldig zijn , 
die eigenschappen heb ik door de jaren van Chris moeten leren, en om die reden was hij een 
uitstekende promotor voor mij. Want die skills had ik wel degelijk nodig, er deden zich 
namelijk al snel heel wat problemen voor. Natuurlijk zijn problemen zeer eigen aan een 
doctoraat, ze hadden mij hiervoor gewaarschuwd. Ik hoor Joleen nog zeggen “Je moet niet 
verwachten dat je doctoraat zo’n succes zal zijn als je masterthesis, want er zal héél veel 
mislukken”. Maar bijna een jaar lang wachten op de juiste stammen (omdat het Clostridium 
wereldje niet graag samenwerkt met onbekenden, daarom, geen dankwoordje voor hun!) en 
anderhalf jaar wachten op een anaeroob werkstation (toch wel écht nodig om C. botulinum te 
kunnen manipuleren, we hebben het ook geprobeerd zonder…), dat was niet de beste start. 
Laurence, voor jou wel een dikke merci. Door jouw hulp kon ik eindelijk aan de slag met de 
NCTC 8266 stam. Vanaf toen raasde de roller coaster even de lucht in. Een paar weken 
voordien stonden Koen en ik in Bocholt nog in het slib van een vijver op zoek naar C. botulinum 
sporen (ja ja, eigen isolatie is ook een plan geweest).  
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Het was niet eenvoudig om alles van nul op te starten. Welke media, welke protocols, welke 
materialen, zuurstofproblemen, alles was anders dan wat de rest in het labo deed. Tijdens de 
eerste maanden dat ik werkte met de toxische stammen ben ik ook verschillende keren bang 
geweest omdat ik dacht symptomen van verlamming op te merken. Maar het onderzoek ging 
toch -al was het aan een slakkentempo- vooruit, gelukkig zonder botulisme. Mijn grote doel 
was een atoxigene mutant te maken, en ik had de eerste jaren nooit verwacht dat ik verder 
zou geraken dan dat. Met een tevreden gevoel kan ik nu terugblikken op de bekomen 
resultaten, en ben ik gerustgesteld dat het onderzoek zal worden verdergezet (go go go 
Aurélie!). Ik ben nu wél een grote fan van sporenonderzoek, “mijn Botje” zal mij zonder twijfel 
voor altijd bijblijven, net als de mensen uit mijn omgeving.  
Chris, dankuwel om in mij te geloven en dit onderzoek aan mij toe te vertrouwen. Je liet me 
mijn eigen ding doen, en stuurde bij waar nodig. Als ik ’s morgens in de kast naar mijn platen 
stond te kijken en jij meteen bij aankomst kwam vragen naar nieuwe resultaten, moest ik vaak 
zeggen “hmm, dit ziet er weer wat raar uit”. Dat vond ik niet altijd plezant, maar ik was wel 
dankbaar voor je interesse in de voortgang van het onderzoek. Merci dat ik steeds mijn eigen 
mening mocht hebben, om naar mij te luisteren, en om mijn doctoraat en publicaties naar een 
hoger niveau te tillen. Ik denk dat wij op een aantal vlakken echte tegenpolen zijn, maar dat 
betekent dus niet dat je niet kan samenwerken. In tegendeel, dat ging heel goed. Tot slot, het 
meest van al ben ik u dankbaar dat ik naar Interagency Botulism Research Coordinating 
Committee mocht gaan in Frederick, Maryland. Dat was een ongelooflijke ervaring voor mij. 
Danku!   
Abram, als studente leerde ik u kennen bij het vak “Toepassingsdomeinen: micro-
organismen”, en ik vond u de meest interessante prof uit mijn masterjaren. Als copromotor 
van Joleen vond ik u al minder leuk want jij was degene die alle goede resultaten zwaar in 
twijfel trok. Als copromotor van mijzelf vond ik u de ideale persoon. Ik ben blij dat ik jouw 
oneindige passie voor onderzoek, en de meest zotte ideeën die daarbij horen, van dichtbij (maar 
toch op voldoende afstand) heb mogen meemaken. Bedankt om regelmatig te vragen naar mijn 
onderzoek, en bepaalde experimenten voor te stellen of in twijfel te trekken. Ik heb veel van u 
geleerd en uw werkmethodes hebben bijgedragen aan mijn manier van onderzoeken en 
kritisch nadenken. 
Naast de hulp van de proffen, maakte ik dit doctoraat niet alleen. Een welgemeende dankuwel 
aan Bram Van den Bergh en Cédric Lood voor de genoomanalyses, aan Laurence Delbrassinne 
voor de muizentesten en aan Yves Briers en Rob Lavigne voor de begeleiding bij en het 
gebruik van de supercomputer bij GenTech. Ook mijn thesisstudenten Veerle en Bénine 
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verdienen een dikke merci voor hun harde werk en fijne samenwerking. Lut en Katrien, jullie 
zijn twee absolute toppers. Danku voor alle praktische hulp en de aangename babbels. 
Je collega’s, die kies je niet… maar het voelde als een voorrecht om hun te leren kennen. Zij 
speelden een hoofdrol in mijn avontuur, en maakten van deze doctoraatsbeleving een mooi 
verhaal om op terug te kijken.   
De grootste kanjer en degene die mij er al- al- altijd doorsleurde als ik zei dat ik dit onderzoek 
niet van de grond zou krijgen, is Kristof. Niet enkel de laborant van het labo, maar in mijn 
ogen het fundament dat alles recht houdt. Zonder hem is ons labo gewoon pure chaos. En voor 
mij was je nog veel meer. In de eerste plaats was je een ijzersterke hulp om het C. botulinum 
onderzoek opgestart te krijgen (zonder jou zou ik nu nog altijd met anaerobe zakskes aan het 
werken zijn), en daardoor werden we al snel échte buddies, met een officiële start in Melle. Ik 
heb mij super goed geamuseerd met u, maar daarnaast stond je ook te allen tijde voor mij 
klaar, je luisterde naar mij, je begreep mij, je wou altijd helpen. Met uw (zeer aanwezige) 
humor zorgde je voor groot vermaak op het labo en bij elke LMM uitstap. Ik denk dat ik toch 
wel de meeste mopkes/plagerijen van u te incasseren kreeg (als Gil dan ook nog in de buurt 
was, kregen die mopkes een heel specifiek karakter), maar die probeerde ik zoveel mogelijk 
terug te kaatsen. We hebben vaak hard gelachen en als we samen in het labo waren, was het 
leute gegarandeerd (ik had de beste plek in ’t labo, tegenover u!), maar ook de minder fijne 
dagen werden beter als jij er was. Ik heb echt zóveel aan u gehad, dat ik het niet kan 
neerschrijven. Wij zijn vrienden voor altijd. Bedankt voor alles Kristof. 
Een tweede reden dat ik mijn plek in het labo de beste vond, is door die wittekop die langs mij 
zat. Als masterstudente leerde ik u kennen doordat ik af en toe bij LMM passeerde om te 
replica platen, en onze relatie bestond destijds uit twee zinnen: elke week opnieuw vroeg ik 
“Straks Ethiek?”, waarop jij elke week opnieuw lachend (of geërgerd?) antwoordde “Neeheee 
ik volg dat vak niet”. Wie had toen gedacht dat wij zo’n goede vrienden zouden worden als 
we nu zijn. “Peppi & Kokki” heeft iemand ons ooit genoemd, en terecht… Wij begonnen samen 
aan ons doctoraat (waarbij we twee keer faalden op het IWT), deelden een bureau, deelden 
een bench, wij waren de practicumbegeleiding, we pikten een etentje mee in de top van het 
Atomium, we deden samen een tripke naar Dublin (goeie Guinness daar in ’t zonneke, en 
Marcel zijn hemden hoop ik ook nooit te vergeten)… We hebben heel vaak gelachen tijdens 
het labowerk, en als jij niet in het labo was, miste ik u langs mij. Goede liedjes werden meteen 
luid gezet waarbij er dan wel eens gelachen werd met mijn danskes, en nog grappiger waren 
de vele keren dat ik iets schaamtelijk deed, en dan bleek dat Chris net was binnengekomen en 
achter mij stond. Het practicum geven met u was als een warm mes door de boter (een 
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spreekwoord van mij, kijk eens aan ;)), wij waren een topteam! Het was echt super om alles 
samen door te maken met u, van begin tot eind, en nu allebei op naar het volgende… Ik wens 
u het allerbeste toe, met uw volgende job, met Jitka, met de sport. Het waren geweldige jaren, 
en daar was jij de grootste bijdrage aan. 
Een andere topkerel in de hoofdrol, is meneer Alexander Cambré. En die titel mag ervoor 
want ik vind u echt een grote meneer. Doordat we samen gethesist hadden, -dacht- ik u al te 
kennen bij de start van ons doctoraat, maar ik had het mis. Ik wist toen nog niet dat ik zoveel 
aan u zou hebben, en zeker niet dat ik -u- zo graag zou hebben. Ik wil u bedanken voor de vele 
raad die ik van u heb gekregen in het labo (Cambré weet áltijd raad), en de veeele hulp met de 
microscoop, maar bovenal ben ik dankbaar dat wij vrienden zijn geworden. Onze meningen of 
ideeën zijn misschien niet altijd dezelfde, maar ik hou van uw eerlijkheid, en ik kon voor een 
goed gesprek altijd bij u terecht. Alex, jij hebt een groot hart en bent een super gezellig 
persoon, waar ik hoop nog mijn leven lang hapje-tapjes mee te mogen doen. Daarom zeg ik 
nu geen succes voor alles wat nog gaat komen, want ik hoop dat geregeld in real life te kunnen 
doen. 
Zoals hierboven al vermeld, ik werd gerustgesteld dat het C. botulinum onderzoek werd 
verdergezet. En dat is volledig te danken aan Aurélie. Ik was zo blij dat ik in mijn laatste jaar 
niet meer op mijn eentje moest verder -potteren- en dat ik al mijn kennis over Botje op tijd 
kon doorgeven aan jou. Het is een zeldzaamheid hoe goed wij overweg kunnen met elkaar, 
niet alleen werkgerelateerd, maar op heel veel gebieden zijn we a perfect match. Heel erg 
bedankt voor alle hulp in het labo met experimenten te herhalen, resultaten te checken in de 
weekends, stockplaten te maken, er was nooit iets teveel gevraagd. Ook een dikke merci om 
zo gemotiveerd mee te helpen aan het practicum in het jaar dat Gil en ik bezig waren met de 
finalisatie van ons doctoraat. Zonder jou was het een hel geweest om dat te combineren, maar 
jij maakte het ons erg gemakkelijk. Bedankt voor alle babbels en de fijne terrasjes na het werk. 
Als jij de LMM groep niet had vergezeld, was het maar een sober laatste jaar geweest. Super 
veel succes de komende jaren, gewoon doorzetten en dan geloof ik dat je dat uitstekend gaat 
doen! Ik kijk nu al uit naar jouw verdediging. 
Hyacintha, ook jij was voor mij een grote meerwaarde aan de LMM sfeer. Een meid die niet 
op haar mondje gevallen is, dat heb ik graag. Ik vind het knap hoe jij in het leven staat, en 
sterk wat je allemaal doet. We zijn snel vriendinnen geworden en ik hoop dat we dat altijd 
zullen blijven (ondanks de niet zo kleine afstand Bocholt-Gent). Bedankt voor alle hulp in het 
labo!   
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De heren William, Johan en Sander zijn al een tijdje weg, maar desalniettemin spelen ook zij 
een grote rol in dit verhaal. Door hun vertrek veranderde de LMM groep sterk en de 
achterblijvers hebben nog vaak over de fijne herinneringen met hun gesproken. Het zijn alle 
drie toppers die mij hielpen waar nodig, die de werksfeer leuker maakten, en die ik mis 
aangezien ze alle drie andere oorden hebben opgezocht. Ik hoop dat ik hun, op LMM reünies 
waar ik bij deze voor pleit, nog vaker ga zien. 
Andere collega’s die een bijdrage hebben geleverd aan deze ervaring; Julie en Bram: Het was 
gezellig met jullie als bureau- en practicumvriendjes, danku om Gil en mij zo goed op te 
vangen. Angela: You made the lab a better place, I liked your jokes, your good spirit, you 
strolling by saying ‘Hi Charlene’. I respect your hard work and your always happy mood. 
Thank you for all your kindness. Oscar: Man, you’re funny. I’m glad I got to know you better, 
because at first I thought ‘he’s weeeird’, but now I know you’re really a wonderful person. 
Sanne: ik vind u een super plezante madam! Fijn dat jij er bij bent gekomen, jij maakte de after 
work terrasjes alleen maar leuker (lees: grappiger). Ines: Misschien iets minder terrasjes 
gedaan met jou, maar wel een heel vrolijke ‘goeiemoooorgen’ erbij in het labo, en dat is goud 
waard. Voor jou ook een welgemeende dankuwel voor alle hulp met de microscoop. Elisa and 
Wubishet: Although we’re maybe not so close friends, I really respect what you do since it 
must be hard being away from home, friends and family. You are both nice people and I wish 
you all the best with work and in life. Tom: You’re a great guy and a wonderful colleague, and 
I think it’s a bit sad that you joined the team only recently because I’d have liked to get to 
know you better. Good luck with everything! 
Voila, allemaal kanjers dus, waardoor alle mislukte experimenten snel goedgemaakt werden 
en waardoor ik geen één dag met tegenzin ben gaan werken. 
Maar de grootste dank gaat uit naar mijn mama, want zonder haar hulp en steun, was dit 
doctoraat niet eens een optie geweest. Mama, ik sta waar ik sta en ik ben wie ik ben, doordat 
ik van jou alle mogelijkheden heb gekregen. Dankuwel om altijd zo geïnteresseerd te zijn in 
mijn studies en in mijn doctoraat, om steevast trots te zijn, om mij aan te moedigen en mij 
gerust te stellen en om altijd met raad en daad klaar te staan. 
Om dit voorwoord af te sluiten, een laatste woordje van dank voor mijne grote schat. Koen, 
dankuwel om de stresskip in mij af en toe te kalmeren en om te allen tijde in mij te geloven. 
De wetenschap is misschien een -ver van uw bed show-, maar toch heb je altijd interesse in 
wat ik doe. Jij bent voor mijn doctoraat van Bocholt naar Leuven verhuisd, wat mijn 
(weekend)werk en de after work terrasjes erg gemakkelijk maakte. Een hele grote dankuwel 
voor alles wat je voor mij doet. 
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Samenvatting 
Clostridium botulinum is een strikt anaerobe sporenvormende bacterie, en produceert het meest 
dodelijke toxine dat tot op heden gekend is, het botulinum neurotoxine (BoNT). Voedsel dat 
besmet is met (sporen van) deze pathogeen, kan daarom een groot gevaar vormen voor mens 
en dier. Bacteriële sporen zijn resistente structuren die zich in een metabolisch inactieve staat 
bevinden waardoor ze weerstandig zijn tegen allerlei stressfactoren zoals verhoogde 
temperatuur, droogte, gebrek aan nutriënten, UV, chemicaliën en zuurstof. Wanneer de 
condities gunstig zijn, kunnen zij uitgroeien tot vegetatieve cellen hetgeen gepaard gaat met 
toxineproductie. Vermits sporen een complex kiemingsproces moeten doorlopen vooraleer 
vegetatieve groei mogelijk is, is het in principe mogelijk om uitgroei en toxineproductie te 
voorkomen wanneer men sporenkieming kan verhinderen. Nochtans is het kiemingsproces 
van C. botulinum sporen nog maar zeer beperkt ontrafeld, voornamelijk omdat onderzoek met 
deze bacterie wordt bemoeilijkt door risico’s met betrekking tot bioveiligheid en 
bioterrorisme, en omdat strikt anaerobe werkomstandigheden noodzakelijk zijn om de 
bacterie te manipuleren. In deze doctoraatsthesis werd gefocust op psychrotrofe groep II C. 
botulinum (gIICb), een belangrijke doelwitpathogeen in minimaal behandelde gekoelde kant-
en-klare voedingsmiddelen met een lange houdbaarheid.   
Om bioveiligheidsredenen werden eerst niet-toxigene mutanten geconstrueerd om het 
onderzoek naar het kiemingsproces te vergemakkelijken. Hiervoor werd een nieuwe 
deletiestrategie ontwikkeld waarmee vervolgens een ∆bontE mutant van C. botulinum NCTC 
11219 werd verwezenlijkt. Het betreft de allereerste constructie van een deletiemutant in 
gIICb, een species groep die genetisch zeer moeilijk te manipuleren is en waarvoor de 
genetische toolbox nog zeer gelimiteerd is. Daarnaast werd ook een bontE insertiemutant 
gecreeërd in dezelfde parentale stam, via het ClosTron systeem. De groei- en 
sporulatiekarakteristieken alsook de hitteresistentie van de sporen van beide mutanten bleken 
grotendeels identiek te zijn aan de wildtype stam. Echter, ook enkele fenotypische verschillen 
werden waargenomen, en deze werden toegeschreven aan bijkomstige mutaties die 
geïdentificeerd werden via whole genome sequentieanalyse. Daarnaast kon uitgesloten worden 
dat de fenotypische verschillen gerelateerd zijn met de uitschakeling van BoNT-productie, 
doordat dezelfde atoxigene mutanten (via deletie en insertie) werden aangemaakt in een 
andere C. botulinum stam (NCTC 8266). Deze mutanten vertoonden geen verschil met de 
parentale stam, behalve een groeidefect bij verlaagde temperatuur voor de ClosTron mutant. 
De deletiemutanten van beide stammen bieden interessante perspectieven als veilige 
surrogaatorganismen voor gIICb in challenge testing van voedingsmiddelen.  
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In een tweede onderdeel van dit doctoraatsonderzoek, werd de sporenkieming in meer detail 
onderzocht. Hiervoor werd eerst het kiemingsinducered effect getest van het nutriëntmengsel 
L-alanine/L-lactaat/NaHCO3, hoge-druk-behandeling, calciumdipicolinaat (Ca2+-DPA) en 
dodecylamine. Op basis van het verlies van hitteresistentie en de vrijzetting van DPA werd 
geconcludeerd dat enkel de nutriënten en het surfactant dodecylamine sporenkieming 
induceerden. Dodecylamine-gekiemde sporen behielden echter hun refractiliteit in 
fasecontrastmicroscopie, hetgeen betekent dat ze geen water hebben opgenomen. Deze sporen 
waren ook enkel hittegevoelig in aanwezigheid van dodecylamine, en niet meer wanneer 
dodecylamine eerst werd weggewassen. Dit wijst er op dat dodecylamine geen echte kieming 
induceert. 
Vervolgens werd het kiemingsinhiberend effect van vier natuurlijke antimicrobiële 
componenten (carvacrol, kaneelaldehyde, essentiële olie van wortelzaad en hop β-zuren) 
onderzocht. Hoewel natuurlijke componenten voornamelijk bestudeerd zijn voor hun groei-
inhiberend effect, kan kiemingsinhibitie ook een bijdrage leveren tot de controle van 
sporenvormende bacteriën in voedingsmiddelen. De resultaten toonden dat de minimale 
concentratie nodig voor een significante vermindering van nutriëntkieming, vele malen lager 
ligt dan de minimale inhibitorische concentratie (MIC) op vegetatieve cellen voor carvacrol, 
kaneelaldehyde en essentiële olie van wortelzaad. Omdat relatief lage smaak- en geur-
grenswaarden de applicatie van deze componenten in voeding vaak in de weg staan, zouden 
lagere concentraties dus mogelijk effectief kunnen zijn om gIICb sporenkieming te 
controleren. 
In een meer mechanistisch gericht gedeelte, werden via deletieanalyse specifieke genen 
onderzocht die voorspeld worden een rol te spelen in het kiemingsproces van gIICb. De 
aanwezigheid van slechts één Ger-type germinant receptor, GerX3b, in gIICb stammen is 
atypisch omdat andere sporenvormers doorgaans meerdere dergelijke receptoren hebben. Het 
is bovendien intrigerend, omdat onduidelijk is hoe één receptor kan reageren met de vele 
verschillende nutriënten die kieming van gIICb sporen kunnen induceren. De gerBAC 
gencluster, die codeert voor de drie subeenheden van de GerX3b receptor, kon succesvol 
worden gedeleteerd. Kiemingsexperimenten met deze deletiemutant toonden aan dat de 
GerX3b receptor geen rol speelt in kieming geïnduceerd door verschillende nutriëntmengsels. 
Verder werd getracht twee voorspelde cortex hydrolasen, SleB and SleC, uit te schakelen met 
dezelfde deletiestrategie. Enkel voor SleB was dit succesvol. Sporen zonder SleB bleken nog 
steeds in staat om te kiemen, waaruit geconcludeerd kan worden dat dit enzym niet essentieel 
is om de cortex te hydrolyseren, zoals eerder voor SleB van C. difficile werd gerapporteerd. 
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Een beperkte rol in sporenkieming kan echter niet worden uitgesloten omdat de 
kiemingsexperimenten een grote variabiliteit vertoonden. 
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Summary 
Clostridium botulinum is a strictly anaerobic spore-forming bacterium, and produces the most 
deadly toxin known, the botulinum neurotoxin (BoNT). Therefore, food contaminated with 
(spores of) this pathogen constitutes an important threat to humans and animals. Bacterial 
spores are highly resistant dormant structures that are resilient against many hostile 
conditions like heat, dryness, lack of nutrients, UV, chemicals and oxygen. When conditions 
become favorable, they can grow out and resume vegetative growth, which is accompanied 
with toxin production. Since spores first have to complete a complex cascade of events 
designated as germination, before they can grow out, outgrowth and toxin production can in 
principle be prevented by inhibition of germination. However, the germination mechanism of 
C. botulinum spores has only been unraveled in very little detail, mainly due to biosafety and 
bioterrorism restrictions and because a strict anaerobic environment is required to grow the 
pathogen. In this PhD thesis, we focused on psychrotrophic group II C. botulinum (gIICb), the 
major pathogen of concern in minimally processed chilled ready-to-eat foods with extended 
shelf life. 
Due to biosafety reasons, nontoxigenic mutants were first constructed to facilitate the 
research on the germination mechanism. To this end, a novel deletion strategy was developed 
and used to create a ∆bontE mutant in C. botulinum NCTC 11219. This was the first report of 
a deletion mutant in gIICb, a species group that is known to be less genetically tractable than 
other clostridia, and for which the genetic toolbox is still very limited. In addition, a bontE 
insertional knockout mutant was created by the ClosTron system. While most characteristics 
of the mutants showed to be identical to the parental strain, also some differences were noted. 
Presumably, these changes are due to some spontaneous mutations that were identified by 
whole genome sequence analysis. It could be excluded that the changed properties are 
associated with BoNT inactivation, since the same atoxigenic mutants were constructed (by 
insertion and deletion) in a different parental strain (NCTC 8266) and these did not show any 
altered properties, except for a growth defect at lowered temperatures for the ClosTron 
mutant. The deletion mutants of these two strains offer safe surrogate organisms for gIICb in 
challenge testing of foods.  
In a second part of this PhD research, the spore germination process was investigated. First, 
the ability to induce germination of the nutrient mixture L-alanine/L-lactate/NaHCO3, high 
pressure treatment, calcium dipicolinic acid (Ca2+-DPA) and dodecylamine was assessed. 
Based on the loss of heat resistance and the release of DPA, it was concluded that only the 
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nutrient mixture and the surfactant dodecylamine could induce germination. However, 
dodecylamine germinated spores did not loose their refractility in phase-contrast microscopy, 
indicating that they had not rehydrated. In addition, these spores only became heat sensitive 
when dodecylamine was present, whereas they remained resistant when dodecylamine was 
washed away before the heat treatment. This suggests that dodecylamine does not induce 
genuine germination.  
Furthermore, four natural antimicrobial compounds (carvacrol, cinnamaldehyde, carrot seed 
essential oil and hop β-acids) were tested for their inhibitory action on germination. Although 
these compounds have mainly been studied for their growth inhibiting action, the inhibition 
of spore germination could also contribute to the control of spore-formers in foods. The 
results demonstrated that the minimal concentration of carvacrol, cinnamaldehyde and carrot 
seed essential oil that could significantly reduce nutrient germination, was many times lower 
than the minimal inhibitory concentration (MIC) on vegetative growth. This could be of 
interest because the low sensory- and odor thresholds often interfere with the application of 
these compounds in foods.  
In a more mechanistically oriented part, specific genes that are predicted to encode proteins 
involved in germination of gIICb, were investigated via deletion analysis. The presence of 
only one Ger-type germinant receptor, GerX3b, in these strains is unusual because other 
spore-formers generally contain more receptors. Moreover it is intriguing, because it is 
unclear how a single receptor can respond to the many different nutrients that can induce 
germination in gIICb. The gerBAC gene cluster, encoding the three subunits of the GerX3b 
receptor, was successfully deleted. Germination experiments with this mutant showed that 
the GerX3b receptor is not involved in germination induced by different nutrient mixtures.  
Furthermore, two predicted cortex hydrolases, SleB and SleC, were investigated via the same 
knockout strategy, but a deletion mutant could only be successfully created for SleB. Because 
spores lacking SleB could still complete cortex hydrolysis, it was concluded that SleB is not 
an essential cortex hydrolase in gIICb, similar to what has been reported for SleB of C. difficile. 
Nevertheless, an auxiliary role in other germination events can not be excluded since the 
germination assays showed a large variability.  
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1.1 Historical overview, from sausage poisoning to foodborne botulism 
In 1895, an outbreak of what was then called “sausage poisoning” occurred in the small 
Belgian village Ellezelles 1,2. Thirteen persons became poisoned after eating a meal with 
pickled and smoked ham, and three of them died. After examination of the food and the victims, 
Emile Van Ermengem, a microbiologist at the University of Ghent, isolated the strictly 
anaerobic microorganism causing the illness and named it Bacillus botulinus. Sausage 
poisoning, also named ‘botulism’ after the Latin word botulus (sausage), was a known disease 
at that time, described in detail by Kerner (1786-1862). This German physician made several 
important observations about the poison: it was commonly found in spoiled sausages where it 
develops under anaerobic conditions, it interrupts motor neuron signal transmission in the 
peripheral and autonomic nervous systems, and is lethal in small doses. He also accurately 
described the symptoms, which include vomiting, intestinal spasms, mydriasis, ptosis, 
dysphagia and respiratory failure. Interestingly, Kerner speculated about the use of small 
doses of the poison as a therapeutic treatment for hyperexcitability of the nervous system, an 
application that has been developed about a century later. 
After Van Ermengem’s discovery, the botulinum toxin producing pathogen could be linked to 
more foodborne intoxications, and it was discovered that different strains could produce 
serologically distinct variants of the toxin (further discussed in 1.2). 
1.2 The botulinum neurotoxin (BoNT) 
The botulinum neurotoxin (BoNT) is produced by Clostridium (C.) botulinum, and also by some 
strains of C. baratii, C. butyricum and C. argentinense as a single inactive polypeptide chain of 
150 kDa. The protein is activated by a specific proteolytic cleavage within a surface-exposed 
loop subtended by a disulfide bridge. The active neurotoxin thus consists of a heavy chain 
(100 kDa) and a light chain (50 kDa) which remain associated via protein-protein interactions 
and covalently bound by the interchain S-S bond. Until exposed to reducing conditions, such 
as in the neuronal cytosol, the two chains remain linked 3,4. 
The heavy chain comprises a receptor-binding and a translocation domain, by which the toxin 
binds to high-affinity receptors on peripheral nerve endings and translocates by endocytosis 
to its cytosolic target, respectively (Fig. 1.1). Further, it is believed that the heavy chain 
subsequently mediates translocation of the light chain from the endosomes into the cytosol, 
where it acts as a zinc endopeptidase that cleaves SNARE proteins (soluble N-ethylmaleimide-
sensitive factor attachment protein receptor). A thioredoxin reductase-thioredoxin system in 
the cytosol is responsible for cleavage of the BoNT disulfide bond, enabling toxicity of the 
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light chain 5. The SNAREs form a complex which mediates the fusion of neurotransmitter-
containing vesicles to the neuron’s presynaptic membrane (Fig. 1.1 A). When the BoNT light 
chain cleaves these SNAREs, no neurotransmitter can be released, resulting in muscle 
paralysis (Fig. 1.1 B) 3,6. To date, seven serotypically distinct BoNTs (type A-G) which cleave 
different SNARE proteins have been identified: BoNT/A and E cleave synaptosome-
associated protein (SNAP-25), BoNT/B, D, F and G cleave vesicle-associated membrane 
protein (VAMP), also known as synaptobrevin. BoNT/C is unique because it is able to cleave 
both SNAP-25 and syntaxin, a target membrane protein. The amino acid sequences of the 
seven toxin serotypes differ by 35 to 70 % 7,8.  
 
Fig. 1.1 : The mode of action of BoNT. A) In case of normal neurotransmitter release, SNAREs enable vesicles 
containing acetylcholine to dock to the neuron’s presynaptic membrane. B) When BoNT reaches the high -affinity 
receptors on the peripheral nerve endings, the heavy chain ensures translocation of the toxin by endocytosis,  
whereafter translocation of the light chain into the cytosol occurs. In the neuronal cytosol, the light chain acts 
as a zinc endopeptidase that cleaves the SNAREs. Consequently, acetylcholine-containing vesicles can no longer 
dock to the membrane, resulting in muscle paralysis. Source: 8 
The seven serotypes are further subdivided in forty subtypes in which amino acid differences 
may be minor (1–7 % difference among type B) or major (3–36 % among type F) 9. BoNT/C 
and D are closely related, as are types B and G, and E and F. Some C. botulinum strains produce 
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more than one serotype, i.e. type A together with type b, A with f, B with a, or B with f, where 
capitalized letters refer to the predominant toxin type. Several C. botulinum strains producing 
type A toxin have been found to also encode a silent bont/B gene that does not express active 
toxin due to mutation or truncation. They are denoted A(B) 10. In 2013, a C. botulinum strain 
with three bont gene clusters (subtypes A2, F4 and F5) was reported 11, but this remains 
exceptional. Also mosaic toxins have been described, for example BoNT/DC which comprises 
a light chain of serotype D and a heavy chain of serotype C, or BoNT/CD with the converse 
configuration. Recently a novel BoNT serotype was reported, designated BoNT/H, and this 
was the first new toxin type since the discovery of type G about forty years ago. However, a 
genetic comparison with known bont sequences suggested that the gene is a hybrid containing 
regions of BoNT/A1 and BoNT/F5, and the toxin was correspondingly renamed mosaic 
BoNT/FA 12. 
In all botulinum producing clostridia, the bont gene is located in a 12-15 kb gene cluster where 
it is preceded by a set of accessory genes. In some strains the cluster is located on a plasmid 
or on a prophage. Two primary cluster types are identified: a hemagglutinin (ha) cluster and 
an orfX cluster (Fig. 1.2). The type B, C, D and G bont genes are organized in a ha cluster, 
whereas the type E and F genes are in an orfX cluster. Only bont/A can occur in either type of 
arrangement 13–15. The ha cluster comprises two transcriptional units. One unit encoding a 
transcriptional activator (botR), non-toxic-non-hemagglutinin (ntnh) and the bont neurotoxin 
gene. The second unit, transcribed in the opposite direction, encodes three ha genes ha33, ha17 
and ha70, named according to the molecular weight in kDa of their protein products. BotR 
drives transcription of both the ntnh-bont and ha operons, but cannot promote transcription of 
the individual genes 16. The orfX cluster has a somewhat similar organization: one 
transcriptional unit encodes the gene p47 of unknown function, ntnh and bont, and the second 
unit consists of three open reading frames of unknown function, orfX1, orfX2 and orfX3, but 
lacks the ha genes. Interestingly, the orfX cluster of all bont/E subtypes, as well as of bont/F6 
and bont/F7 lacks the botR gene and, based on the available genome sequences, botR is absent 
from their whole genomes. It is not known how BoNT expression is regulated in these types 
nor if p47 might play a role in regulation. The intergenic regions of some orfX clusters also 
contain insertion elements.   
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Fig. 1.2: Schematic overview of different BoNT gene clusters. Two main types have been described: a 
hemagglutinin (ha) cluster is present in type A1, A5, B, C, D and G producing strains, whereas an orfX cluster is 
present in type A1-4, E and F producing strains. Varying gene arrangements per cluster are shown and the 
presence of insertion elements (is’) is indicated. ha33, ha17 and ha70 are shown as ha1, ha2 and ha3. bont/A is 
encoded in either type of cluster, due to a horizontal recombination of ntnh + bont/A within the bont/B cluster.  
Groups I-IV represent C. botulinum, group V represents C. baratii and group VI represents C. butyricum. Adapted 
from 17 
1.3 Regulation of bont expression 
It has been observed that botR/A (i.e. the botR gene in BoNT/A producing strains) is 
expressed together with bont/A, ntnh and ha predominately during the transition from the 
exponential to the stationary growth phase 18. botR/A acts as a specific alternative sigma factor 
that activates the two operon promotors in the bont/A gene cluster upon association with RNA 
polymerase core enzyme 16. BotR/A seems to be related to a new subgroup of the sigma-70 
family, that also includes TetR, TcdR and UviA, which respectively regulate production of 
tetanus neurotoxin in C. tetani, toxins A and B in C. difficile and the bacteriocin BCN5 in C. 
perfringens 16. Moreover, Marvaud et al. (1998) showed that BotR/A and BotR/C can 
functionally regulate in vivo expression of the tetanus neurotoxin gene tetX in C. tetani 19. 
Therefore it has been proposed that this new group of alternative sigma factors mediate toxin 
and bacteriocin production in several pathogenic clostridia via a common mechanism. In 
addition, three two-component regulatory systems (TCSs) positively control the expression 
of bont/A, ntnh and the ha genes, and one additional TCS negatively regulates expression of 
these genes in the model strain C. botulinum Hall A 20,21. Furthermore, BoNT production is 
regulated by quorum sensing. Quorum sensing accessory gene regulator (Agr) systems 
regulate bacterial cell density by measuring the concentration of small autoinducers. In ten C. 
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botulinum (group I) genomes two agr loci were identified, agr-1 and agr-2. Both were 
maximally expressed during the late exponential phase. While agr-1 seems to control 
sporulation, agr-2 is proposed to regulate BoNT production 22. In addition, there may also be 
a link between sporulation and toxin production, since insertional inactivation of Spo0A, 
which is the master regulator in sporulation (further discussed in 2.1.1), resulted in reduced 
synthesis of BoNT in three type E strains besides loss of sporulation 23. Furthermore, Zhang 
et al. (2014) demonstrated that also CodY positively regulates the ntnh-bont transcript and 
BoNT production in C. botulinum Hall A 24. CodY is conserved amongst the Firmicutes and 
controls more than hundred genes in B. subtilis by sensing levels of GTP and branched-chain 
amino acids 25–27, and it determines the cell to adapt during transition of exponential growth 
to stationary phase. In addition, CodY controls virulence gene expression in C. difficile, C. 
perfringens, B. cereus, Listeria monocytogenes etc. 28–31. CodY-dependent regulation of BoNT 
production was GTP-dependent, suggesting that it is associated with nutritional status 24. 
1.4 The BoNT accessory proteins  
BoNT associates with NTNH in a 1:1 molecular stoichiometry to form a noncovalent 
BoNT/NTNH complex. Furthermore, in the strains that contain the ha-type neurotoxin 
cluster, three HA-70, three HA-17, and six HA-33 molecules associate with this complex. 
Together they form the progenitor toxin complex (PTC), which is the largest bacterial toxin 
complex known.  
After oral ingestion, NTNH protects BoNT against acid and proteolytic degradation in the 
gastrointestinal tract of animals and humans. In vitro studies showed that free BoNT is much 
more easily detoxified by pepsin, pancreatin, and by gastric and intestinal juices 32,33. As a 
result, without formation of the complex, the oral lethal dose of free BoNT/A is about ten- to 
hundredfold higher 32,34,35. Protection is accomplished because of NTNH’s similar crystal 
structure to BoNT, which enables the formation of a tight NTNH/BoNT complex in which a 
large surface area is buried 36. Acidic conditions are essential to achieve this mutual fit, because 
acidity induces a specific conformation in NTNH. Moreover, specific pH-sensing residues on 
both proteins allow electrostatic interactions that strengthen the complex. After passage of 
the stomach, the toxin has to transfer through the intestinal wall to reach circulation. It has 
been shown that the HAs facilitate transcytosis of BoNT across this barrier by interacting 
with the epithelial cells 37,38. Without the HA complex, NTNH/BoNT is also capable of 
transcytosis, but less efficiently, and thus resulting in lower oral toxicity 32. The HA complex 
is believed to anchor the PTC to the intestinal wall by interacting with highly glycosylated 
proteins on the epithelial cell surface, using multiple carbohydrate-binding sites. This model 
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is supported by the observation from mouse oral toxicity assays showing that carbohydrate 
receptor mimics extended the survival of the mice after intake of a lethal BoNT/A dose 39. 
Additionally, a PTC that was mutated in carbohydrate binding showed drastically reduced 
oral toxicity 40. Furthermore, the HA-glycan interaction shows some serotype specificity, 
which may contribute to the observed different oral toxicity and host susceptibility among 
different BoNT serotypes 41,42. In mice, the receptor for PCT/A was recently shown to be 
glycoprotein 2 of the microfold (M) cells 38.  
Subsequent to adhesion to the intestinal cells, the complex is transcytosed through the 
epithelial layer. Once the PTC is transported to the basolateral side, the HA complex interacts 
with epithelial cadherin (E-cad) on the basolateral side, resulting in a disrupted barrier which 
enables paracellular influx of PTC 43. The interaction between the HA proteins and E-cad is 
serotype- and species-specific: the HAs of BoNT/A and B bind efficiently to human, bovine, 
or mouse E-cad, but not to chicken E-cad. Conversely, the HA of BoNT/C does not recognize 
human E-cad. This observation correlates well with the finding that human foodborne 
botulism is rarely associated with BoNT/C, but mostly with types A, B, E and F, while avian 
botulism is linked to types A and C, and ruminant botulism to types C and D. However, host 
specificity is probably not only determined by the HA-E-cad interaction, but the additional 
mechanisms are poorly understood.  
After transcytosis, the PTC reaches systemic circulation, where BoNT and NTNH dissociate 
from the complex because the transition from acidic to neutral or alkaline pH causes 
deprotonation of specific sensor residues in BoNT. It is currently investigated whether these 
unique properties of these accessory proteins can be exploited to shield certain therapeutic 
proteins and promote their active uptake during gastrointestinal passage.  44 
Interestingly, the HA genes are absent in BoNT/E, BoNT/F and BoNT/A2 strains. These 
strains contain the orfX cluster, but the expression and function of the OrfX proteins are 
unknown. It has been suggested that their function is similar to the HA proteins because of 
their analogous location and orientation in the genome. However, further studies are definitely 
required to elucidate the intestinal absorption mechanism of these BoNTs.  
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1.5 Botulism 
The BoNT producing clostridia are widespread in soil and sediments of rivers and lakes. 
Moreover, clostridia are sporeforming bacteria, of which the spores can persist for decades. 
Because of the strictly anaerobic metabolism of clostridia, their spores can only grow out to 
vegetative cells and produce toxin in the absence of oxygen. Decomposition of plants, algae, 
invertebrates, and animals creates such anoxic environments. From these niches, outbreaks of 
animal botulism can spread rapidly, leading to the intoxication of thousands of animals in only 
a few days 10. What causes human botulism and how it is treated, is discussed below.  
1.5.1 Different forms of human botulism 
Dormant spores from the environment are unlikely to cause human botulism orally because 
healthy adults and children over one year of age have a mature digestive system that prevents 
the survival of germinated C. botulinum spores, whereas the dormant spores will pass through 
the digestive system. 
Foodborne botulism occurs when food is contaminated with spores that are able to grow out 
and produce toxin in the food, and if the toxin is not inactivated by heat treatment before 
consumption. Woodburn et al. (1979) demonstrated that 105 MLD50 (mouse lethal dose 
causing 50 % mortality) of BoNT type A, B, E and F was reduced to undetectable levels (with 
the mouse bioassay) by heating foods at 79 °C for 20 min, or at 85 °C for 5 min, and suggested 
that these heat treatments could be used as a guideline for safe food preparation 45. 
Additionally, many authors showed that heat denaturation of BoNT is biphasic in time, with 
most activity destroyed rapidly, but with an additional heat resistant fraction (1-5 %) that is 
inactivated more slowly 46. Therefore, the U.S. Center for Disease Control and Prevention 
(CDC) recommends boiling food for 10 min to ensure complete inactivation 47. The most 
common source of foodborne botulism are home-made preserved foods that have not been 
correctly processed or preserved and that are not heat treated before consumption. The first 
signs of botulism appear typically between 12 to 36 hours after toxin ingestion, although the 
onset time can range from a few hours to as late as ten days depending on the dose. Symptoms 
include blurred or double vision, dry mouth, difficulty in swallowing and speaking, drooping 
eyelids, paralysis of face muscles, nausea, vomiting, descending bilateral flaccid paralysis and 
generalized muscle weakness. If left untreated, this may lead to fatal respiratory failure and 
cardiac muscle paralysis 48. It is estimated that as little as 30-100 ng BoNT (3000 MLD50) is 
sufficient to cause foodborne human botulism 49,50.  
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Besides foodborne botulism, where food contaminated with pre-formed toxin is the cause of 
disease, other forms have been described. Infant botulism occurs when clostridial spores are 
ingested and subsequently colonize the gut and release toxin in situ. Particularly infants under 
one year of age are at risk for this form of botulism because they lack a mature gut microbiota 
that can prevent spore germination and outgrowth. Although there are several possible 
sources of infection for infant botulism, spore-contaminated honey has been associated with a 
number of cases 51. The estimated incubation period for development of infant botulism is 
three to thirty days after exposure of spores 52. Typical symptoms are constipation, floppy 
movements due to muscle weakness, weak cry, drooling, drooping eyelids, difficulty feeding, 
and paralysis. The youngest reported victim was only 38 h old at onset of the illness 53.  
Another form of botulism, designated wound botulism, occurs when spores germinate and 
produce toxin in anaerobic zones of wounds or abscesses. This form is primarily associated 
with drug users using injection needles under unhygienic conditions. Symptoms are similar 
to foodborne botulism, but may take up to two weeks to appear.  
Inhalation botulism does not occur naturally and is associated with accidental (e.g. in the 
laboratory) or intentional (e.g. bioterrorism) release of toxin in aerosols. Although the exact 
human lethal inhalation dose has not been quantified, extrapolation from primate studies lead 
to an estimate of ~0.70-0.90 µg purified BoNT/A 8. Contrary to oral poisoning, inhalation 
poisoning does not benefit from the presence of auxiliary proteins.  Transcytosis experiments 
demonstrated that purified BoNT/A is actively transported from the apical to the basolateral 
side of polarized alveolar epithelial cells 54. Following inhalation, symptoms become visible 
between one to three days, with longer onset times for lower levels of toxin. Symptoms 
proceed in a similar manner as described above.  
Finally, some very rare cases of C. botulinum intestinal overgrowth have been reported of in 
adults with surgically altered gastrointestinal tracts. Also, injection-related botulism can 
occur after injection of licensed or unlicensed toxin for therapeutic or cosmotic purposes (such 
as Botox®). An estimated human lethal dose of 0.09-0.15 µg was reported, when crystalline 
BoNT/A was introduced intravenously 8.  
In the U.S., 161 cases of botulism were laboratory-confirmed and reported to CDC in 2014. 
Foodborne botulism accounted for 9 %, infant botulism for 80 %, wound botulism for 10 % of 
the cases, and botulism of unknown or other etiology for 1% 55. In Europe, 133 botulism cases 
including three deaths were reported to the European Centre for Disease Prevention and 
Control (ECDC) in 2015. The average case fatality rate in Europe from 2010 to 2015 was 5.4 
% 56.  
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1.5.2 Treatment 
Early diagnosis of botulism is very important to maximize the chances of complete and fast 
recovery. Administration of antitoxin should not be delayed while awaiting laboratory 
confirmation because the antitoxin does not reverse the disease or the existing paralysis, but 
only halts its progression by binding toxin that is still in the blood circulation. Patients given 
a trivalent antitoxin (towards toxin types A, B, E) within the first 24 hours after symptom 
onset had shorter hospital stays, shorter duration of ventilatory support, and a lower fatality 
rate of 10 % than those given antitoxin more than 24 hours after onset (15 %) or those who 
did not receive antitoxin at all (46 %) 3. Since 2013, a heptavalent (A-G types) equine antitoxin 
was approved by the U.S. Food and Drug Administration (FDA). BabyBIG® is used to treat 
infant botulism, and consists of human-derived neutralizing antibody to A and B type toxins.  
In case of severe botulism accompanied by respiratory failure, the patient requires not only a 
mechanical ventilator but also intensive care for weeks or even months. The paralysis reverses 
only slowly over several weeks because nerve axons have to be regenerated.  
1.5.3 The use and abuse of BoNT  
Despite its extreme lethal potency, BoNT is used in a wide range of therapeutic and cosmetic 
applications. In 1989, Botox® (BoNT/A) was approved by the FDA as an orphan drug for the 
treatment of (i) a disorder in which both eyes do not line up in the same direction (strabismus), 
(ii) hemifacial spasms and (iii) abnormal contraction or twitch of the eyelids. In 2002, approval 
was granted for the cosmetic use of Botox® for temporarily reducing glabeller forehead frown 
lines. The range of applications has further expanded since then, and Botox® has now proven 
valuable in the management of a wide variety of medical conditions, especially strabismus and 
focal dystonias, hemifacial spasm and various spastic movement disorders, headaches, 
hypersalivation, and other chronic conditions that only partially respond to medical 
treatment. The cosmetological applications include correction of lines, creases and wrinkles 
all over the face, chin, neck, and chest to treatment of dermatological conditions such as 
hyperhidrosis. 57 
In Europe, BoNT/A is marketed by another company as well, under the brand name 
Dysport® (Speywood, United Kingdom). One unit of Botox® has a potency that is 
approximately equal to four units of Dysport®. Doses of all commercially available BoNTs 
are expressed in terms of units of biological activity. One unit of toxin corresponds to the 
median intraperitoneal lethal dose (LD50) in female Swiss-Webster mice. 58 
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Due to its high toxicity, BoNT can also be abused as a biological warfare weapon or for 
terrorist attacks. One gram of crystalline toxin, evenly dispersed and inhaled, could 
theoretically kill more than one million people. In reality, technical factors make such even 
dissemination difficult and unpredictable. Attempts have been made to use BoNT as a weapon 
for terrorist attacks at multiple sites in Japan, but they failed, possibly because of faulty 
microbiological techniques or deficient aerosol-generating equipment. Several countries, 
including the US, Russia, Iran, Iraq, North Korea and Syria have developed BoNT weapons 
in the past, and in some countries these programs may still be ongoing.  8 
1.5.4 Laboratory safety  
Despite the high toxicity of BoNT, C. botulinum and other BoNT producing clostridia are 
graded as biosafety class II pathogens in Europe because they are noninvasive and 
noncontagious. Therefore, biosafety level II facilities and trained personnel are a minimum 
requirement. However, activities with high potential for aerosol formation or production of 
large amounts of toxin, require specific biosafety level III working procedures. In addition, 
access to the strains needs to be restricted because of the bioterrorism threat. 59 
1.6 A closer look into the heterogeneous species C. botulinum 
The species C. botulinum is distinguished from other clostridia mainly based on its ability to 
produce BoNT. However, it is a physiologically and genetically heterogeneous species that is 
divided into four distinct groups, designated as groups I-IV. Fig. 1.3 illustrates the genetic 
diversity of the groups in a dendogram generated from 16S rRNA sequences of different 
clostridial species. 
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Fig. 1.3: Relatedness of C. botulinum and some related species in a dendogram based on 16S rRNA sequences. 
Groups I-IV of C. botulinum are indicated, as well as group V C. baratii, and group VI C. butyricum strains. BoNT 
types B and F can either be produced by proteolytic group I as well as nonproteolytic group II strains. The scale 
of 0.03 represents 3 % diversity between sequences. Source: 60    
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Group I strains (gICb), also designated as the proteolytic strains, are mesophilic bacteria with 
an optimum growth temperature of about 37 °C and a minimum growth temperature of 10-
12 °C (Table 1.1). They can grow down to a pH of 4.6 and a water activity of 0.93. gICb strains 
form spores with high heat resistance (D121°C ~ 0.21 min) and are the main target for the 
“botulinum cook”, the process used in canning of low acid foods (121 °C/3 min or equivalen t, 
in order to achieve at least a 12-D reduction). Because of its strong physiological similarity 
and close genetic relationship to gICb, C. sporogenes strain PA 3679 has been widely used as a 
safe surrogate to study the effectiveness of food preservation processes 61,62. Recent 
phylogenetic analysis of whole genomes showed that the two species separate into two 
discrete clades with 93 % average nucleotide identity, supporting their distinction as two 
species 63. Moreover, in the same study it was demonstrated that several BoNT/B producing 
strains, previously classified as gICb, appear more like C. sporogenes strains with an acquired 
bont gene. Similarly, the presence of strains lacking bont genes in the C. botulinum clade 
suggests the possibility that these strains were C. botulinum that have lost their toxin genes 
(which are often located on a plasmid in type B strains) and were therefore characterized as C. 
sporogenes. Furthermore, it was shown recently that C. sporogenes ATCC 15579, which belongs 
to the C. sporogenes clade based on average nucleotide identity, has a different set of germinant 
receptor genes and different germination behavior from C. botulinum ATCC 3502 64. 
Therefore, the use of C. sporogenes as a safe surrogate for gICb may not always be warranted.  
Group II C. botulinum (gIICb) comprises nonproteolytic strains producing toxin types B, E or 
F, which are saccharolytic and psychrotrophic with an optimum growth temperature of 30 °C 
and a minimum growth temperature of 3 °C. Their spores are less heat resistant than those of 
gICb (D82.2°C ~ 2.4 min), even in the presence of lysozyme (D82.2°C ~ 231 min), which strongly 
increases the recovery of survivors of gIICb spores (explained in more detail in 1.7). gIICb 
strains can grow down to pH 5.0 or water activity 0.97 (with NaCl as a solute). In the food 
industry, gIICb is a major concern for the safety of minimally processed chilled ready-to-eat 
foods with an extended shelf life, because spores surviving the mild processing treatments 
may subsequently germinate, grow out and produce toxin during refrigerated storage 65,66. 
The specific proteolytic cleavage that activates BoNT to become toxic is mediated by 
endogenous proteolytic enzymes of gICb strains. On the contrary, this is not the case in 
nonproteolytic gIICb strains, where BoNT needs to be activated by proteolytic enzymes of 
the host or the environment.   
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Table 1.1: Phenotypic characteristics of C. botulinum groups I-IV. +: all strains positive, v: some strains positive, 
-: all strains negative, NR: not reported. 67–70 
 Group I Group II Group III Group IV 
Neurotoxins formed A, B, F a B, E, F C, D G 
Ferment glucose + + + - 
Ferment maltose v + v - 
Ferment fructose v + v - 
Ferment mannose - + + - 
Proteolysis b + - - + 
Lipase production + + + - 
Lecithinase - - - - 
Minimum growth temperature 12 °C 3 °C 15 °C NR 
Optimum growth temperature 37 °C 30 °C 37 °C 37 °C 
Minimum pH for growth 4.6 5 NR NR 
NaCl concentration preventing 
growth 
10 % 5 % NR NR 
Minimum water activity for 
growth with NaCl 
0.94 0.97 NR NR 
 
Minimum water activity for 
growth with glycerol 
0.93 0.94 NR NR 
Spore heat resistance c D121°C = 0.21 min D82.2°C   
= 2.4 min  
= 231 min d 
D104°C  
= 0.1-0.9 min 
D104°C  
= 0.8-1.1 min 
Non-neurotoxigenic 
equivalent clostridia 
C. sporogenes No species 
name 
assigned 
C. novyi,  
C. haemolyticum 
C. subterminale 
 
a More than one toxin type may be formed; b proteolysis denotes an ability to degrade native proteins; c D-value 
in phosphate buffer pH 7; d Decimal reduction time (D-value) without/with lysozyme in recovery medium.  
 
Group III strains produce BoNT/C and /D and are responsible for the majority of botulism 
outbreaks in animals. These strains are mostly nonproteolytic, have an optimal growth 
temperature around 37 °C and a minimum growth temperature of 15 °C. The spores have an 
intermediate heat resistance (D104°C ~ 0.9 min) 59. Studies have shown that group III is 
genetically related to the nontoxic C. novyi and C. haemolyticum (based on 16s rRNA and whole 
genome analysis) 71,72. C. botulinum strains producing type G toxin belong to group IV, 
sometimes designated as a different species, C. argentinense. These strains are proteolytic and 
asaccharolytic and differ from other groups in not producing lipase. They ferment amino acids 
and convert these into organic acids including acetate, butyrate, iso-valerate and 
phenylacetate. C. argentinense grows optimally at 37 °C and their spore heat resistance is 
similar to group III (D104°C ~ 0.8-1.12 min). C. subterminale is the nontoxigenic phenotypic 
counterpart of BoNT/G producing strains.  
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1.7 Control of group II C. botulinum in modern food processing 
The causative agents of human foodborne botulism are gICb and gIICb strains. Since both 
groups have very different properties (Table 1.1), they present different risks in foods. Spores 
of gICb strains have a very high heat resistance and because of the severity of the toxin, they 
are the main safety target for processing of low acid shelf-stable foods. gICb strains are not a 
significant concern in acidic (pH < 4.6) or reduced moisture products (aw < 0.93) because they 
are not able to grow and produce toxin in these conditions. Foodborne botulism cases 
associated with gICb strains are therefore mostly caused by inadequately processed home-
preserved foods, such as cured meat, canned vegetables and fermented fish products. 
Commercial canned products rarely cause botulism because commercial processes are well 
designed to deliver a 12-D reduction of this pathogen, and because the processes are well 
controlled. However, commercial pasteurized low acid products like mascarpone and carrot 
juice have been implicated in botulism outbreaks due to failure to respect proper refrigerated 
storage conditions and/or shelf life. 49,73,74 
As noted earlier, gIICb is a major concern for the safety of refrigerated processed foods of 
extended durability (REPFEDs). Guidelines for control of this hazard in the food industry 
have been developed more than two decades ago, requiring either a 6-D reduction of the spores 
by heat treatment and no possible recontamination, or control of spore outgrowth by 
limitation of the refrigerated storage time to < 10 days, inclusion of ≥ 3.5% NaCl, ≥ 100 ppm 
nitrite, acidifying to pH  5.0, water activity < 0.97, or an appropriate combination of these 
or additional hurdles. Table 1.2 shows examples of foodborne botulism outbreaks due to gIICb 
strains in commercial foods since 1985. It is rare that commercially produced REPFEDs are 
the cause of botulism, but when it happens, it is mostly due to temperature and/or time abuse 
during storage. 75–77 
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Table 1.2: Foodborne botulism cases due to gIICb strains in commercial foods from 1985-2016.  
Country Year Number of 
cases 
(deaths) 
BoNT 
type 
Vehicle food item Reference 
Egypt  1991 91 (18) E Salted mullet fish 78 
Germany 1998 4 E Smoked salmon trouts 79 
Japan 1998 6 B Salted olives www.promedmail.org c 
Russia 1999 72 ND a Fish www.promedmail.org 
Morocco 1999 11 (1) B b Mortadella sausage 80 
Poland 2001 7 ND a Canned fish 81 
Alaska 2002 8 E Whale 82 
France 2003 4 B Beef and poultry 
sausages, 'halal' 
83 
Canada 1985-2005 70 (5) E Seal meat and fat 84 
Canada 1985-2001 19 (3) E Salmon eggs 84 
Switzerland 1993-1994 12 B b Cured ham 85 
U.S.A. 2014 3 (1) E Fermented fish heads www.promedmail.org 
Ukraine 2015 7 (2) ND a Dried fish www.promedmail.org 
Spain and 
Germany 
2016 2 in Spain 
4 in 
Germany 
E Dried salted roach www.promedmail.org 
a ND, no data available ; however, botulism related to fish products is frequently due to BoNT/E. 
b The genetic group of BoNT/B producing C. botulinum was not reported. 
c “ProMED : the Program for Monitoring Emerging Diseases - is an Internet-based reporting system dedicated 
to rapid global dissemination of information on outbreaks of infectious diseases and acute exposures to toxins 
that affect human health.” 
 
To achieve a 6-D reduction, a treatment of 90 °C/10 min or equivalent has been proposed in 
the 1990’s by the Advisory Committee on the Microbiological Safety of Food, and has long 
been widely accepted. In general, spore heat resistance varies considerably depending on the 
spore history, the heating medium and its pH, water activity, protein and fat content, and also 
shows important strain to strain variation. In addition, the presence of lysozyme or related 
enzymes in the food is known to increase the number of heat treated survivors of gIICb spores. 
Without lysozyme in the recovery medium, gIICb spores are rapidly inactivated at 
temperatures above 80 °C, because the cortex hydrolases which are required for spore 
germination are heat sensitive and thus germination and outgrowth is abolished. However, 
when exogenous lysozyme is incorporated in the recovery medium/food, this enzyme can 
substitute the role of the cortex hydrolases, resulting in a much higher fraction of survivors 
at high temperatures. In addition, the existence of a lysozyme-impermeable and -permeable 
fraction in a spore population is well described, and it is estimated that the latter represents 
0.02-3.1% of the spore population 86–88. As a result of this, heat inactivation of gIICb spores in 
the presence of lysozyme typically follows a biphasic course. Wachnicka et al. (2016) recently 
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did a systematic assessment of the heat resistance of gIICb spores based on 753 D-values and 
436 z-values extracted from literature 88. Based on their results, summarized in Fig. 1.4, they 
concluded that the time required for a 6-D reduction in spore load at 90 °C is ~5 min in the 
absence of lysozyme, indicating that the current guidance provides a suitable level of safety. 
However, they additionally concluded that in the presence of lysozyme, ~80 min at 90 °C may 
be required to achieve a 6-D reduction. This study therefore calls for a re-evaluation of the 
existing safety guideline with regard to psychrotrophic C. botulinum. This is particularly 
important in view of the trend towards further reduction of intrinsic hurdles (salt, 
preservatives, pH) while maintaining or increasing shelf life. Furthermore, innovations like 
the use of natural food preservatives and nonthermal processing methods such as high 
pressure or pulsed electric field treatment, will require new studies to investigate their 
effectiveness to eliminate or control gIICb. Finally, also the use of novel ingredients or food 
raw materials, (e.g. various alternative protein sources like insects and algae, non-acidic juices 
and beverages) may have an effect on the gIICb risk, for example because some of these sources 
may contain lysozyme, and should therefore be investigated.  
Fig. 1.4: Summary of D-values of gIICb spores extracted from literature sources. Data points and error bars 
correspond to mean +/- standard deviations of all D-values found at a particular temperature in the absence of 
lysozyme. Black squares correspond with all the data and blue crosses, red circles, orange circles and open 
triangles correspond with B, E and F and mixed toxin types, respectively. The solid lines represent the best fit 
to experimental data in the temperature range from 50 °C to 83 °C and for the whole data set, respectively. The 
inset graph compares D-values measured in the absence of lysozyme (blue closed squares), and in the  presence 
of lysozyme (heat sensitive fraction = red open squares; heat resistant fraction = closed triangles).  Source: 88 
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Chapter 2 
Sporulation and germination 
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2.1 Sporulation  
Bacterial endospores, hereafter called spores, are dormant cellular structures that in some 
cases can survive for thousands or even millions of years with little or no metabolic activity, 
and return to active vegetative cell division in only a few minutes 89. In the dormant form, 
spores are highly resistant to conditions such as heat, salinity, acidity, radiation, oxygen 
(depletion), low availability of water or nutrients 90–92. Spore-forming bacteria thus ensure 
their future under harsh conditions by forming dormant spores. Despite being dormant, 
spores have a system for sensing specific nutrients in the environment that serves to activate 
the spore germination mechanism and return to the metabolically active vegetative state. In 
order to preserve the potential for viability, spores have to prevent damage to the critical 
cellular components needed for germination and outgrowth, or have to repair those damaged 
components during germination.  
Spore-forming bacteria are widespread in different metabolic groups of the low-GC Gram-
positive bacteria (Firmicutes): aerobic heterotrophs (e.g. Bacillus and Sporosarcina spp.), 
microaerophilic lactate fermenters (e.g. Sporolactobacillus spp.), anaerobes (e.g. Clostridium, 
Moorella, Thermoanaerobacterium, Caloramator, Oxobacter and Anaerobacter spp.), sulfate 
reducers (e.g. Desulfotomaculum spp.) and even phototrophs (e.g. Heliobacterium and 
Heliophilum spp.). However, the sporulation process has been studied in most detail in Bacillus, 
more specifically B. subtilis and B. cereus, and to a lesser extent in Clostridium. 93 
2.1.1 The sporulation process 
When environmental conditions become unfavorable, spore-forming bacteria can initiate the 
sporulation process, a complex cascade of events that is strictly regulated at the 
transcriptional and post-translational level. B. subtilis has been used extensively as a model to 
study this process, and although sporulation proceeds via the same basic morphological stages 
in other sporulating bacteria including clostridia, recent studies have indicated major 
differences in regulation. Even the trigger that initiates sporulation is under debate in 
clostridia. While nutrient deprivation has long been considered as the universal trigger in all 
sporulating bacteria, recent evidence points to accumulation of the fermentation end products 
butyrate and acetate in C. acetobutylicum to cause initiation of sporulation, even in excess of 
nutrients. In general, a decline in growth rate leads to onset of sporulation, but in contrast to 
what is the case for bacilli, clostridia need an exogenous supply of energy (possibly because 
anaerobic metabolism is less efficient). Different stresses, for example oxygen exposure, could 
therefore play a role in initation. 94–96 
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The different stages of sporulation are shown in Fig. 2.1 96. Stage 0 represents the vegetative 
state, undergoing normal binary fission. Before the onset of sporulation or in stage I, cells 
undergo a transition that is unique to clostridia, into what is known as the ‘clostridial form’. 
Cells in this stage are swollen and accumulate vesicles containing components such as 
polysaccharides or polyhydroxybutyrate. In C. saccharobutylicum this polysaccharide was 
designated granulose, while in C. botulinum (type E) accumulation of the polymer amylopectin 
was demonstrated 97. However, it should be noted that the production of these spore-
associated polysaccharides has not been confirmed or further studied since it was first reported 
in the 1970s. Stage II is when the cells divide asymmetrically, which is the first clear indication 
that the sporulation process has started. The smaller compartment that is initially separated 
by a septum, subsequently gets engulfed by the mother cell in stage III. This happens in a way 
similar to phagocytosis, creating a cell within a cell. In stage IV peptidoglycan  (PG) is 
deposited between the membranes of the mother cell and the prespore. The PG wall is 
composed of an inner layer, the germ cell wall, which is synthesized first, followed by the outer 
layer, the cortex, that consists of modified PG with very little cross-linkage. The germ cell 
wall and cortex are synthesized from within the prespore and the mother cell, respectively 98. 
Subsequently, spore coat and cortex proteins, synthesized by the mother cell, are deposited 
after which the mature spore is released by lysis of the mother cell (stage V-VII). 
 
Fig. 2.1: The sporulation model of clostridia. Adapted from 96 
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Although the complex sporulation process was first assumed to be well conserved, substantial 
differences in the sporulation genes and their regulation have been found between bacilli and 
clostridia in recent years. Sporulation in Bacillus begins with a phosphorelay, involving five 
histidine kinases, of which the last one phosphorylates Spo0A, the master regulator of 
sporulation. In contrast, clostridia do not possess this phosphorelay, but Spo0A is 
phosphorylated directly by an orphan histidine kinase. Other differences are found 
downstream of Spo0A, in the mode of activation and function of sporulation sigma factors (σF, 
σE, σG, and σK), not only compared to Bacillus but also among Clostridium species. Recent 
studies showed that σK, the last sigma factor that is activated in the B. subtilis model, is 
involved in the early stages of sporulation in C. acetobutylicum, C. perfringens, and C. botulinum 
as well as in the late stages of spore maturation in C. acetobutylicum 96. For a more detailed 
discussion of the cellular mechanism and regulation of sporulation in clostridia and the 
differences with bacilli, we refer to Al-Hinai et al. (2015) and Dürre (2014) 95,96. 
2.1.2 Spore structure and spore resistance characteristics 
The specific physiological features of bacterial spores can be explained by their unique 
structure and by the presence of some unique constituents. As shown in Fig. 2.2, spores consist 
of a dehydrated core surrounded by different protective layers. From inside to outside, the 
core, the inner membrane, the germ cell wall, the cortex, the outer membrane, the coat and 
the exosporium can be distinguished 91. 
 
Fig. 2.2: Schematic overview of bacterial spore structure. The various spore layers are not drawn to scale, and 
sizes of the various layers vary significantly between spores of different species. Source: 91 
The spore core is derived from the mother cell protoplast and forms an environment that 
stabilizes DNA, RNA and enzymes, mainly because it is dehydrated. It contains minimal levels 
of common high-energy compounds, such as ATP and other nucleoside triphosphates. In 
contrast, AMP and ADP are present in significant amounts, as well as 3-phosphoglyceric acid, 
a potential rapid source of ATP 99. Further, the core contains two unique macromolecules, 
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pyridine-2,6-dicarboxylic acid or dipicolinic acid (DPA), and small acid soluble proteins 
(SASPs). DPA is not produced by vegetative cells and comprises 5-15 % of the dry weight of 
both Bacillus and Clostridium spores, where it occurs mostly as a 1:1 chelate with Ca2+ and 
other divalent cations. By replacing core water, the large depot of DPA contributes to a low 
water content (25-50 % of wet spore weight) and as such it plays a role in the spore’s resistance 
to wet heat. The low water content and activity is believed to be the major factor in the spore’s 
enzymatic dormancy and wet heat resistance. Unfortunately, the mechanism for water content 
reduction during sporulation is not known. A remarkable side effect of DPA accumulation is 
that it decreases UV resistance, because DPA acts as a strong photosensitizer 90,100,101.  
The second type of macromolecules that plays an important role in spore resistance are the 
SASPs, small proteins that comprise 7-20 % of the total spore protein. Two types of SASPs 
are distinguished based on their primary sequence. α/β-type SASPs (molecular weight 5 – 7 
kDa) are found in Bacillus and Clostridium, and up to seven variants can be present in a spore. 
γ-type SASP (molecular weight 8 – 11 kDa) appears to be present in Bacillus only, and only a 
single variant is normally produced. The α/β-type SASPs are basic proteins that 
nonspecifically bind the spore DNA and alter its structure and properties. As a result the DNA 
is protected against damage by heat, UV radiation and chemicals. When the spore germinates, 
the SASPs are degraded and serve as a source of amino acids during reinitiation of protein 
synthesis. γ-SASP does not bind DNA and thus doesn’t play a role in DNA protection. This 
SASP solely acts as a reservoir of amino acids during germination. 91,102  
The spore core is confined by the inner membrane, which is the major permeability barrier 
for entry of molecules into the core. Although the lipid composition of th is membrane is 
similar to that of a vegetative cell, its water permeability is three to four orders of magnitude 
lower. It is noteworthy though that the membrane is by no means impermeable to water and 
some other small solutes, and spores in an aqueous environment, despite their dehydrated 
core, exchange water with the environment at a timescale of hours 103,104. The reduced 
permeability has been attributed to the fact that the majority of lipids in the inner membrane 
is immobile. One possible explanation for this is that the cortex is a rigid shell that compresses 
the membrane during sporulation. During spore germination, the cortex hydrolases are 
activated and cause a relaxation of the pressure exerted by the cortex, which leads to water 
uptake into the core. As a result the volume that the membrane encloses increases up to 
twofold without new membrane synthesis, and this normalizes lipid mobility and membrane 
permeability. 105,106  
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The germ cell wall is located between the inner membrane and the cortex, and serves as a 
primer for vegetative cell wall assembly during outgrowth. It is composed of PG with a similar 
structure to that of vegetative cells. The cortex also consists of PG, with the same basic 
architecture but with some distinguishing features. The shared basic architecture consists of 
alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues which 
are coupled by a β-1,4-glycosidic bond. All NAM residues have short peptide side-chains of 
which some form peptide cross-links to peptide chains on adjacent NAG-NAM glycan strands. 
However, the degree of cross-linking is significantly reduced in cortex PG, which can be 
attributed to two main changes. First, 50 % of the NAM residues are converted to muramic-
δ-lactam (MAL) and thus have no peptide side chains. This MAL also serves as a recognition 
signature for cortex lytic enzymes, which selectively hydrolyze the cortex PG while leaving 
the germ cell wall intact. Secondly, 25 % of the remaining NAM residues have their peptide 
chains cleaved to a single L-alanine residue, preventing them to participate in cross-linking. 
107,108 
The cortex is surrounded by the outer membrane. Although it is essential in spore formation, 
there is discussion on whether this membrane remains intact in the mature dormant spore 
because it is difficult to observe it with electron microscopy. There are also no reports of the 
isolation of a purified outer membrane. The outer membrane lipid composition is probably 
similar to that of a vegetative cell membrane, since it is a remnant of the mother cell. The 
outer membrane is believed not to be an important permeability barrier or to have any 
important influence on spore properties. 90,93,109  
A next structure that is crucial for spore resistance is the spore coat, a layer composed of at 
least seventy different proteins in B. subtilis that are produced by the mother cell and begin to 
localize to the spore surface during engulfment. Bioinformatic evidence indicates that about 
half of the known B. subtilis coat protein genes have recognizable orthologues in 
other Bacillus species, whereas the other half do not appear to be conserved at all. In the 
genomes of Clostridium spp., conservation of B. subtilis coat genes is even more limited, with 
only eighteen orthologues identified in C. difficile 110,111. It has been speculated that diversity 
in coat composition may reflect ecological niche adaptation of the spore-former 111, although 
no clear associations have been reported so far. The coat acts as a shield that restricts access 
of harmful molecules to the vital structures of the spore in two different ways. First, it acts as 
a permeability barrier to large molecules, e.g. lytic cortex-degrading enzymes. In addition, the 
coat contains enzymes that detoxify oxidizing agents such as peroxides, nitrous acid, 
halogens, and aldehydes. However, the coat seems to be unable to protect the spore from 
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certain other small toxic chemicals like alkylating agents. In addition, spore germinants can 
penetrate through the coat and cortex to reach the germinant receptors that are located in the 
inner membrane. 93,106,109 
The outermost structure of the spore is the exosporium , although it is not present in all 
spores. The exosporium layer has been studied in detail in B. anthracis, B. cereus and B. 
thuringiensis and recently also in C. sporogenes spores 112,113. In these species it is described as a 
sac-like structure which consists of a basal layer surrounded by an external nap of hairlike 
projections, and it likely contributes to adhesion, dissemination, and sometimes virulence.  
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2.2 Spore germination  
When conditions become favorable, spores exit their dormant state and return to active 
growth through a complex process called germination. This process is of great importance in 
food microbiology, because only upon germination a spore can become a vegetative cell that 
can cause food spoilage or poisoning. Germination is induced when specific environmental 
nutrient germinants are sensed by the spore germinant receptors. After binding of these 
nutrients, a signal transduction pathway is activated that triggers a self-propagating and 
irreversible cascade of events, starting with the release of monovalent cations (H+, Na+, K+) 
and Ca2+-DPA from the core, followed by degradation of the spore cortex leading to core 
rehydration and eventually to reinitation of metabolism and outgrowth. This process is 
accompanied with the loss of the spores’ resistance properties. The presence of oxygen has no 
effect on the initial steps of Clostridium spore germination, reflecting that the process is 
independent of active metabolism. However, oxygen inhibits subsequent outgrowth.  
Besides the classical germinants also other inducers have been described, termed non-nutrient 
germinants, e.g. exogenous Ca2+-DPA, cationic surfactants like dodecylamine, muropeptides, 
and even high pressure. Unfortunately most of these studies were performed with Bacillus 
spores, emphasizing the need for more research in Clostridium. 
2.2.1 Nutrient induced germination 
2.2.1.1 The Ger family of receptors 
Germination is naturally induced by nutrient germinants binding to germinant receptors 
(GRs) that are located in the spore’s inner membrane. These germinants are species and strain 
specific, and the most common include L-amino acids, purine bases and D-sugars. The most 
widespread GRs are the Ger-type receptors, and these have long been believed to be universal 
to all spore-forming bacteria. These GRs are typically composed of three protein subunits 
(designated A, B and C), often encoded in a tricistronic operon. The first Ger receptor 
identified in B. subtilis, which binds to L-alanine, was designated GerA and its three subunits 
as GerAA, GerAB and GerAC. Besides GerA, B. subtilis contains two additional Ger receptors 
named GerB and GerK. These two receptors act cooperatively to trigger germination with 
either L-asparagine supplemented with glucose, fructose, and potassium ions (GFK) or L-
alanine supplemented with GFK. The number of Ger receptors varies between genera, species 
and even strains, and some strains have up to seven different Ger-type receptor operons 114. 
Because more and more receptors are being identified, Ross & Abel-Santos (2010) addressed 
a problem regarding the inconsistency in nomenclature of the Ger receptors 115. In many cases, 
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GR names were designated randomly, without consideration for phylogenetic relationships 
or functionality. The new proposal attempts to remediate this issue by introducing a 
systematic nomenclature, based on phylogeny and functionality. Unfortunately, they only 
addressed Ger receptors in bacilli, because they found that there is not yet enough genomic 
and functional information of receptors in the Clostridium genus. In C. botulinum, the 
designation GerX is sometimes used because the cognate germinant(s) of the encoded 
receptors is/are still unknown.  
The A and B subunits of Ger receptors are both predicted to be integral membrane proteins. 
The A protein consists of four to six predicted membrane-spanning domains, as well as large 
N and C terminal hydrophilic domains. The B protein contains seven to twelve 
transmembrane helices, and despite low sequence homology, its predicted tertiary structure 
resembles that of a superfamily of membrane-associated single-component membrane 
transporters. The C subunit is predicted to be a lipoprotein that is anchored via a 
diacylglycerol unit to the outer surface of the spore inner membrane 90. It was recently 
suggested that subunit B is responsible for germinant binding in B. megaterium 116,117. In this 
study, a nongerminating mutant was complemented with various plasmid-borne mutant 
receptor genes, revealing amino acid residues that may be directly involved in germinant 
binding. Unfortunately, the fact that two GR subunits are integral membrane proteins has 
hampered their purification, and thus the study of their biochemical properties.  
Many different GR loci have been described next to the gerABC architecture, especially in 
clostridia 118,119. Some receptor subunits are encoded as orphan monocistronic genes, while 
some operons encode duplicated subunit genes. Brunt et al. (2016) recently reported on the 
variety of genomic Ger clusters in groups I-IV of C. botulinum, based on in silico analysis of 
156 C. botulinum and C. sporogenes genomes 120. The latter were included because of their close 
relatedness to gICb. Four different gerX clusters were identified, as shown in Fig. 2.3 D. These 
clusters could be further separated into six subtypes for cluster gerX1 (ABC configuration), 
three subtypes for gerX2 ((AB)ABCB configuration), two subtypes for gerX3 (CA-B bicistronic 
configuration) and one single type gerX4 (ACxBBB configuration). The x putative subunit in 
the latter is a hypothetical protein of which the functionality is unknown so far. The similarity 
within the subtypes of GerX1 and GerX3 is more than 90 % (except for GerX1c, 85 %), while 
the similarity between subtypes of different groups is 20 – 65 %.  
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Fig. 2.3: Distribution of Ger receptor gene clusters in C. botulinum and C. sporogenes. The phylogenetic trees in 
A-C are based on single nucleotide polymorphisms as determined using ParSNP. Values shown at branches 
represent bootstrap values provided by ParSNP. (A) shows the Ger cluster distribution in C. botulinum group I 
and C. sporogenes genomes where the latter is indicated with asterisks, (B) shows the distribution in C. botulinum  
group II and (C) in group III. The colors in trees (A-C) correspond with the colors attributed to each individual 
ger subtype shown in (D). White blocks represent absence of the specific GR subtype. (D) Genetic organization 
of the ger subtypes. ger1f is only found in C. botulinum group IV which is not shown in (A-C). Adapted from 120 
gICb and C. sporogenes strains typically encode three to five different Ger receptor subtypes, 
and this may relate to their ability to germinate by various amino acids, often in combination 
with L-lactate, although the latter is not always essential 64,121. The functionality of Ger 
receptors in C. botulinum has been experimentally demonstrated only in one gICb strain and 
one C. sporogenes strain by construction and analysis of insertional knockout mutants 64. 
Unexpectedly, although both strains contained gerX1a and gerX1d (Fig 7A), only GerX1d was 
essential for nutrient induced germination in C. sporogenes whereas both GerX1a and GerX1d 
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were essential in the gICb strain. Subtle differences in amino acid sequences could thus lead 
to different functionalities, although other (unidentified) proteins could also play a role. The 
same study showed that neither GerX2b or GerX2c, both also present in the gICb and C. 
sporogenes strains, could promote germination alone. Some gICb strains also have a gerX3 
locus. This locus is also present in all sequenced gIICb strains (Fig 2.3 B/D), and is organized 
in two transcriptional units with gerB transcribed in the opposite direction of gerA and gerC.  
Similarly to gICb, gIICb strains respond to several amino acids, although for gIICb the 
presence of L-lactate is considered essential for germination. Plowman and Peck (2002) 
demonstrated optimal germination of three gIICb strains in L-alanine, L-cysteine or L-serine, 
all in combination with L-lactate 122. Moreover, an older study had reported that germination 
of gIICb spores was also possible by single amino acids (without addition of L-lactate) at pH 
9, as well as by the combination of L-alanine with glucose, galactose or maltose at neutral pH 
123. In large contrast to gICb strains, gIICb strains contain only one receptor, GerX3. It 
remains to be clarified how one receptor can respond to such a variety of nutrients.  
Mutational studies in C. perfringens, which contains the gerK locus that has a similar bicistronic 
organization to gerX3 led to the conclusion that GerKC is the main receptor protein involved 
in nutrient and non-nutrient germination (by dodecylamine and Ca2+-DPA, discussed further 
in 2.2.2) 124,125. In addition to the gerK locus, there is a monocistronic gerAA located rather far 
away from gerK. The fact that the A and B subunits are dispensable in C. perfringens is in 
striking contrast with the situation in B. subtilis, where all three subunits are essential for 
formation of a functional GR. The GerKC receptor reacts to germinants such as KCl,  L-
asparagine, or an L-asparagine–KCl mixture.  
Despite the wide distribution of Ger-type receptors in sporulating bacteria, the genome 
sequences of at least two Clostridium species, C. barletti and C. difficile, do not contain Ger gene 
homologs. Nevertheless, spore germination in these bacteria is also induced by specific 
germinants, consistent with a mechanism involving one or more specific receptors. C. difficile 
spores do not react to amino acid germinants, but germinate in response to taurocholate, a 
characteristic component of bile. The use of this compound as a germinant therefore allows C. 
difficile to germinate in its primary niche, the animal gut. Francis et al. (2013) identified that 
the catalytically inactive serine protease CspC functions as the receptor of the germinant 
taurocholate in C. difficile 126. This was found by analysing different germination-null mutants, 
of which many carried SNPs in cspC. The finding was further corroborated by analysis of a 
mutant that germinated in response to chenodeoxycholic acid, a compound related to 
taurocholate but that normally acts as a competitive inhibitor of germination . This mutant 
  
30 
 
contained a mutated CspC residue that was proposed to modify the bile acid binding pocket 
to be less stringent. It was thus suggested that CspC is able to bind bile salts, resulting in a 
conformational change that is transmitted to CspB (another, but active serine protease). CspB 
would then cleave the N-terminal part of the cortex hydrolase SleC, thereby converting the 
inactive zymogen into an active cortex lytic enzyme, leading to germination. Unfortunately, 
while many clostridia contain these Csp serine proteases, of which the encoding genes (A, B 
and/or C) are located directly upstream of sleC, it has not been studied so far if they act as 
GRs as well 127. 
2.2.1.2 Signal transduction and cortex hydrolysis 
The binding of GRs with their germinants induces an irreversible cascade of events, 
suggesting that a signal is transduced from the GR. Although it is currently unknown how 
this signal is transduced, the subsequent events are well described in Bacillus. First, Na+, K+ 
and H+ ions are released from the core, followed by Ca2+-DPA. In many Bacillus species, the 
released DPA then activates a cortex hydrolase. However, C. perfringens spores lacking DPA 
germinate similarly to wild-type spores, showing that DPA is not involved in the signalling 
cascade in this case 128. DPA release during germination as well as DPA uptake in the 
developing spore during sporulation are suggested to be mediated by the SpoVA proteins, and 
also in this respect there are differences between clostridia and bacilli: B. subtilis and many 
other Bacillus species have a heptacistronic spoVA operon (SpoVAA, B, C, D, Eb, Ea and F, 
encoded in this order), whereas C. perfringens, C. botulinum, C. difficile and other clostridia have 
a tricistronic spoVA operon (SpoVAC, -D and –Eb). Tetra- and pentacistronic operons exist as 
well (e.g. in C. asparagiforme, C. hathewayi), but SpoVAC, -D and –Eb are always present 127,129. 
It is not clear how GRs transduce the signal further downstream, but protein-protein 
interactions have been detected with some SpoVA proteins in B. subtilis 130. Unfortunately the 
precise function of the SpoVA proteins is unknown, as is the exact organization of the channel 
that they form and how it works 90,131.  
Although DPA release precedes cortex hydrolysis in B. subtilis and C. perfringens, it is the other 
way around in C. difficile 132. In C. botulinum this is yet unknown. Cortex hydrolysis is an 
essential step in germination since it allows the core to further take up water, which is a 
prerequisite for resuming metabolism. The cortex lytic enzymes (CLEs) are the necessary 
players in this process. They recognize and cleave the spore cortex PG with its characteristic 
modification as described in 2.1.2, leaving the germ cell wall intact. These enzymes are 
preformed and need to be activated during germination. Two different machineries are well 
conserved in Bacillus and Clostridium species. The first system involves two CLEs, CwlJ and 
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SleB, both synthesized in a mature form during sporulation of most bacilli and some clostridia 
127,133,134. In some bacilli it has been demonstrated that either CLE alone is sufficient for 
completion of germination, whereas spores of a cwlJ sleB double mutant exhibit extremely low 
viability 90. It has been shown that Ca2+-DPA release activates CwlJ and that this CLE 
requires GerQ for proper localization to the cortex/coat boundary 135,136. In contrast, the 
mechanism of SleB activation is unknown. In Bacillus, sleB is located upstream of ypeB in a 
bicistronic operon and it appears that YpeB is required for localization and/or activity of SleB 
137,138,139. In many clostridia, including gIICb, in which sleB is encoded, no ypeB gene is 
identified 127. This questions the activity of SleB in these species. In contrast, gICb strains 
encode sleB as well as ypeB.  
The second and mechanistically different CLE machinery involves SleC. This CLE is well 
conserved in most Clostridium species and has been studied in C. perfringens and C. difficile. 
SleC is synthesized as an inactive zymogen containing a pro-region that is cleaved by Csp 
proteases early in germination, converting the zymogen into an active CLE. The proteases 
belong to the subtilisin subfamily. To date, the mechanisms that regulate the activity of the 
Csp proteases are unknown. Functional studies showed that SleC is the essential cortex 
hydrolase in both C. perfringens and C. difficile, which additionally possess a SleM and a SleB 
homolog respectively. SleM is synthesized as a mature muramidase which is believed to 
degrade PG fragments generated by SleC during germination. In C. perfringens, deletion of 
sleM led to spores that germinated as wild type spores 140. In C. difficile, insertional inactivation 
of the SleB homolog also had no effect on germination and outgrowth 141. The lack of ypeB 
could possibly explain SleB’s inactivity in C. difficile, but this would have to be confirmed with 
the construction of a double mutant sleB sleC.  
The study of Brunt et al. (2016) that was described above for its detailed in silico analysis of 
Ger receptors in C. botulinum, also catalogued the CLE homologs in 156 genomes of C. 
botulinum I-IV and C. sporogenes 120. All gICb and group III strains contained at least one sleB 
copy (with a single exception) as well as a single copy of cwlJ and ypeB. Meaney et al. (2015) 
showed that SleB and YpeB are required for optimal germination in gICb strain ATCC 3502, 
and that no functional CwlJ enzyme is formed although its encoding gene is present 133. 
However, insertional inactivation of cwlJ in another gICb strain, ATCC 15579, decreased the 
germination rate 120.  
The bioinformatic analysis additionally revealed genes in group I-III encoding four ‘SleB-like’ 
proteins, designated SleB2-5. SleB2 is found in group I, II and III and is a putative cell wall 
hydrolase. SleB3, found in group I and III, consists of two LysM domains which are involved 
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in PG-binding. The coding sequences of both proteins are preceded by a ydaO element, except 
in gIICb strains. This element is a riboswitch that is often associated with genes involved in 
polysaccharide degradation in Bacillus 142. SleB4 is found in only three gIICb strains (CB11/1-
1, 20536 and ATCC 17786), and also belongs to the cell wall hydrolase family. SleB5 is found 
in only one group III strain, contains two PG-binding domains and shares ~40 % amino acid 
identity with proteins annotated as spore cortex-lytic enzymes 120.  
gIICb strains possess sleB2, sleM, sleC, and also other sleC-like genes designated as sleC2a/b, 
whereas ypeB and cwlJ appear to be absent 119,120,127. Like SleC, SleC2a/b contains a 
SpoIID/LytB domain. However, there is only one PG-binding domain in SleC, compared to 
five in SleC2a and four in SleC2b. Thus, SleC is ~443 residues long, SleC2a is ~792 and SleC2b 
~698 residues. The latter is mainly found in type E strains. The functionality of all these 
predicted proteins needs to be confirmed experimentally, but it is clear that there is a large 
diversity in CLEs in C. botulinum strains.  
2.2.2 Non-nutrient induced germination 
While nutrient germinants are considered to be the natural inducers of germination, some 
other agents are capable of causing germination as well. The mechanism differs from nutrient 
induced germination as it can bypass certain events described in 2.2.1. For example, 
exogenous Ca2+-DPA can directly activate CwlJ in Bacillus without the involvement of GRs 
135. In contrast, GRs do play a role in Ca2+-DPA germination in C. perfringens since spores in 
which the receptor GerKC was insertionally inactivated, germinated very poorly with Ca2+-
DPA125. In contrast to B. subtilis and C. perfringens, C. difficile spores do not germinate with 
Ca2+-DPA although a CwlJ homolog is present (30 % amino acid identity with B. subtilis) 143.  
Another group of non-nutrient germinants are cationic surfactants such as dodecylamine. 
Although the exact mode of action of this compound is not yet clear, one possibility is that it 
triggers germination by opening the spore’s Ca2+-DPA channels 131,144. Vepachedu & Setlow 
(2007) proposed two possible mechanisms 131. Either dodecylamine directly opens a channel 
in the inner membrane, or the interaction of the surfactant with the membrane causes an 
alteration in the membrane’s properties, which in turns opens the channel 131. In addition, it 
has been suggested that the formation of salt bridges between the -NH2 head groups of 
dodecylamine and carboxylate anions in the spore cortex would destabilize the cortex and 
make the core unable to maintain its low water content 145. In B. subtilis it was reported that 
dodecylamine induced DPA release occurs without the involvement of the GRs since spores 
lacking all GRs released DPA at a similar rate to that of wild-type spores upon exposure to 
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dodecylamine 144. Observations were somewhat different for C. perfringens, where GerKC 
deficient spores released slightly less DPA than wild-type spores 125. Dodecylamine has been 
shown to induce germination in C. difficile as well 143. In all these studies, germination was 
mainly assessed based on DPA release, and it has been demonstrated that further germination 
is halted because spores do not swell and do not take up enough water to reinitiate metabolism 
125,143,144. This type of germination is sometimes described as lethal germination because viable 
spore counts are drastically reduced in the presence of this surfactant 145.  
In B. subtilis it has been demonstrated that also PG-derived muropeptides can act as a 
germination trigger, even at extremely low concentrations (<1 pg/ml). Muropeptides are 
released during vegetative growth, when there is a high PG turnover with balanced 
degradation and synthesis activities. Consequently, muropeptides in the environment could 
serve as a signal for spores that conditions are favorable for outgrowth. Only muropeptides 
that have meso-diaminopimelate at position three of the stem peptide linked to the 
oligosaccharide backbone could induce B. subtilis spore germination. PG fragments from some 
other Gram-positive bacteria, like Staphylococcus aureus, contain L-lysine in the third position 
and are thus ineffective in inducing B. subtilis spore germination. The ser/thr protein kinase 
PrkC was shown to be essential for signal transduction in the muropeptide germination 
mechanism. The extracellular domain of PrkC contains PASTA (penicillin and ser/thr kinase 
associated) repeats that can mediate PG binding. In response to this binding, PrkC 
phosphorylates the essential translation factor EF-G, as it similarly does in stationary phase 
cells. It is suggested that the phosphorylated EF-G subsequently modulates ribosome activity 
and hereby stimulates translation, thereby inducing an exit from the spore’s dormancy  146–148. 
However, it is yet unclear how spore rehydration, cortex degradation and other essent ial steps 
in germination fit into this mechanism. Since prkC is strongly conserved between clostridia 
and bacilli, it is postulated that this germination pathway may be universal. However, 
muropeptide induced germination nor the role of PrkC have been documented in spore-
formers other than B. subtilis.  
Besides specific molecules, also physical treatments like high hydrostatic pressure (HP) can 
trigger spore germination. While pressures over 1000 MPa or the combination of HP and 
heat are required to kill bacterial spores 149, less extreme conditions can induce germination. 
Although this has been well studied in Bacillus species, less is known about clostridial spore 
germination by HP. In B. subtilis, there is a difference in the germination mechanism 
depending on the pressure level 100. Moderate pressures (50-300 MPa) induce germination 
only in the presence of intact GRs, and thus appear to somehow activate the germination 
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pathway similar to nutrients. In contrast, higher pressures (400-800 MPa) seem to directly 
act on the Ca2+-DPA channels causing DPA release, without the involvement of the GRs 150–
152. However, in the latter case germination may be incomplete because SASPs are not 
degraded and ATP is not produced. The reason for this may be that the HP treatment 
inactivates some enzymes in the core. Since α/β-SASPs are not degraded, spores remain 
partly resistant to an additional HP treatment, hydrogen peroxide and UV radiation, but not 
to moist heat 153. When high pressure (> 500 MPa) is applied in combination with elevated 
temperatures (T > 90 °C), spores are rapidly killed, probably by a mechanism similar to 
thermal inactivation that does not involve a physiological germination mechanism. This 
combined treatment has potential commercial applications to produce high quality, low acid, 
shelf-stable foods 154.  
HP induced germination has been studied less extensively and in less depth in clostridia, but 
the picture that is emerging is that HP may induce germination in some, but not in all 
Clostridium species. A recent study revealed some interesting differences between C. difficile 
and C. perfringens 155. C. difficile spores showed no germination at 150 MPa (37 °C) and did not 
lose their heat resistance, while C. perfringens spores became heat sensitive and released DPA, 
although they did not rehydrate completely. The authors proposed that the inability of C. 
difficile spores to germinate under mild HP was due to the absence of Ger-type receptors in 
this species. When the C. perfringens spores were heat activated before HP treatment, complete 
germination was demonstrated. HP treatments at 550 MPa (50 °C) led to DPA release in both 
clostridial species, although C. difficile remained heat resistant and did not complete 
germination. The 550 MPa treatment induced complete germination of C. perfringens spores 
only when they were first heat activated. This study opposes the results obtained in a previous 
study by Akhtar et al. (2009), who reported that HP does not trigger C. perfringens spore 
germination 156. However, in this study no heat activation step was performed.  
It has been shown that germination of C. sporogenes spores was only significantly induced by 
a mild HP treatment (200 MPa) when temperatures were above 40 °C and germinants were 
present 157. Also gIICb spores do not seem to germinate under pressure at mild temperatures, 
although studies are very scarce. For C. botulinum type E spores, Reddy et al. (1999) reported 
that spores cannot be inactivated by high pressures (maximum tested: 827 MPa) at 
temperatures below 35 °C 158. However, inactivation increases with increasing temperatures, 
resulting in ~3 log and ~5 log reduction of the type E strain Alaska spores at 40 °C and 50 
°C respectively (827 MPa, 5 min). Unfortunately, germination was not documented in this 
work, although germination is assumed to be a crucial step in the HP-mediated inactivation 
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of spores at mild temperatures 158,159. More recent work by Lenz et al. (2015) modeled HP 
thermal inactivation of type E spores, and also reported on spore germination 160. The authors 
concluded that only very limited (maximum 0.6 log) germination was triggered by pressures 
up to 600 MPa, combined with temperatures up to 45 °C 160.  
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Scope of the work 
 
Group II C. botulinum (gIICb) is an important pathogen of concern in mildly processed chilled 
ready-to-eat foods with an extended shelf life, because it can grow and produce the lethal 
botulinum neurotoxin during cooled storage. Chapter 1 gave an overview of the current 
knowledge on this toxin and the lethal illness it causes, the heterogeneous species C. botulinum, 
and the hazards of gIICb in foods. In Chapter 2, the processes of sporulation and spore 
germination were described in more detail, because it is important to understand the 
properties of spores in order to understand the risk of gIICb in foods, and to develop adequate 
methods to control this risk, based on controlling spore germination and outgrowth.  
In this PhD thesis, the general aim was to gain more insight in the germination mechanism 
of gIICb spores. Studies with these organisms are rather scarce in comparison with other 
foodborne pathogens, mainly because C. botulinum studies are subject to important biosafety 
and bioterrorism restrictions, and because their culture requires strict anoxic conditions. 
Moreover, gIICb are reported to be less amenable to genetic manipulation than other 
clostridia, and the genetic toolbox for these strains is still very limited. Therefore, we first 
aimed to construct nontoxigenic mutants by a novel knockout strategy that can provide a safe 
alternative for basic research with gIICb strains. Moreover, nontoxigenic mutants could be 
used as non-pathogenic surrogates that would greatly facilitate food challenge testing and 
process validation studies. There is a growing need for such studies in view of innovations in 
the food industry, that are driven by an increasing consumer’s demand for fresh-tasting 
healthy ready-to-eat foods that have been minimally processed, contain less salt and no 
artificial preservatives, yet have a long shelf life. Furthermore, novel ingredients and novel 
food processing and preservation technologies have found their way to commercial food 
production, but data regarding their efficiency to control gIICb is lacking.  
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Since it is an advantage to have knowledge of the whole genome sequences (WGS), not only 
to support genetic analysis but also because they provide information on the metabolism and 
physiology, we assembled the WGS of three gIICb type E strains. In Chapter 3 the WGS are 
presented of C. botulinum NCTC 8266 and NCTC 8550, and the nearly complete draft genome 
of NCTC 11219, consisting of four contigs. At the time these sequences were published, only 
two other WGS were available for gIICb type E strains: C. botulinum E1 strain Beluga (in six 
contigs) and strain Alaska E43. 
In Chapter 4 the construction of two nontoxigenic mutants of strain NCTC 11219 is reported. 
Besides the construction of an insertion mutant by the ClosTron system, we additionally 
developed a new gene replacement method that can be applied to delete any non-essential 
gene in gIICb and other clostridia. Moreover, the properties of both NCTC 11219 
nontoxigenic mutants were compared with their parental strain, and this revealed some small 
changes in phenotype. Although it was concluded that the strains could still be useful as safe 
surrogates for challenge testing and basic research, we further investigated in Chapter 5 if 
the observed changes were related to the toxin gene inactivation or whether they were the 
result of adventitious mutations that had occurred during mutant construction. This was done 
by constructing and analysing similar nontoxigenic mutants in a second gIICb strain (NCTC 
8266), and by identifying all mutational changes of the mutants by WGS analysis. 
Spore germination of C. botulinum NCTC 11219 ∆bont was studied in Chapter 6. First, 
different known germination inducers were tested on this particular strain and subsequently 
the inhibitory effect of four natural antimicrobial compounds (carvacrol, trans-
cinnamaldehyde, carrot seed essential oil and hop β-acids) on germination was determined. 
Their activity has mostly been studied on vegetative bacteria, but only limited data are 
available on the effect of these natural compounds on endospores. Natural antimicrobials are 
being investigated to address concerns over the safety of some traditional preservatives like 
nitrite, and documenting the effect of these compounds on spore germination will contribute 
to a more complete assessment of their potential to control gIICb in foods.  
In the following two chapters we attempted to enhance our understanding of the spore 
germination mechanism in gIICb by analysing the role of specific genes predicted to encode 
germination proteins. In Chapter 7, the inactivation of the only germinant receptor identified 
in gIICb strains (GerX3b) is decribed and its function in germination is examined. In Chapter 
8, finally, we inactivated the cortex hydrolase SleB, and report on its role in spore germination.  
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CHAPTER 3* 
Two complete and one draft genome sequence(s) of 
three nonproteolytic Clostridium botulinum type E strains 
NCTC 8266, NCTC 8550 and NCTC 11219 
 
 
 
 
 
 
 
 
 
 
* This chapter is based on the following publication: Clauwers, C., Briers, Y., Lavigne, R. & 
Michiels, C. Two complete and one draft genome sequence(s) of three nonproteolytic 
Clostridium botulinum type E strains NCTC 8266, NCTC 8550 and NCTC 11219. Genome A. 
3, e00083-15 (2015).  
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At the start of this PhD research, only two whole genome sequences were available for gIICb 
type E strains: C. botulinum E1 strain Beluga (six shotgun sequences; NZ_ACSC01000000) 
and strain Alaska E43 (whole genome; CP001078). Here, we present the high-quality whole 
genome sequences of C. botulinum type E NCTC 8266 and NCTC 8550 and the whole genome 
shotgun project of NCTC 11219, consisting of four contigs. Strains NCTC 8266 and 11219 
are linked to botulism outbreaks caused by salmon (in 1944 and 1978) 161,162, NCTC 8550 has 
been isolated at the Pasteur Institute (Paris, France) in 1952.  
To obtain high-quality genomic DNA (gDNA), formaldehyde was used for fixation of cells 
prior to isolation 163. This step was essential to avoid DNA degradation by abundant 
extracellular DNase activity in gIICb cultures. Paired-end libraries were constructed using 
the NEBNext Ultra gDNA library prep protocol and analysed on the Agilent BioAnalyzer 
(VIB nucleomics core, Leuven, Belgium). Sequencing was performed on an Illumina Miseq 
sequencer, yielding 3,795,388; 3,669,738 and 4,733,175 reads of 150 bp for NCTC 8266, 8550 
and 11219, respectively (with 157-, 152-, 187-fold total coverage). Genome assembly was 
performed using the CLC Genomics Workbench (v.7) (CLC Bio, Aarhus, Denmark) applying 
a combinatorial approach of reference assembly against C. botulinum Alaska E43 (3,659,644 
bp), de novo assembly of non-assembled reads and manual editing.  
Strains NCTC 8266 and 8550 are highly similar to strain Alaska (99 % identity) with a similar 
genome size of 3,611,897 and 3,611,898 bp. The draft genome sequence of NCTC 11219 
(3,792,082 bp) differs more from Alaska (93 % identity). Gene predictions and annotations 
with the Prokaryotic Genome Annotation Pipeline identified 3218 genes for NCTC 8266 and 
8550, and 3426 genes for NCTC 11219, of which 3060 and 3215 are protein-coding, 
respectively. For all three strains 34 rRNA and 79 tRNA sequences were found. PHAST 
(Phage Search Tool 164) identified two potential prophages in NCTC 8266 and NCTC 8550, 
of which one appears intact (39.2 Kb) and one incomplete (24.4 Kb). In contrast, NCTC 11219 
encodes five prophage regions, of which three potentially intact (39.6 Kb; 28.4 Kb; 26.1 Kb) 
and two incomplete (27.8 Kb; 13.9 Kb). 
Nucleotide sequence accession numbers. The complete genome sequences have been 
deposited at DDBJ/ENA/GenBank under the accession no. CP010520 (NCTC 8266) and 
CP010521 (NCTC 8550). The whole genome shotgun project of NCTC 11219 has been 
deposited under the accession JXMR00000000. The version described in this paper 
is version JXMR01000000.  
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Genes of interest for this PhD work. The whole genome sequences of the three gIICb 
strains were searched by BLAST analysis for the presence of genes encoding BoNT using 
group II strain Alaska as a query sequence, and for genes with a possible role in spore 
germination as discussed in section 2.2 using query sequences from strain Alaska and group I 
strain ATCC 3502. In the following Chapters of this PhD, we specifically focused on bont/E, 
gerX3b, sleB and sleC. 
Table 3.1: Overview of putative genes involved in BoNT production and spore germination that were (+) or 
were not (-) identified in the WGS of NCTC 11219, NCTC 8266 and NCTC 8550, using query sequences from 
group II strain Alaska and group I strain ATCC 3502. Gene content of strain Alaska is included for comparison.  
 
gIICb strains 
Homologous genes Alaska NCTC 11219 NCTC 8266 NCTC 8550 
     
bont/E a E3 E3 E1 E1      
gerX3b (BAC) + + + + 
sleB2 + + + + 
ypeB - - - - 
cwlJ - - - - 
sleC + + + + 
sleC2a/b b b b b 
sleM + + + + 
csp + + + + 
spoVA CDE CDE CDE CDE 
sasp α/β 5 5 5 5 
sasp γ - - - - 
prkC + + + + 
 
a The subtypes of the bont gene have been reported in literature 165.    
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CHAPTER 4* 
Construction of nontoxigenic mutants of nonproteolytic 
Clostridium botulinum NCTC 11219 by insertional 
mutagenesis and gene replacement 
 
 
 
 
 
 
 
 
 
 
 
* This chapter is based on the following publication: Clauwers, C., Vanoirbeek, K., 
Delbrassinne, L. & Michiels, C. Construction of nontoxigenic mutants of nonproteolytic 
Clostridium botulinum NCTC 11219 by insertional mutagenesis and gene replacement. Appl. 
Environ. Microbiol. 82, 3100-3108 (2016).   
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4.1 Introduction 
Botulism is a rare but severe paralytic illness in humans and animals, caused by the botulinum 
neurotoxin (BoNT) produced by C. botulinum. Botulinum toxins are 150 kDa proteins with 
zinc endopeptidase activity, consisting of two subunits, a 100 kDa heavy chain and a 50 kDa 
light chain. The heavy chain is responsible for binding and translocation of the light chain 
into the cytosol of neuronal cells, whereas the light chain cleaves SNARE proteins that are 
involved in docking of acetylcholine-containing vesicles and fusion to the presynaptic 
membrane. When the SNARE proteins are cleaved, neurotransmitter release is inhibited, 
leading to paralysis of the corresponding muscle 166,167 (see 1.2). 
C. botulinum is a strictly anaerobic bacterium that thrives in decaying organic matter in soils 
and sediments of ponds, lakes and oceans. It also forms dormant endospores that are highly 
resilient to hostile conditions and therefore can be found widespread in the environment. 
These spores may contaminate foods via the raw materials or other sources, possibly leading 
to foodborne botulism when they are not eliminated by processing and when their outgrowth 
is not controlled 76,168,169. C. botulinum is divided into four distinct groups (I to IV) based on 
phylogenetic and physiological characteristics, of which only group I and II are typically 
associated with human botulism 49 (see 1.6). Group I C. botulinum consists of proteolytic 
mesophilic strains producing toxin types A, B and/or F. These strains form heat resistant 
spores and are the main target for the so-called “botulinum cook”, the process used in canning 
of low acid foods (121 °C/3 min or equivalent). Group II C. botulinum (gIICb) comprises 
nonproteolytic strains producing toxin types B, E or F, which are saccharolytic, 
psychrotrophic (with minimum growth temperatures of 3 °C) and whose spores are less heat 
resistant than those of group I. In the food industry, gIICb is a major concern for the safety 
of refrigerated minimally processed foods of extended durability, because spores surviving the 
mild processing treatments may subsequently germinate, grow out and produce toxin during 
refrigerated storage 76,170,171. The combination of the heat resistance of its spores and the 
ability to grow under refrigeration conditions makes this pathogen to be the main target 
pathogen that must be controlled in these foods. Guidelines for control of this hazard in the 
food industry have been developed more than two decades ago, requiring either a 6-D 
reduction of the spores by heat treatment (90 °C/10 min or equivalent), or control of 
outgrowth by limitation of the refrigerated storage time to < 10 days, inclusion of ≥ 3.5% 
NaCl, ≥ 100 ppm nitrite, acidifying to pH  5.0 or an appropriate combination of these or 
additional hurdles.  
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However, the increasing consumer’s demand for fresh-tasting healthy ready-to-eat foods that 
have been minimally processed, contain less salt and no artificial preservatives, yet have a long 
shelf life, represent a challenge for the food industry in view of these botulinum safety 
guidelines. Furthermore, novel food processing and preservation technologies (e.g. high 
pressure or pulsed electric field treatment, natural preservatives) have found their way to 
commercial food production, but data regarding their efficiency to control gIICb is scarce 
160,172–174 (see 1.7). This is in sharp contrast to the attention given in this context to other 
pathogens like L. monocytogenes, Salmonella and enterohemorrhagic Escherichia coli. The main 
reason for this paucity of data is that C. botulinum studies are subject to important biosafety 
and bioterrorism restrictions, and because their culture requires strict anoxic conditions. One 
possible approach to circumvent these difficulties is the use of nonpathogenic surrogate 
organisms. For example, C. sporogenes has been widely used as a surrogate for proteolytic C. 
botulinum in the studies on thermal processing of low-acid shelf-stable foods 175. However, a 
suitable validated surrogate for gIICb is lacking up to date. Recently, Parker et al. (2015) 
studied previously isolated natural nontoxigenic Clostridium spp. that could possibly be used 
as surrogates for gIICb 176. Two out of the three strains analysed showed equal or faster 
growth than toxigenic gIICb under most (but not all) stress conditions (low temperature, 
reduced pH and aw), making them potentially useful for challenge studies with refrigerated 
foods, at least under some conditions. However, the spores of the three strains had lower heat 
resistance than some gIICb strains, and thus could not be used for validation of heating 
processes. Furthermore, it could not be excluded that the strains still carried bont or other 
toxin genes, and the (phylo)genetic relatedness of the strains to gIICb was not documented. 
This makes the behaviour of these strains under other than the tested environmental 
conditions unpredictable (e.g. sensitivity to nitrite and other preservatives, sensitivity to 
organic acids…).  
As an alternative approach to develop safe strains for challenge studies and process validation, 
we attempted in the present work to construct nontoxic derivatives from a toxic gIICb strain 
by making a targeted knockout of the bont gene. The resulting derivative strains are then 
expected to differ from their parent only in toxin production, and thus to be a highly reliable 
alternative for challenge studies. Although the inactivation of specific genes in clostridial 
species has proven to be a rather difficult, slow and inefficient task for a long time, the genetic 
toolbox for knockout mutagenesis has been expanding the last few years. The ClosTron  
system, which makes use of a mobile intron that can be retargeted to a sequence of interest, 
has proven to be particularly efficient for insertional mutagenesis in  a range of clostridial 
species 177, but only a few studies have used ClosTron mutagenesis in gIICb thus far 178,179. 
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Interestingly, ClosTron has been used to knockout the bont gene both in gICb and gIICb 
178,180, but the properties of the gIICb knockout strain in view of its possible usefulness for 
challenge or process validation studies in foods were not further investigated. Importantly, a 
disadvantage of ClosTron mutagenesis is that reversion to the toxigenic state by excision of 
the intron from the bont gene cannot be excluded. For this reason, we additionally developed 
a method for bont deletion that makes use of pyrE, a gene encoding the enzyme orotate 
phosphoribosyltransferase which is required for de novo pyrimidine biosynthesis. This gene 
has been used before in various clostridia (C. sporogenes, C. difficile, C. acetobutylicum) as a 
positive/negative selection marker. PyrE is essential for growth in the absence of uracil, while 
cells lacking PyrE become resistant to 5-fluoroorotic acid (5-FOA), a substrate analogue in de 
novo uracil biosynthesis that is converted by PyrE to a toxic metabolite. Therefore, cells 
encoding pyrE can be selected on uracil-free medium or counterselected in the presence of 5-
FOA 181–183. We used this bidirectional selection to delete bont/E and replace it by an 
erythromycin resistance cassette. This is the first report of a targeted gene deletion in gIICb. 
In addition, our gene replacement strategy is novel in that it allows a single-step selection of 
gene replacement by double homologous recombination and loss of the plasmid on which the 
donor DNA is supplied. 
 
4.2 Materials and Methods  
4.2.1 Bacterial strains and growth conditions 
Cultures of C. botulinum type E NCTC 11219 (obtained from National Collection of Type 
Cultures, Public Health England) were routinely grown at 30 °C in trypticase peptone glucose 
yeast extract broth (TPGY; 50 g/l trypticase (Becton-Dickinson, MD, USA), 5 g/l 
bacteriological peptone (Oxoid, Basingstoke, UK), 20 g/l yeast extract (Oxoid), 4 g/l glucose 
(Acros, New Jersey, USA), 1 g/l sodium thioglycollate (Sigma, Steinheim, Germany)) and 
plated on reinforced clostridial medium (RCM (Thermo Fisher Diagnostics, Groot-
Bijgaarden, Belgium); 37 g/l RCM + 15 g/l agar), TPGY agar (TPGY broth + 15 g/l agar) 
or tryptone yeast extract thioglycollate agar (TYG; 30 g/l tryptone (Lab M, Heywood, UK), 
20 g/l yeast extract, 1 g/l sodium thioglycollate, 15 g/l agar). Trypticase glucose yeast broth 
(Bio-Rad, CA, USA) supplemented with 0.1 % trypsin (Thermo Scientific, Darmstadt, 
Germany) was used to grow cultures for the mouse bioassays. Uracil-deficient medium was 
accomplished by replacing yeast extract in TPGY agar with 20 g/l Acid Hydrolysed Casein 
(Lab M)184. Clostridial vegetative cultures were manipulated and incubated in a Don Whitley 
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DG250 anaerobic workstation (initial gas mixture comprised of 80% N2, 10% CO2, and 10% 
H2) using overnight pre-reduced media. E. coli strains were grown in lysogeny broth (LB; 10 
g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl) or on LB agar (LB + 15 g/l agar) at 37 °C.  E. 
coli DH5α was used for cloning and maintenance of plasmids, while E. coli CA434 (HB101 
containing plasmid R702, 185) was used as conjugation donor. Media were supplemented with 
the following antibiotics (Applichem, Darmstadt, Germany): thiamphenicol (Tm, 15 μg/ml in 
agar, 7.5 μg/ml in broth) and erythromycin (Em, 2.5 μg/ml) for C. botulinum, and cycloserine 
(Cy, 250 μg/ml) and chloramphenicol (Cm, 25 μg/ml in agar, 12.5 μg/ml in broth) for E. coli. 
5-Fluoroorotic acid (5-FOA, 500 µg/ml (Manchester Organics, Chesire, UK)) was used for 
the screening of uracil auxotrophs. 
4.2.2 Sporulation and purification of spore crops 
Spore crops were prepared using a two-phase sporulation medium as described before, with 
minor adjustments 186. First, a single colony was inoculated in 1 ml TPGY broth at 30 °C. 
After 24 h of growth, this culture was added to a two-phase medium consisting of 4 ml distilled 
deoxygenated water over solid sporulation medium (3 g cooked meat medium (Oxoid), 0.03 g 
glucose, 0.45 g agar in 30 ml water). Spore production in this medium was regularly monitored 
by phase-contrast microscopy (DMLB Leica, Diegem, Belgium), by placing 2 µl of the culture 
on a microscopy slide, and observing the presence of phase-bright or phase-dark spores. 
Spores were harvested from the liquid phase after six days incubation at 30 °C by 
centrifugation (3400 × g, 4 °C, 15 min). The resulting pellet was washed four times with 0.85 
% sterile saline by centrifugation, concentrated fivefold and stored in saline at 1-4 °C outside 
the anaerobic workstation. 
4.2.3 Construction of plasmids 
The ClosTron technology was used for the generation of an insertion mutant. This system is 
based on retargeting a bacterial group II intron to insert in a gene of interest 177,187. Possible 
target sites in the bont/E gene of C. botulinum NCTC 11219 were identified using an intron 
design tool on the ClosTron website (www.clostron.com), and one site was chosen based on a 
high score according to the algorithm as well as proximity to the N-terminus of the toxin. 
The plasmid pMTL007C-E2:Cbo:bontE-211a, containing the intron flanked by the specific 
targeting sequences was obtained from DNA 2.0 Inc. (Menlo Park, CA, USA). 
(GGTCATAATAACTACTATCTCCATTTTTTA<intron>CTAATTATTTACAAA)  
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The second knockout strategy consisted of an allelic exchange of bont/E with ermB, an Em 
resistance gene. A novel three-step strategy was designed, with each step requiring a specific 
plasmid construct. Oligonucleotide primers used in these constructions are listed in Table 4.1 
and were obtained from Integrated DNA Technologies (Heverlee, Belgium). Constructs were 
routinely transferred to E. coli DH5α by electroporation and verified by sequencing before 
further use. The first plasmid construct was used to generate a pyrE deletion (locus tag 
SR42_16845) in strain NTCT 11219. To this end, flanking loci of pyrE were cloned in 
pMTL84151 188 to yield pMTL84151_pyr5’pyr3’. More specifically, the 5’ fragment (1086 bp) 
was amplified from gDNA of NCTC 11219 with primers pyrE_5’F/pyrE_5’R and the 3’ 
fragment (1164 bp) with primers pyrE_3’F/pyrE_3’R. Amplicons were restricted with 
respectively KpnI/BamHI, and BamHI/XhoI, ligated end-to-end in pMTL84151 opened with 
KpnI and XhoI, and electroporated to E. coli DH5α.  
Secondly, the plasmid pMTL84151_∆bont, used to replace bont/E for ermB was constructed 
as illustrated in Fig. 4.1. Flanking loci (5’ locus: 1080 bp; 3’ locus: 1261 bp) of bont/E were 
first cloned in pMTL84151, using primers bontE_5’F/bontE_5’R and bontE_3’F/bontE_3’R 
for amplification. These loci include the first two codons of bont/E in the 5’ fragment and the 
last sixteen codons in the 3’ fragment. After restriction of the PCR products with respectively 
KpnI/BamHI and BamHI/XhoI, the 5’ and 3’ fragments were ligated end-to-end in 
pMTL84151 opened with KpnI and XhoI. Subsequently, ermB (amplified from pMTL82254 
with pMTL82254ermB_F/pMTL82254ermB_R and restricted at both ends with BamHI) 
was inserted in the BamHI site of this plasmid, resulting in pMTL84151_5’bont_ermB_3’bont. 
In addition, wild type pyrE of NCTC 11219 (675 bp) was amplified from start to stop codon 
with primers pyrE11219_F/pyrE11219_R, restricted with NdeI/SacI and placed after 
promotor pfdx in pMTL83353 opened with the same enzymes. pfdx was used to drive pyrE 
expression because pyrE is located at the end of an operon in NCTC 11219 and thus could not 
be simply transcribed with its native promotor. Hereafter, the fragment containing p fdx and 
pyrE was amplified with pMTL83353_F/pyrE11219_R, digested with SbfI and SacI and 
cloned in pMTL84151_5’bont_erm_3’bont, restricted with the same enzymes. This resulted in 
the plasmid pMTL84151_∆bont.  
A third plasmid was designated pMTL84151_WTpyr, used for restoring the pyrE deletion 
back to wild type. This was created by cloning a pyrE amplicon with its 5’ and 3’ flanking 
regions (2956 bp) generated with primers pyrE_5’F/pyrE_3’R and restricted with KpnI and 
XhoI, into pMTL84151, cleaved with the same enzymes. In this construct, a promotor is 
absent thus pyrE is not expressed on the plasmid.  
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Table 4.1: PCR oligonucleotides used for cloning and construct verification. Restriction sites are underlined: 
KpnI (GGTACC), BamHI (GGATCC), XhoI (CTCGAG), NdeI (CATATG), SacI (GAGCTC) and SbfI 
(CCTGCAGG). The primers’ coordinates of NCTC 11219 are indicated in the third column, based on accession 
numbers JXMR01000001a or JXMR01000004b. 
Name Sequence (5'-3') Coordinate  
of 3’ end 
ClosTron 
  
bontE_F CCAGGCGGTTGTCAAGAATTTTAT 2298420a 
bontE_R TCAAATAAATCAGGCTCTGCTCCC 2298057a 
RAM_F ACGCGTTATATTGATAAAAATAATAATAGTGGG 
 
RAM_R ACGCGTGCGACTCATAGAATTATTTCCTCCCG 
 
pCD6_F GTTGGGAGTAGTTGTGC 
 
pCD6_R ATGGTATCTCATTATTGGC 
 
ClosTron_R GTTTCAGACACTTTCCTCTATCGAG 
 
Y-linker primer TTTCTGCTCGAATTCAAGCTTCTAACGATGTACGGGGACACATG 
∆pyrE 
  
pyrE_5'F AACGGTACCCCACTACGTTCTCTCTTAGAGG 246521b 
pyrE_5'R AACGGATCCTGAGTTTAAGGTTTTTAGTTGG 247564b 
pyrE_3'F CATGGATCCTCCTCCCAAATTTCATAATGT 248312b 
pyrE_3'R CATCTCGAGTGTTTTATGCTGTGGTCCTG 249436b 
pyrE_5'Fb CCAACTTTATCAAAAGCTCAG 246369b 
pyrE_3'Rb CTAATACAGGAAAGCATGGC 249503b 
pMTL84151_mcsF AGGAAACAGCTATGACCG 
 
pMTL84151_mcsR GACGTTGTAAAACGACGG   
∆bontE 
  
pyrE11219_F AGGCATATGGAAGCATATAAAAAAGAG 248264b 
pyrE11219_R CTTGAGCTCCTACTTAGCACCATATTC 247627b 
bontE_5'F TAAGGTACCGTTATTGGAGATACATCCGG 2299564a 
bontE_5'R TAAGGATCCTGGCATATACAGCATCTCC 2298522a 
bontE_3'F TAAGGATCCAGAGATCATACAAACAGCAATGG 2294800a 
bontE_3'R TAACTCGAGCTATTCGAGAGAGCATTGGTCG 2293583a 
upbontE_F GAACTACTTATAAAAGAACAAACCTCACC 2299627a 
downbontE_R GAATGGATATCTTAGGATAATCATTCCAC 2293466a 
pMTL83353_F GAGCCTGCAGGATAAAAAAATTGTAG 
 
pMTL82254ermB_F  GTTGGATCCGAAGCAAACTTAAGAGTGTG 
 
pMTL82254ermB_R TACGGATCCACATTCCCTTTAGTAACGTG   
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Fig. 4.1: Scheme showing the different fragments cloned between SbfI and AscI restriction sites of shuttle vector 
pMTL84151 (TmR) to create pMTL84151_∆bont (TmR EmR), that was used for replacing the bont/E gene for 
an ermB marker. The pfdx promotor (bended arrow) was derived from pMTL83353 and drives expression of pyrE, 
which was amplified from gDNA of NCTC 11219. The 5’ and 3’ fragments of bont/E were also amplified from 
NCTC 11219 gDNA, and flank ermB derived from pMTL82254. 
4.2.4 Mating  
Each of the four plasmid constructs described above was introduced in E. coli CA434 by 
electroporation and selecting CmR transformants (the catP marker encodes Cm/Tm 
resistance; Cm is used in E. coli whereas Tm is used in C. botulinum). Hereafter, plasmid 
transfer to C. botulinum was accomplished by conjugation. The pMTL84151 backbone carries 
the Gram negative ColE1 replicon (theta replication), the transfer functions of incP plasmid 
RK2, and the Gram positive pCD6 replicon of which the exact mechanism of replication is not 
clear 189,190.  
For plasmid transfer to C. botulinum NCTC 11219, one ml of an overnight LB culture of E. 
coli donor containing the appropriate plasmid was centrifuged, the pellet was washed with 
PBS (phosphate buffered saline, 8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 0.24 g/l KH2PO4, 
pH adjusted with HCl to 7.4) and taken in the anaerobic workstation. Next, the pellet was 
resuspended in 200 µL of the NCTC 11219 recipient grown for 24 h in TPGY broth, 
whereafter the mixture was spread on a cellulose acetate filter (poresize 0.45 µm) on non-
selective TYG agar. After 24 h of incubation at 30 °C, the cells were washed off the filter with 
1 mL PBS, and 200 µL was plated on selective RCM plates (Tm for resistance encoded on the 
plasmid, Cy against E. coli donor). Colonies appearing within three days were restreaked to 
purity on the same selective medium. 
4.2.5 Isolation and verification of bont/E ClosTron insertion mutant 
To confirm transfer of the ClosTron plasmid pMTL007C-E2:Cbo:bontE-211a to NCTC 
11219, TmR colonies were purified after mating and analysed by PCR using primers 
RAM_F/RAM_R. Subsequently, transconjugants were streaked on RCM supplemented with 
Em, and well-developed colonies appearing within three days were restreaked on the same 
medium for purification. PCR and sequence analysis with primers bontE_F/bontE_R were 
performed to verify successful intron insertion in bont/E. Individual colonies from a verified 
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clone were then screened for Tm sensitivity, indicating loss of the ClosTron plasmid, which 
was hereafter confirmed by PCR using primers pCD6_F/pCD6_R.  
To investigate whether only one insertion event took place, the Y-linker PCR described by 
Kwon & Ricke was used 191. In this method, gDNA of the ClosTron mutant is restricted to 
completion with NlaIII and ligated to a Y-shaped linker, generated by mixing two 
oligonucleotides that are complementary only at one end. The complementary parts of these 
oligonucleotides form the stalk of the linker, which has a 3’ CATG overhang that stocks to 
the NlaIII chromosomal DNA ends. The non-complementary parts of the oligonucleotides 
form the Y-linker arms. PCR is then conducted on the ligation mixture with a ClosTron 
specific primer (ClosTron_R) and a Y-linker primer with a sequence identical, not 
complementary, to one of the arms. Only when the ClosTron_R primer extends DNA 
synthesis during the first PCR cycle into the Y-linker arm, the Y-linker primer can anneal 
and a PCR product will be formed. Consequently, the two primers selectively amplify all 
fragments in the genome containing the ClosTron insert so that the amount of insertions 
could be determined.  
4.2.6 Isolation and verification of bont/E deletion mutant  
After conjugation of pMTL84151-pyr5’pyr3’ to NCTC 11219, transconjugants were streaked 
on RCM supplemented with 5-FOA to select for PyrE deficient mutants generated by double 
homologous recombination between the plasmid-based pyrE-flanking fragments and the 
corresponding chromosomal sequences. Deletion was confirmed by PCR and sequence 
analysis with primers pyrE_5’Fb/pyrE_3’Rb, which anneal outside the homologous 
fragments involved in recombination. Further, a clone from which the plasmid was cured, was 
isolated by screening for Tm sensitivity. Next, NCTC 11219 ∆pyrE was mated with E. coli 
CA434 containing pMTL84151_∆bont. Transconjugants were streaked on RCM 
supplemented with Em and 5-FOA, to select for clones in which double homologous 
recombination as well as loss of the plasmid had occurred. Plasmid loss was confirmed by the 
Tm sensitivity of the clones. PCR and sequence analysis with primers 
upbontE_F/downbontE_R, annealing outside the homologous fragments, were performed to 
confirm that bont/E was deleted and replaced by ermB. Finally, the pyrE gene was restored to 
wild type by first conjugating pMTL84151-WTpyr to NCTC 11219 ∆pyrE ∆bontE::ermB and 
subsequently propagating one transconjugant in liquid TPGY medium for about 60 
generations and subsequently plating on uracil-deficient medium. Only clones in which the 
chromosomal pyrE gene is restored by allelic exchange with the plasmid-based promotorless 
pyrE grow well on these plates. One such clone, confirmed by PCR and sequence analysis to 
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be identical to the wild type in the pyrE locus and from which the plasmid was cured as 
explained before, was isolated and designated NCTC 11219 ∆bontE::ermB.  
4.2.7 Mouse bioassays 
Mouse bioassays were performed for detection of active botulinum toxin in clostridial cultures. 
The assays were performed with bont/E knockout strains NCTC 11219 bontE211a::CT and 
NCTC 11219 ∆pyrE ∆bontE::ermB, and with the corresponding positive control strains NCTC 
11219 wild type and NCTC 11219 ∆pyrE, respectively. Supernatants from five-day cultures 
of the strains in trypticase glucose yeast broth supplemented with trypsin at 30 °C were used 
for toxin testing. A seroneutralization test using anti-E antitoxin which specifically 
neutralizes the toxic effects of BoNT/E was included. Neutralized (i.e. mixed with antitoxin) 
and untreated filtered supernatants were injected intraperitoneally in mice for evaluat ing the 
toxicity. Two animals were used per sample. Mice were observed at regular intervals for a 
period of four days for signs of botulism (ruffling of the fur, hypotonic abdomen, wasp-waist, 
difficulty in breathing, weakness of the limbs, and total paralysis) or death. Typical paralysis 
and/or death of the mice with prevention of these effects by the administration of antitoxin 
establishes a positive test for BoNT/E.  
4.2.8 Phenotypical analysis of wild type NCTC 11219 and NCTC 11219 bont/E mutants 
Unstressed growth. Wild type C. botulinum NCTC 11219 and mutants bontE211a::CT and 
∆bontE::ermB were inoculated in triplicate (three independent single colonies of each strain) 
in 1 ml TPGY broth and incubated for 24 h at 30 °C. The stationary cultures were diluted 
5x103-fold in 50 mL TPGY (= t0), and incubated at 30 °C. Cell numbers were determined by 
plate counting on TPGY agar every 2 h during 16 h and again 8 h later. 
Stressed growth. Six independent overnight cultures of wild type and mutants were streaked 
on RCM plates with different pH (5.7, 5.5, 5.2, 4.9; adjusted with HCl and measured before 
and after autoclaving) or NaCl content (1.9 %, 2.1 %, 2.3 %, 2.5 %; taking into account that 0.5 
% NaCl is already present in RCM). The plates were incubated at 30 °C in an anaerobic 
workstation and colony formation was observed macroscopically for several days. Growth at 
lower temperatures was analysed by streaking six independent single colonies from each 
strain that were pregrown at 12 °C on RCM plates, and incubating the plates in AnaeroGen 
bags (Oxoid) at 8 °C and 12 °C. Colony formation was observed daily, and the time that was 
required to form 1 mm colonies was noted for each replicate.  
Heat resistance of spores. Spore crops were made in triplicate from different colonies per 
strain and used within two weeks for this experiment. The init ial spore count was determined 
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by plate counting on TPGY after a heat treatment to inactivate remaining vegetative cells (65 
°C, 10 min), but non-preheated samples were used for the heat inactivation experiment. Heat 
treatments were conducted in a heating block at 70 °C, 73 °C, 90 °C and 93 °C. At different 
time points, samples were taken and cooled immediately to stop inactivation, diluted in 0.85 
% NaCl, plated on TPGY and incubated at 30 °C for colony counting. For the treatments at 
90 °C and 93 °C, lysozyme (10 µg/ml; Carl Roth GmbH, Karlsruhe, Germany) was added to 
the plating medium. The D-value was determined as the negative reciprocal of a regression 
line fitted on a plot of the logarithm of the plate count versus time.  
Onset of sporulation. Single colonies were inoculated in 1 ml TPGY broth in triplicate and 
incubated for 14 h at 30 °C. Then, these cultures were diluted hundredfold in 5 mL TPGY (= 
t0), and incubated at 30 °C. After different incubation times, aliquots were heat treated (65 °C, 
10 min) in a heating block and then plated on TPGY plates, to determine the spore counts. 
Total cell numbers were determined by plate counting without receiving the heat treatment.  
4.2.9 Statistical analysis  
To statistically assess the equivalence of unstressed growth, spore yield, spore fraction and 
spore heat resistance between the wild type and the bont/E mutants, the two-tailed unpaired 
Student's t test was used with a significance level of 0.05. Since growth at low temperature 
was analysed in a ‘time to colony formation’ experiment, in this case a logistic regression 
model was fitted using the day, temperature and strain as predictor variables. The proposed 
model was highly significant (P-value whole model likelihood ratio test < 0.001; generalized 
R² = 0.9063) and showed no lack of fit (P-value lack of fit likelihood ratio test ~ 1), indicating 
it was suitable for testing the individual parameters. 
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4.3 Results and Discussion  
C. botulinum NCTC 11219 is a group II type E strain, of which we reported the genome 
sequence in four contigs (accession number JXMR01000001-JXMR01000004) in Chapter 3 
192. Here, we used this strain for the construction of atoxigenic mutants. The ClosTron system 
was used for insertional inactivation of the bont/E gene, whereas a new approach based on 
double homologous recombination using the selection markers pyrE and ermB was designed 
to create a bont/E deletion.  
4.3.1 Construction of insertion mutant C. botulinum NCTC 11219 bontE211a::CT  
Plasmid pMTL007C-E2:Cbo:bontE-211a, containing an intron retargeted to insert in bont/E, 
was transferred by conjugation to NCTC 11219. Since the intron contains a 
retrotransposition-activated marker (RAM) based on the ermB gene, successful insertion of 
the intron in the genome is selectable by the expression of Em resistance. EmR clones were 
picked up and analysed by PCR and sequence analysis. The intron was correctly located in 
one clone at position 211 in the bont/E open reading frame with an antisense orientation of 
ermB relative to bont/E (Fig. 4.2, Fig. 4.3 lane 2-3). Further analysing this clone by Y-linker 
PCR and sequencing of the PCR product, confirmed that only a single intron was present in 
the genome. The efficiency of the different steps in the ClosTron mutagenesis procedure was 
rather low. For conjugation of the ClosTron plasmid to NCTC 11219, several attempts were 
needed to obtain only two transconjugants. Similarly, several clones of transconjugants had 
to be streaked to obtain fifteen EmR colonies, and only one of these had the correct intron 
insertion. This confirms earlier statements in the literature that C. botulinum is less genetically 
tractable than most other clostridia 178,193. 
4.3.2 Construction of deletion mutant C. botulinum NCTC 11219 ∆bontE::ermB 
A deletion strategy to knockout bont/E was developed by combining different genetic tools 
that have not yet been used in gIICb, despite their success in other clostridia. Since effective 
suicide plasmids have not yet been described for C. botulinum, and given the reported low 
frequency of DNA transfer into gIICb, we chose to make use of pseudo-suicide plasmids for 
conjugation 187,194. These plasmids autonomously replicate but are segregationally unstable, 
providing the advantage to be lost more rapidly in the absence of selection after successful 
conjugation. A set of modular shuttle vectors, the pMTL80000 series, carrying four different 
Gram-positive replicons was constructed by Heap et al. (2009) for use in the clostridia 188. We 
selected pMTL84151 with the pCD6 replicon from this set since this plasmid has the lowest 
stability in gICb and gIICb (188, unpublished results). Another key element in the knockout 
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strategy was the use of the pyrE gene as a bidirectional selection marker. First, pyrE was 
deleted from NCTC 11219 resulting in a 5-FOA resistant and uracil auxotroph strain (Fig. 
4.3. Lane 4-5). Then the obtained ∆pyrE mutant was used as background to delete bont/E and 
replace it with an ermB marker. This was achieved by first conjugating pMTL84151_∆bont 
(Fig. 4.1) to the ∆pyrE mutant and selecting for Tm  resistance, then streaking a 
transconjugant on medium containing both Em and 5-FOA. Since the plasmid expresses pyrE 
in trans, 5-FOA selects for its loss. Further, clones that lost the plasmid can only remain 
resistant to Em when the ermB gene was exchanged with the bont/E gene by double 
homologous recombination. Although this procedure selects for two events simultaneously, 
the frequency was sufficient to allow isolation of several colonies from a single streak. 
Obviously, the efficiency benefits from the low segregational stability of the plasmid. Loss of 
the plasmid was confirmed by loss of Tm resistance, and PCR and sequence analysis confirmed 
the replacement of bont/E by ermB (Fig. 4.2, Fig. 4.3 lane 6-7).  
Finally, the pyrE deletion was restored to wild type by swapping pyrE and its flanking regions 
back to the chromosome by double homologous recombination with pMTL84151_WTpyr. To 
this end, the plasmid was first conjugated to NCTC 11219 ∆pyrE ∆bontE::ermB. The TmR 
transconjugants remained resistant to 5-FOA, which confirmed that pyrE was not expressed 
on pMTL84151_WTpyr. Since pyrE was cloned without its promotor (which is further 
upstream the pyr operon) on this plasmid, this result indicates that there is no leaky expression 
from plasmid promoters. In line with this observation, the transconjugants did not grow when 
they were plated on uracil-deficient medium, except for some rare colonies which showed 
normal growth when restreaked on the same medium. From these, subclones having lost the 
plasmid with a TmS phenotype were isolated. These were confirmed to have a wild type 
chromosomal pyrE allele, and were designated as NCTC 11219 ∆bontE::ermB. 
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 Fig. 4.2: Schematic representation of A) bont/E with its upstream and downstream genes in C. botulinum NCTC 
11219. Locus tags for all genes are also shown. B) Position of the ClosTron insert after the 211 th nucleotide of 
the bont/E open reading frame in the NCTC 11219 bontE211a::CT mutant, with ermB positioned antisense to 
bont/E. Also shown are primers bontE_F/bontE_R, annealing up- and downstream of the ClosTron target site, 
and primers upbontE_F/downbontE_R, annealing outside the loci used in double homologous recombination to 
delete bont/E. C) NCTC 11219 ∆bontE::ermB mutant with bont/E deleted and replaced by ermB, confirmed by 
PCR using primers upbontE_F/downbontE_R. The positions of the cloning primers bontE_5’F/bontE_5’R and 
bontE_3’F/bontE_3’R, used for construction of pMTL84151_∆bont, also are indicated.  
 
 
Fig. 4.3: PCR analysis of different strain constructs. Lane 1 and 8: Molecular size marker (GeneRuler from 
Thermo Scientific); lane 2: NCTC 11219, bont/E fragment amplified with primers bontE_F/bontE_R (expected 
size: 410 bp); lane 3: NCTC 11219 bontE211a::CT, bont/E fragment with ClosTron insertion amplified with 
primers bontE_F/bontE_R (expected size: 2008 bp); lane 4: NCTC 11219, pyrE region amplified with primers 
pyrE_5Fb/pyrE_3Rb (expected size: 3174 bp); lane 5: NCTC 11219 ∆pyrE, pyrE region amplified with primers 
pyrE_5Fb/pyrE_3Rb (expected size: 2474 bp); lane 6: NCTC 11219 ∆pyrE, bont/E region amplified with primers 
upbontE_F/downbontE_R (expected size: 6218 bp); lane 7: NCTC 11219 ∆bontE::ermB, bont/E region amplified 
with primers upbontE_F/downbontE_R (expected size: 3449 bp).  
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4.3.3 Mouse bioassays 
The presence of BoNT/E in culture supernatants of the NCTC 11219 wild type and the ∆pyrE 
strain was confirmed whereas no active toxin was detected for the bont/E insertion and 
deletion mutants. All mice injected with supernatant of wild type and ∆pyrE died within a day, 
while mice injected with supernatants of the mutants or supernatants from the bont/E wild 
type strains mixed with antitoxin E, survived till the end of observation at four days. Thus, 
loss of toxicity in both mutants was confirmed. In addition, the seroneutralization test using 
anti-E antitoxin confirmed that only one neurotoxin is produced by NCTC 11219, as was 
already predicted from the genome sequence (Chapter 3,192). 
4.3.4 Phenotypical analysis of wild type NCTC 11219 and NCTC 11219 bont/E mutants 
Nontoxic mutants of gIICb have the potential to greatly facilitate basic research and food 
challenge studies with this organism, provided that their properties related to growth, 
sporulation, survival and inactivation are not modified due to the knockout of the bont/E gene. 
Here, we compared the growth, sporulation and spore heat resistance of both constructed 
bont/E mutants and the wild type NCTC 11219 strain.  
Unstressed growth. The growth curves of the mutants and the wild type at 30 °C were very 
similar (Fig. 4.4). The DMFit software was used to determine the maximum growth rate µmax 
and the upper asymptote yend. The lag phase could not be evaluated because there were not 
enough points available to measure this accurately. No significant differences existed between 
µmax and yend of the wild type, ClosTron and ∆bontE mutant. The values were 0.7 +/- 0.2, 0.5 
+/- 0.1, 0.4 +/- 0.0 (log CFU/ml)/h for µmax, and 7.8 +/- 0.3, 8.0 +/- 0.0; 8.0 +/- 0.1 log 
CFU/ml for yend, respectively.  
Stressed growth. A quantitative comparison of growth under acidic, NaCl and low 
temperature stress was performed by assessing the time to colony formation on RCM plates 
using six replicates per strain. On acidified RCM, results of both mutants and wild type were 
identical in sixfold. Single colonies of 1 mm were visible after 24 h at pH 5.7 and after 30 h at 
pH 5.5, while pinpoint colonies appeared after 72 h at pH 5.2. No colonies were formed at pH 
4.9 up to 5 days. Under NaCl stress, all three strains showed clear single colonies in sixfold 
after 24 h at 1.9 % and 2.1 % NaCl. Unexpectedly, a small difference was observed at 2.3 % 
NaCl between the ∆bontE::ermB strain compared to the wild type and ClosTron mutant. Strain 
∆bontE::ermB formed clear 1 mm colonies after 24 h (sixfold) while those of the wild type and 
ClosTron mutant were pinpoint sized, and reached 1 mm only after 48 h (sixfold). No colonies 
appeared on 2.5 % NaCl for any strain. The third stress condition tested, was growth at low 
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temperature. Single colonies grown at 12 °C on RCM were restreaked in sixfold on RCM, 
then incubated at 12 °C and 8 °C, and the time to formation of colonies (1 mm) was registered. 
As opposed to the data for acid and NaCl stress, the time to colony formation at low 
temperature showed variability among the six replicates per strain as well as between strains, 
as indicated in Table 4.2. A logistic regression model was fit on this data and showed that 
there was no significant effect of the strain (P-value effect likelihood ratio test 0.2388). 
Therefore, it can be concluded that there is no significant difference in growth at low 
temperature between the three strains. 
 
Fig. 4.4: Growth in TPGY broth at 30 °C of wild type NCTC 11219, NCTC 11219 bontE211a::CT and NCTC 
11219 ∆bontE::ermB determined by plate counting on TPGY. Means +/- standard deviations are shown from 
three independent replicates of each strain. The growth curves were modeled with DMFit to determine the 
growth rate and upper asymptote yend. No significant differences were found between the three strains (p > 0.05).  
 
Table 4.2: Growth at 12 °C and 8 °C of wild type NCTC 11219, NCTC 11219 bontE211a::CT and NCTC 11219 
∆bontE::ermB on RCM plates. Single colonies were restreaked in sixfold and the time to formation of 1 mm 
colonies was noted. 
 
Number of plates showing single colonies  
  at 12 °C at 8 °C 
 Days (d) 3 d 4 d 7 d 8 d 9 d 
NCTC 11219 5/6 6/6 4/6 5/6 6/6 
bontE211a::CT 4/6 6/6 4/6 6/6 6/6 
∆bontE::ermB  3/6 6/6 3/6 4/6 6/6 
 
Spore production. Sporulation was performed in two-phase sporulation medium and 
observed regularly with phase-contrast microscopy. Spore formation started within 72 h for 
all strains. Spore counts were determined after six days by plate counting after inactivation of 
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the vegetative cells at 65 °C for 10 min. No differences were observed in spore yield between 
wild type, bontE211a::CT and ∆bontE::ermB. Spore crops used for treatments at 90 °C/93 °C 
had a yield of 7.8 log +/- 0.1 CFU/ml, 8.1 +/- 0.3 CFU/ml and 7.9 +/- 0.1 CFU/ml, 
respectively. The spore crops used for heat treatments at 70 °C/73 °C all had the same yield, 
7.6 log +/- 0.1 CFU/ml. 
The NCTC 11219 ClosTron mutant shows an early onset of sporulation. Although the 
spore yield after six days was identical for the NCTC 11219 mutants in comparison with the 
other strains, we observed with microscopy that particularly high numbers of NCTC 11219 
bontE211a::CT spores were already present in early stationary-phase cultures while this was 
not the case for the deletion mutant (note: the wild type strain could not be observed under 
the microscope because of biosafety restrictions). To compare the degree of sporulation in the 
early stationary phase, we determined the spore counts as well as the total counts in cultures 
of the ClosTron mutant and the wild type strain at different time points. It is important to 
note that sporulation is assessed here in TPGY growth medium, not in the sporulation 
medium that is used for sporulation (which follows the six days protocol). 
First, single colonies were inoculated in TPGY and incubated for 14 h. Then, this pre-culture 
was diluted hundredfold in fresh TPGY and plated, and this point was defined as time 0. 
Already at time 0, 2.3 +/- 0.4 log spores/ml could be detected for the ClosTron mutant while 
spore counts of the wild type strain were under the detection limit at this time point (< 1 log 
spores/ml). Despite this difference in spore counts, the total cell counts did not show any 
significant difference, with 5.3 +/- 0.1 log cfu/ml and 5.5 +/- 0.2 log cfu/ml for the ClosTron 
mutant and parental strain respectively. Thus, a significant higher fraction of spores per total 
count was demonstrated for the ClosTron mutant, as shown in Table 4.3. Also after 10 h of 
growth, the spore fraction remains to be significantly higher for the bontE211a::CT mutant, 
while no significant difference is shown after 23 h and 40 h. 
Table 4.3: The fraction of spores in cultures of the wild type strain and the bontE211a::CT mutant. Means +/- 
standard deviations are shown of experiments in triplicate. Significant differences in the spore fraction are 
indicated with * (P < 0.05). 
Time (h) NCTC 11219 
 
bontE211a::CT 
0 <3.79 x 10-5 +- 2.13 x 10-5 * 1.33 x 10-3 +- 1.12 x 10-3  
10 1.20 x 10-5 +- 6.16 x 10-6 * 1.78 x 10-3 +- 2.96 x 10-4 
23 5.26 x 10-5 +- 8.44 x 10-5 
 
1.00 x 10-3 +- 8.66 x 10-4 
40 4.22 x 10-3 +- 5.01 x 10-3 
 
6.07 x 10-3 +- 1.29 x 10-3 
 
In a variant of this experiment, colonies were picked up from a plate and directly inoculated 
in TPGY broth in triplicate, without making a preculture in TPGY. After 10 h of growth, the 
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spore counts were determined. At the start of inoculation, t = 0, no spores were detected for 
both strains (< 1 log spores/ml). 10 h after inoculation, the ClosTron mutant already showed 
3.0 +/- 0.2 log spores/ml, while spore counts of the wild type strain were still under the 
detection limit at this time point. 14 h after inoculation, 4.0 +/- 0.3 log spores/ml could be 
detected for the mutant whereas 1.6 +/- 0.5 log spores/ml were present in the wild type 
culture, thus again a significant higher spore number was shown for the mutant. Although no 
total cell counts were recorded in this second experiment, the results are in line with the first 
experiments, and indicate that the ClosTron mutant sporulates earlier during growth than 
the wild type strain.  
Spore heat resistance. In the analysis of spore heat resistance, we incorporated lysozyme in 
the recovery medium because this is known to increase the number of survivors of gIICb 
spores (see 1.7) 186,195. This is because the cortex hydrolases which are required for spore 
germination are very heat sensitive, but can be substituted by exogenous lysozyme. The 
inactivation curves at 90 °C and 93 °C showed a biphasic trend, with an initial rapid decrease 
of about 2 – 2.5 log, followed by a slower log-linear decrease (Fig. 4.5). This is in line with 
previous reports, and has been attributed to the existence of a lysozyme-impermeable and -
permeable fraction in the spore population 196. The D-values were calculated only from the 
log-linear part, corresponding to the presumed lysozyme-permeable fraction. No differences 
were observed in the D90°C and D93°C between the three strains, suggesting that spore heat 
resistance is not affected by inactivation of bont/E. In addition, we chose to report heat 
resistance without lysozyme in the recovery medium. This reduces the apparent heat 
resistance of the spores, and treatments were therefore performed at 70 °C and 73 °C. 
Inactivation was log-linear in this case (Fig. 4.6), and presumably correlates with the 
inactivation of the spore cortex hydrolases. The D70°C of the two mutants was slightly but 
significantly lower than that of wild type, but no difference was found between the D70°C of 
both mutants. In contrast, the D73°C was not different between the three strains. Together, 
these results indicate that spore heat resistance is unaffected in the mutants, except for a small 
difference at 70 °C. Since this difference was observed both in the insertion and deletion 
mutant, it is unlikely to result from an accidental mutation unrelated to the knockout of the 
bont/E gene. One possible explanation is that the effect is due to a polar effect on one or more 
genes upstream or downstream of bont/E. However, given the gene context as shown in Fig. 
4.2, it is difficult to imagine how the same polar effect could exist in both mutants. Finally, it 
cannot be excluded that the difference is a direct consequence of the abolition of toxin 
production. For example, it has been recently demonstrated that there is a regulatory link 
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between sporulation and toxin production in gIICb strain Beluga via the Spo0A gene product 
23.  
 
Fig. 4.5: Heat inactivation of spores of wild type NCTC 11219, NCTC 11219 bontE211a::CT and NCTC 11219 
∆bontE::ermB at 90 °C and 93 °C. Means +/- standard deviation of three independent experiments are shown, as 
well as average D-values +/- standard deviation at 90 °C and 93 °C derived from the linear part of the curve.  A 
common letter superscript at the same temperature indicates that there is no significant difference.  
 
 
 
Fig. 4.6: Heat inactivation of spores of wild type NCTC 11219, NCTC 11219 bontE211a::CT and NCTC 11219 
∆bontE::ermB at 70 °C and 73 °C. Means +/- standard deviation of three independent experiments are shown, as 
well as average D-values +/- standard deviation at 70 °C and 73 °C. A common letter superscript at the same 
temperature indicates that there is no significant difference. Since tailing occurred after 40 min at 70 °C and after 
15 min at 73 °C, the corresponding data is not shown or used.  
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4.4 Conclusion 
In this chapter, two strategies were employed for obtaining a gIICb surrogate in which the 
bont/E gene is inactivated. Besides the well-known ClosTron system which generates 
insertional knockouts, we additionally developed a new approach based on double homologous 
recombination for the replacement of bont/E with an ermB cassette. Growth under unstressed 
and stressed conditions, spore yield and spore heat resistance of both mutants, compared with 
the wild type NCTC 11219, were unaffected, except for two properties where small differences 
were noted. Heat resistance of the spores at 70 °C was slightly lower for both mutants,  and 
growth of the deletion mutant in 2.3 % NaCl was faster than for the other strains. In addition, 
an early onset of sporulation was demonstrated for the ClosTron mutant. In this mutant, the 
fraction of spores was much higher (~10-3) than the fraction in the wild type strain (~4.10-5) 
at time points where the cultures are reaching stationary phase.   
The reason for these changes is currently unclear, and it could be of interest to investigate 
whether they are related to the loss of toxin production or to random mutations that have 
occurred during strain construction. However, since the deviations in the mutants are small 
(except for the early sporulation onset in the ClosTron mutant) compared to the natural 
strain-to-strain variation within gIICb, the nontoxic strains will be useful to investigate the 
safety of novel food processing and preservation techniques and for food challenge studies. 
Furthermore, the method for gene deletion developed in this work is a novel tool to construct 
nontoxic derivatives of type B and F gIICb strains as well as to inactivate other genes in gIICb 
and other clostridia.  
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Chapter 5 
Validation of nontoxigenic mutants of group II C. 
botulinum type E strain NCTC 8266, and a deeper look 
into the nontoxigenic mutants of NCTC 11219 and 
NCTC 8266 by whole genome sequencing 
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5.1 Introduction 
The previous chapter described the construction of two nontoxigenic mutants of gIICb strain 
NCTC 11219. The ClosTron system 187 was used for creation of a bont/E insertion mutant, 
whereas a new knockout strategy was developed which enabled the construction –for the first 
time- of a bont/E deletion mutant. While most phenotypical characteristics of the mutants 
were identical to the parental strain, also some unexpected differences were noted. Heat 
resistance of the spores at 70 °C was slightly lower for both mutants, and growth of the 
deletion mutant in 2.3 % NaCl was faster than for the other strains. In addition, an early onset 
of sporulation was demonstrated for the ClosTron mutant.  
In this chapter we aimed to investigate whether these changes are related to the ClosTron 
insertion in, or the gene replacement of, the bont/E gene, or are due to random mutations that 
may have occurred at other genomic locations during mutant construction. To investigate the 
first option, both knockout strategies were repeated on a second strain, C. botulinum NCTC 
8266. The phenotypical characteristics of the constructed NCTC 8266 mutants are presented 
in comparison with the wild type strain NCTC 8266. If phenotypical alterations could be 
observed that were also seen for the NCTC 11219 mutants, this could suggest that the 
inactivation of BoNT plays a role in these changes. In Chapter 3 the genome sequences of 
NCTC 11219, NCTC 8266 and NCTC 8550 were determined and this showed that NCTC 
8266 and NCTC 8550 are highly similar (99 % identity) whereas the genome of NCTC 11219 
is more different (93 % identity), e.g. it is larger in size and contains more prophages. 
Therefore, strain NCTC 8266 was chosen arbitrarily. The four sequence contigs of NCTC 
11219 show respectively 93 %, 82 %, 52 % and 89 % query coverage with the WGS of NCTC 
8266, all with 99 % identity (according to BLAST).  
The construction of nontoxigenic derivatives of a second gIICb strain is also relevant for food 
challenge studies since these studies optimally require inclusion of a strain cocktail of the 
pathogen or pathogen surrogates to account for strain-to-strain variability.  
In a second approach, WGS analysis was performed on the NCTC 11219 mutants and on the 
newly constructed NCTC 8266 ∆bont::ermB mutant to detect mutational events that could 
possibly explain the observed phenotypical changes. 
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5.2 Materials and Methods 
5.2.1 Bacterial strains, construction of plasmids and mutants 
C. botulinum type E NCTC 8266 was obtained from Wetenschappelijk Instituut 
Volkgezondheid (WIV, Brussels, Belgium), that obtained the strain from the National 
Collection of Type Cultures (Public Health England). Clostridial and E. coli cultures were 
grown as described in Chapter 4, see 4.2.1. All insertion and deletion knockout protocols that 
were used for the creation of the NCTC 8266 nontoxigenic mutants, were performed exactly 
as described in 4.2.3 - 4.2.6 for the NCTC 11219 strains. Because the upstream locus (1080 
bp) of bont/E differs in only one base pair between NCTC 11219 and NCTC 8266 while the 
downstream locus is identical (1261 bp), the same plasmid (pMTL8415_∆bont, containing the 
up- and downstream loci) was used to delete bont/E in NCTC 8266. Also the same ClosTron 
plasmid that was used for bont/E insertion in NCTC 11219, was employed to create the 
insertion mutant of NCTC 8266 since an identical targeting sequence is present. On the 
contrary, to delete pyrE and to finally restore pyrE, new plasmids were constructed, because 
the 2955 bp pyrE locus in NCTC 8266 (containing up- and downstream loci of pyrE as well as 
pyrE itself) contains 16 base pairs that are different from the pyrE locus in NCTC 11219. 
Therefore, the pMTL84151_pyr5’pyr3’ and pMTL84151_WTpyr plasmids were constructed 
as described in 4.2.3 (with the same primers), by using the gDNA of NCTC 8266 for 
amplification of the homologous loci.  
5.2.2 Phenotypical analysis of wild type NCTC 8266 and bont/E mutants 
All experiments assessing stressed growth (NaCl, pH, low temperature), spore yield and heat 
resistance were performed in an identical manner as for NCTC 11219, described in 4.2.8, and 
microscopic examination was performed as explained in 4.2.2. In contrast, unstressed growth 
was determined differently. While a plate counting assay was used for growth of the NCTC 
11219 strains, growth of the NCTC 8266 strains was assessed by following OD630 in time. 
More specifically, single colonies were inoculated in triplicate in TPGY broth, after which the 
overnight grown cultures were diluted hundredfold in the same medium in a 96-well 
microtiter plate. The plate was sealed with an oxygen impermeable cover foil (EASYsealTm, 
Greiner, Germany) and subsequently the OD630 was measured outside the anaerobic cabinet 
at 30 °C with regular shaking every 15 min.  
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5.2.3 Whole genome sequencing of the mutants 
To identify all mutational changes that eventually occurred during mutant construction, 
whole genome sequencing was performed on an Illumina MiSeq sequencer.  
The gDNA from mutants from two C. botulinum backgrounds (NCTC 11219 and NCTC 8266) 
was isolated from overnight cultures using the GeneJET Genomic DNA purification kit 
(Thermo Scientific). To obtain high-quality gDNA, formaldehyde was used for fixation of cells 
prior to isolation 163. This step is essential to avoid DNA degradation by abundant 
extracellular DNase activity in gIICb cultures. DNA purity and concentration was assessed 
by Nanodrop analysis, gel electrophoresis and Qubit (Thermo Scientific) analysis. Paired-end 
libraries were constructed using the NEBNext Ultra gDNA library prep protocol with an 
average insert size of 240 bp, and analysed on the Agilent BioAnalyzer (VIB Nucleomics Core) 
resulting in on average 1.2 million reads per sample.  
In collaboration with Bram Van den Bergh (Centre of Microbial and Plant Genetics, KU 
Leuven), reads were analysed with Qiagen’s CLC Genomics Workbench (v.7) (CLC Bio), and 
included standard quality control, read trimming and filtering (reads < 15 nucleotides were 
discarded, quality score limit = 0.01, ambiguous nucleotides trim limit=2), read mapping to 
C. botulinum references (NCBI accession numbers CP010520 (NCTC 8266) and 
JXMR00000000 (NCTC 11219), using parameters: mismatch cost = 2, insertion cost = 3, 
deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8). Lists of mutations were 
obtained combining CLC tools: ‘Fixed Ploidy Variant Detection’ for point mutations and small 
INDELs and ‘Coverage Analysis’ and ‘InDels and structural variants’ for larger structural 
rearrangements. All mutations were manually inspected in the mapping. 
 
5.3 Results and Discussion 
We have constructed nontoxigenic mutants of strain NCTC 8266 in an identical manner as 
described for NCTC 11219 (see 4.2.3 - 4.2.6). The same ClosTron plasmid was employed for 
insertion mutagenesis as the one used in Chapter 4, because of an identical targeting sequence. 
In addition, the same bont/E deletion plasmid was used in NCTC 8266 as the one that was 
used in NCTC 11219, because of the highly similar up- and downstream loci (only 1 base pair 
difference). PCR and sequence analysis confirmed bont/E insertion and deletion in the 
bontE211a::CT and ∆bontE::ermB mutant respectively.  
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Here, the phenotypic characteristics of the insertion and deletion mutant are documented in 
comparison with the wild type strain NCTC 8266. In Chapter 4 it was demonstrated that (i) 
the NCTC 11219 deletion mutant shows a faster growth at 2.3 % NaCl than the other NCTC 
11219 strains, (ii) the ClosTron mutant starts sporulation more early than the wild type strain 
and (iii) heat resistance of the spores at 70 °C was slightly lower for both mutants. If the same 
alterations could be observed in the NCTC 8266 nontoxigenic mutants, this would suggest 
that the inactivation of BoNT plays a role in these changes. Furthermore, whole genome 
analysis was performed on three mutants to identify all mutational changes that have been 
introduced during mutant construction.  
5.3.1 Phenotypical analysis of wild type NCTC 8266 and bont/E mutants 
Unstressed growth. The growth curves of the mutants and the wild type at 30 °C showed 
very similar patterns (Fig. 5.1). The DMFit software was used to determine the maximum 
growth rate µmax, the lag phase and the upper asymptote yend. No significant differences existed 
between the wild type, the ClosTron and the ∆bontE mutant (p > 0.05).  
 
Fig. 5.1: Growth in TPGY broth at 30 °C of wild type NCTC 8266, NCTC 8266 bontE211a::CT and NCTC 8266 
∆bontE::ermB determined by OD. Means +/- standard deviations are shown from three independent experiments. 
The growth curves were modeled with DMFit to determine the growth rate, lag and upper asymptote y end. No 
significant differences were found between the three strains (p > 0.05).  
 
Stressed growth. In analogy with Chapter 4, a quantitative comparison of growth under 
acidic, NaCl and low temperature stress was performed by assessing the time to colony 
formation on RCM plates. On acidified RCM, results of both mutants and wild type were 
identical in sixfold (as well as identical to the results of the NCTC 11219 strains). Single 
colonies of 1 mm were visible after 24 h at pH 5.7 and after 30 h at pH 5.5, while pinpoint 
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colonies appeared after 72 h at pH 5.2. No colonies were formed at pH 4.9 up to 5 days.  The 
second stress condition tested, was growth under NaCl stress. In Chapter 4, unexpectedly a 
difference was observed at 2.3 % NaCl between the ∆bontE::ermB strain compared to the wild 
type NCTC 11219. Strain ∆bontE::ermB formed clear 1 mm colonies after 24 h (in sixfold) 
while those of the wild type were pinpoint sized, and reached 1 mm only after 48 h ( in sixfold). 
In contrast, no differences were seen between the NCTC 8266 and the mutants. All strains 
showed clear colonies on RCM containing up to 2.1 % NaCl after 24 h (in sixfold), while 48 h 
was needed to form clear colonies on 2.3 %. No strains formed colonies on 2.5 % NaCl.   
The third condition tested, was growth at low temperature. Single colonies grown at 12 °C 
on RCM were restreaked in sixfold on RCM, then incubated at 12 °C and 8 °C, and the time 
to formation of colonies (1 mm) was registered. As opposed to the data for acid and NaCl 
stress, the time to colony formation at low temperature showed variability among the six 
replicates as well as between the strains, as indicated in Table 5.2. A logistic regression model 
was fit on this data. This model showed that the ClosTron strain was significantly different 
from the wild type at both temperatures (P < 0.05), whereas no difference was shown for the 
deletion strain (P = 0.35 (8°C); P = 1 (12 °C). The ClosTron mutant demonstrates a clear 
deficiency to grow at 8 °C, with only one of six replicates that showed colony formation (even 
after 17 days).  
Table 5.2: Growth at 12 °C and 8 °C of wild type NCTC 8266, NCTC 8266 bontE211a::CT and NCTC 8266 
∆bontE::ermB on RCM plates. Single colonies were restreaked in sixfold and the time to formation of 1 mm 
colonies was noted. 
 
Number of plates showing single colonies  
  at 12 °C at 8 °C 
 Days (d) 3 d 4 d 5 d 6 d 7 d 8 d 9 d 
NCTC 8266 5/6 6/6 6/6 5/6 6/6 6/6 6/6 
bontE211a::CT 0/6 3/6 6/6 0/6 1/6 1/6 1/6 
∆bontE::ermB  5/6 6/6 6/6 3/6 4/6 6/6 6/6 
 
Spore production. Sporulation was performed in a two-phase sporulation medium and 
observed regularly with phase-contrast microscopy. Spore formation started within 72 h for 
all strains. Spore counts were determined after six days by plate counting after inactivation of 
the vegetative cells at 65 °C for 10 min. No differences were observed in spore yield between 
wild type NCTC 8266, bontE211a::CT and ∆bontE::ermB (p > 0.05). Spore crops used for the 
heat treatments at 90 °C/93 °C had a yield of 8.7 +/- 0.4 log CFU/ml, 8.5 +/- 0.3 log CFU/ml 
and 8.7 +/- 0.3 log CFU/ml, respectively. The same crops were used for the heat treatments 
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at 70 °C/73 °C, but because this experiment was performed a few months later, the counts at 
t = 0 are slightly lower due to spontaneous germination during storage: 8.3 +/- 0.1 log 
CFU/ml, 8.3 +/- 0.1 log CFU/ml, 8.5 +/- 0.1 log CFU/ml respectively. 
In Chapter 4, the onset of sporulation was determined in more detail for the NCTC 11219 
bontE211a::CT mutant because we observed with phase-contrast microscopy that unusual 
high numbers of spores were already present in overnight grown cultures. However, this was 
not observed for the NCTC 8266 mutants and therefore, the onset of sporulation was not 
assessed in detail here.  
Spore heat resistance. In the analysis of spore heat resistance at 90 °C and 93 °C, we 
incorporated lysozyme in the recovery medium because this is known to increase the number 
of survivors of gIICb spores. The inactivation curves at 90 °C and 93 °C showed a biphasic 
trend, with an initial rapid decrease of about 2.7 log, followed by a slower log-linear decrease 
(Fig. 5.3). This is in line with previous reports, and has been attributed to the existence of a 
lysozyme-impermeable and -permeable fraction in the spore population 88,196. The D-values 
were calculated only from the log-linear part, corresponding to the presumed lysozyme-
permeable fraction. No differences were observed in the D90°C and D93°C between the three 
strains. Furthermore, the D70°C and D73°C were determined without the addition of lysozyme. 
While in Chapter 4, a D70°C was demonstrated for both NCTC 11219 mutants that was slightly 
but significantly different from the wild type (Fig. 4.6), there was no difference shown here 
between the NCTC 8266 strains (Fig. 5.4).  
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Fig. 5.3: Heat inactivation of spores of wild type NCTC 8266, NCTC 8266 bontE211a::CT and NCTC 8266 
∆bontE::ermB at 90 °C and 93 °C. Means +/- standard deviation of three independent experiments are shown, as 
well as average D-values +/- standard deviation at 90 °C and 93 °C derived from the linear part of the curve.  No 
significant differences were shown between the strains (P value > 0.05).  
 
Fig. 5.4: Heat inactivation of spores of wild type NCTC 8266, NCTC 8266 bontE211a::CT and NCTC 8266 
∆bontE::ermB at 70 °C and 73 °C. Means +/- standard deviation of three independent experiments are shown, as 
well as average D-values +/- standard deviation at 70 °C and 73 °C. No significant differences were shown 
between the strains (P value > 0.05).  
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5.3.2 Whole genome sequencing of the mutants 
To further investigate the altered phenotypes that have been described earlier for the 
nontoxigenic mutants of strain NCTC 11219 (Table 5.3), WGS analysis was performed to 
identify mutational changes that may have occurred during genome engineering. The NCTC 
8266 deletion mutant did not show any altered phenotype, but it was included in the analysis 
as well. In contrast, the NCTC 8266 ClosTron mutant was not included, although it has a 
defect in growth at low temperature that would have been interesting to analyse. This is 
unfortunate in retrospect, and it will be interesting to sequence this strain in the future.  
Table 5.3: Nontoxigenic mutants that were subjected to WGS analysis, and phenotypical differences with their 
corresponding wild type strain.  
Mutant strain Altered phenotype  
NCTC 8266 ∆bontE::ermB No changes detected 
NCTC 11219 ∆bontE::ermB Faster growth at 2.3 % salt; lower D-value at 70 °C  
NCTC 11219 bontEa211::CT Early sporulation onset; lower D-value at 70 °C 
 
Sequencing was performed on an Illumina Miseq sequencer, yielding around 1.2 million reads 
of 150 bp for all mutants with 47-, 49- and 52-fold total coverage of respectively NCTC 8266 
∆bontE::ermB, NCTC 11219 ∆bontE::ermB and NCTC 11219 bontE211a::CT. Table 5.4 
demonstrates all mutational changes (variant frequency > 60 %) introduced in the 
nontoxigenic mutants, in comparison with the parental strains NCTC 8266 and NCTC 11219.  
WGS NCTC 8266 ∆bontE::ermB 
Although no phenotypical alterations of the NCTC 8266 ∆bontE::ermB mutant were found, the 
genome analysis showed four variations in comparison with the parental strain NCTC 8266. 
It should be noted that the SNP that was found in ST13_05335, encoding a protein annotated 
as peptidase M27, was an expected mutation. This locus tag ST13_05335 is the ntnh gene 
which is located directly upstream the deleted bont/E (Fig. 4.2). Because the bont/E flanking 
loci of the NCTC 8266 and NCTC 11219 parental strains differed in one nucleotide, and since 
the same deletion plasmid (on which these homologous regions were located) was used for 
deletion of bont/E, this SNP was introduced on purpose. Further, three other variations were 
found which were unexpected. Frameshift mutations were identified in genes encoding a 
predicted thymidine kinase and a GGDEF-domain containing protein, and an amino acid 
change has occurred in a predicted membrane protein. However, the possible impact of these 
mutations on physiology was not studied further.  
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WGS NCTC 11219 ∆bontE::ermB 
Surprisingly, the genome analysis of NCTC 11219 ∆bontE::ermB showed a high number of 
mutations, with multiple large deletions (~ 18 kb, 20 kb and 51 kb). This was quite 
unexpected, since it was concluded from the phenotypical analysis that the mutant did not 
reveal major differences compared to the wild type strain, except for a small difference in spore 
heat resistance at 70 °C and in growth at 2.3 % NaCl. The 18 kb deletion encompasses 
predicted restriction enzymes, which could possibly explain another observation that was 
made during several experiments, but that was not documented quantitatively: the NCTC 
11219 ∆bontE::ermB mutant is a much better acceptor in conjugation experiments than the 
wild type strain. In general, conjugation of plasmids to the NCTC 11219 wild type strain 
occurred with extremely low frequency. It is therefore possible that a colony was picked up in 
conjugation experiments in which the 18 kb region was deleted, resulting in a better mating 
acceptor. However, this is only speculation and has not been studied further. The other large 
deletions are phage-like regions, encompassing one intact and two incomplete prophage 
regions according to PHAST.
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Table 5.4: Mutational changes introduced during mutant construction. (fs: frameshift; *: stop codon introduced; Met1?: mutated start codon) 
1 in parental strain ; 2 type I restriction enzyme EcoKI subunit R, repressor LexA, restriction endonuclease, HNH endonuclease, DNA helicase, hypothetical proteins ; 3 
According to Phast, encompassing one intact and one incomplete prophage. XRE family transcriptional regulator, Cro/Cl family transcriptional regulator, transcriptional 
regulator, cell wall binding protein, membrane protein, UviB-like protein, tail fiber protein, Xkdt protein, phage like element, N-acetylmuramoyl-L-alanine amidase, 
prophage protein, ABC transporter ATPase, guanosine polyphosphate pyrophosphohydrolase, terminase, DNA primase, phage protein, ERCC4-type nuclease, AbrB family 
transcriptional regulator, hypothetical proteins ; 4 According to Phast, encompassing an 11 kb questionable prophage region. Phage portal protein, terminase, DNA-
directed RNA polymerase sigma-70 factor, site-specific integrase, peptidase M20, nitroreductase, DNA helicase, HNH endonuclease, ParB protein, cellulose biosynthesis 
protein BcsQ, transcriptional regulator, endonuclease, ImmA/IrrE family metallo-endopeptidase, integrase, hypothetical proteins.  
 
Mutation Predicted protein Amino acid change Location 1 Locus tag 1 Accession nr. 1 
(NCBI)  
NCTC 8266 AAATC deletion Thymidine kinase Lys94fs 468617 ST13_02225 CP010520 
∆bontE::ermB A insertion GGDEF containing protein Gln55fs 572028 ST13_02755 CP010520 
 TC Peptidase M27 Ile1131Val 1165722 ST13_05335 CP010520 
 
CT Membrane protein Asp127Asn 2827151 ST13_12815 CP010520 
NCTC 11219 
∆bontE::ermB 
18 kb deletion Multiple proteins 2  442922-461386 SR42_14245 -SR42_14305 JXMR01000002 
 
51 kb deletion Prophage like region 3  15573 - 66817 SR42_15045-SR42_15415 JXMR01000003 
 
20 kb deletion Prohage like region 4  10 000 - 30 000 SR42_15790-SR42_15900 JXMR01000004 
 67 bp deletion DNA-binding transc. 
regulator 
 2310781-2310848 SR42_10440 JXMR01000001 
 
CA Chemotaxis protein CheD Ser29* 1892398 SR42_08525 JXMR01000001 
 
TA Chemotaxis protein CheA Val639Glu 1896625 SR42_08540 JXMR01000001 
 
GA ATPase Gly427Glu 1474459 SR42_06595 JXMR01000001 
 
AC Thymidine kinase Lys56Asn 1577590 SR42_07135 JXMR01000001 
 GT Acetyl-CoA carboxylase 
biotin carboxyl carrier 
Lys52Asn 2268595 SR42_10275 JXMR01000001 
 GA Hypothetical protein Pro67Ser 709267 SR42_03175 JXMR01000001 
 T deletion Cell wall binding protein Ile133fs 688756 SR42_03090 JXMR01000001 
 
GT LacI transcr. regulator Met1? 337323 SR42_01725 JXMR01000001 
 
CTT deletion GTP binding protein YchF Glu245Val  
(- Glu) 
93940 SR42_16260 JXMR01000004 
NCTC 11219 
bontEa211::CT 
TA GGDEF containing protein  
 
Leu210Phe 116622 SR42_16335 JXMR01000004 
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Deletions of such large loci will presumably have an impact on the physiology of NCTC 11219 
∆bontE::ermB. However, according to BLAST, it seems like these large loci are not well 
conserved among gIICb strains. We are currently investigating this in more detail by 
evaluating all available gIICb sequences. 
Besides these large deletions, a number of other mutations were found in the genome of NCTC 
11219 ∆bontE::ermB. For example, two mutations were found in the genes encoding the 
chemotaxis proteins CheA and CheD, and we therefore attempted to detect a modified 
chemotaxis behaviour. However, the standard test to assess swimming motility in 0.3 % agar 
could not be used because the cells produced too much gas and thereby disrupted the agar 
medium. In addition, swarming motility on the surface of 0.4 % and 0.6 % agar could not be 
observed, not even for the wild type strain.  
WGS NCTC 11219 bontEa211::CT 
The NCTC 11219 ClosTron mutant differs from the wild type strain in that it forms spores 
in rich growth medium more rapidly. The genome analysis of NCTC 11219 bontEa211::CT 
identified only one SNP, located in a GGDEF-domain containing protein. These proteins act 
as diguanylate cyclases which synthesize cyclic dimeric guanosine monophosphate (c-di-
GMP), a bacterial intracellular signaling molecule. Interestingly, there was also a mutation in 
a gene encoding a different GGDEF-domain containing protein in the NCTC 8266 
∆bontE::ermB strain (Table 5.4). The NCTC 11219 and NCTC 8266 genomes encode six 
GGDEF-domain containing proteins, and the mutated genes (SR42_16335 and ST13_02755) 
encode proteins that share only 32 % sequence identity over a region encompassing 46 % of 
the entire sequence. The mutations are not located in the predicted GGDEF-domain of the 
proteins. To further investigate the effect of this mutation in the NCTC 8266 ∆bontE::ermB 
mutant, the onset of sporulation was studied in comparison with the wild type strain. 
Remarkably, instead of an early sporulation onset, the NCTC 8266 ∆bontE::ermB showed a 
delayed onset. While the NCTC 8266 wild type strain produced 2.5 +/- 0.3 log spores/ml 14 
h after colony inoculation in TPGY broth, the NCTC 8266 ∆bontE::ermB showed no detectable 
spore count (< 1 log spores/ml) after 14 h and after 18 h, but only after 21 h (1.7 +/- 0.3 log 
spores/ml). However, because NCTC 8266 ∆bontE::ermB has three other mutations, this delay 
in sporulation cannot be directly linked to the mutated diguanylate cyclase without further 
experiments. 
The potential role of diguanylate cyclases in the onset of sporulation would be very interesting 
to investigate further. The messenger c-di-GMP has been mostly studied in Gram-negative 
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bacteria and is known to be a key player in regulation of all kinds of lifestyle changing events, 
such as the transition between motility and sessility, persistence, biofilm formation, cell 
differentiation, changes in adhesiveness and virulence gene expression 197–199. In comparison, 
very little is known about c-di-GMP signaling in Gram-positive bacteria. It has been shown 
that elevated levels of the secondary messenger inhibit motility in C. difficile and B. subtilis 
200,201. Moreover, very recently a regulatory link between c-di-GMP and sporulation was for 
the first time addressed in B. thuringiensis 202. Mutants were constructed in cdg genes, which 
encode enzymes putatively involved in cyclic diguanylate synthesis and/or break-down. 
Although cdgC and cdgJ were predicted to encode inactive proteins because they carry a 
degenerate GGDEF motif, their inactivation showed a small but statistically significant 
change in sporulation. Inactivation of cdgC resulted in 2.5-fold higher sporulation efficiency, 
which was assessed after 20 h of growth. Deletion of cdgJ, in contrast, delayed sporulation 
with no spores detected after 20 h. In another recent study , it was shown that a decreased c-
di-GMP level delays sporulation of Myxococcus xanthus, and it was suggested that a certain 
threshold level of c-di-GMP is essential to start sporulation 203. In contrast, studies with 
Streptomyces indicated that excessive levels of c-di-GMP inhibit certain sporulation genes 204.  
Although fragmentary and not conclusive, these data in different sporulating bacteria suggest 
a role for c-di-GMP signaling in sporulation that would be an interesting topic for future 
research.  
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5.4 Conclusion 
As was done for C. botulinum NCTC 11219 (Chapter 4), a bont/E insertion and deletion mutant 
were constructed in strain NCTC 8266. In this chapter, the characterization of these two 
nontoxigenic mutants has been presented. Because the NCTC 11219 mutants showed some 
changes in phenotypical properties in comparison with the wild type strain (Table 5.3), we 
investigated whether these changes could be related with the inactivation of BoNT. This did 
not seem to be the case, since similar changes could not be seen in the NCTC 8266 mutants. 
The NCTC 8266 ∆bontE::ermB mutant was shown to have identical characteristics as the wild 
type strain for stressed and unstressed growth, spore yield and spore heat resistance. 
Therefore this strain is a very good candidate to be used as a safe surrogate organism. In 
contrast, the insertion mutant demonstrated an altered growth at lower temperature (8 °C 
and 12 °C).  
In a second approach, we investigated whether random mutations were introduced during 
strain construction of the NCTC 11219 mutants, and whether these could explain the 
observed phenotypical changes. Therefore, WGS analysis was performed on both NCTC 
11219 mutants, as well as on NCTC 8266 ∆bontE::ermB. The analysis showed a high number 
of mutations in NCTC 11219 ∆bontE::ermB, whereas the NCTC 8266 ∆bontE::ermB only 
showed four variations (Table 5.4). The gene replacement strategy comprises multiple steps 
(deletion of pyrE, double recombination with flanking loci of bont/E, restoration of pyrE), 
which increases the chance for mutations to occur. However, since both mutants were 
constructed in exactly the same way, the knockout strategy that was employed is not 
necessarily accountable for the high mutational rate in NCTC 11219 compared to NCTC 
8266. However, NCTC 11219 contains more prophage regions than NCTC 8266. Such 
regions are known to be less stable and it is exactly in these regions that major deletions 
occurred. Although we concluded in Chapter 4 that NCTC 11219 ∆bontE::ermB is a good 
candidate for challenge testing, the WGS analysis showed that it should be kept in mind that 
this strain might react differently from the wild type in not yet tested conditions, due to the 
presence of multiple mutations. Next to phenotypical characterization, WGS analysis is thus 
an important tool in the validation of nontoxigenic mutants to be used as surrogates in food 
challenge studies.   
Further, the early onset of sporulation that was observed in the NCTC 11219 ClosTron 
mutant, could tentatively be linked to a mutated diguanylate cyclase because this was the only 
mutation found in this strain. Diguanylate cyclases are involved in the synthesis of the 
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bacterial intracellular signaling molecule c-di-GMP. Although c-di-GMP is known to be a 
key player in regulation of all kinds of lifestyle changing events, a regulatory link with 
sporulation has only been demonstrated very recently by Fagerlund et al. (2016) 202. In this 
study, a knockout of a diguanylate cyclase resulted in a 2.5-fold higher sporulation efficiency 
after 20 h of growth. In comparison, the sporulation efficiency reported in Chapter 4 for the 
NCTC 11219 ClosTron mutant was increased about hundredfold compared to the wild type 
strain. Further study of this mutant should clarify the role of c-di-GMP in sporulation onset 
in gIICb, thus providing an interesting novel insight in the complex developmental program 
of bacterial sporulation. Moreover, since there is evidence that BoNT toxin production is 
linked to sporulation in C. botulinum, c-di-GMP and the early sporulation phenotype may also 
have important implications for food safety.  
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Chapter 6* 
The inhibitory effect of carvacrol, trans-cinnamaldehyde, 
carrot seed essential oil and hop β-acids on germination 
of group II C. botulinum NCTC 11219 spores 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* In collaboration with Aurélie De Jong (Laboratorium of Food Microbiology, KU Leuven)  
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6.1 Introduction 
gIICb strains are a major concern for the safety of mildly heat-processed refrigerated foods 
with long shelf life. Because gIICb strains are psychrotrophic, spores surviving mild heat 
treatment may subsequently germinate, grow out and produce toxin during refrigerated 
storage. Therefore, food producers have to ensure that the formulation of the food (pH, salt, 
preservatives,…) and the storage conditions (temperature, gas atmosphere,…) prevent 
multiplication of gIICb during the shelf life of these foods 67,69,75,76,205. Increasing consumer 
demands for high-quality, natural foods with minimal preservatives challenges the food 
industry regarding botulinum safety, because the effectiveness of emerging nonthermal 
processing techniques and biopreservatives against this pathogen are poorly documented 69,75.  
Natural additives have become very popular to preserve foods. Essential oils (EOs) derived 
from spices and other plants are gaining a wide interest as ‘natural’ antimicrobial preservatives 
in the food industry that can replace traditional chemicals like nitrite, benzoate and others, for 
which studies have increased the concern for adverse health effects 206. It has been well 
established that the active components of these oils have a wide spectrum of antimicrobial 
activity against foodborne pathogens and spoilage bacteria 207. Carvacrol and trans-
cinnamaldehyde, the main active components in respectively oregano EO and cinnamon bark 
EO, are considered broad-spectrum antimicrobials that are effective against many Gram-
positive and Gram-negative bacteria as well as fungi (B. cereus, L. monocytogenes, E. coli, C. 
perfringens, S. aureus, Salmonella strains, Aspergillus spp., Candida albicans, etc.) 208–212. Due to 
their hydrophobic nature, it is suggested that these compounds interact with the lipid bilayer 
of cytoplasmic membranes causing loss of integrity and leakage of cellular compounds 213–215. 
A less studied oil is carrot seed EO, which is mainly composed of carotol and carotenol. The 
antibacterial activity of carrot seed EO against S. aureus, B. cereus, E. coli and S. typhimurium 
has been reported, and for carotol only an antifungal effect has been described so far 216–218. 
Only few studies have documented the activity of natural compounds against C. botulinum. 
One notable exception is a patent application claiming the inhibitory effect of hop extracts on 
growth of C. botulinum (group I and II), C. difficile and Helicobacter pylori, even at 
concentrations as low as 1 ppm 219. The antimicrobial properties of hop extracts have also 
been documented against many other Gram-positives (i.e. Listeria, Bacillus, Staphylococcus), 
while only negligible to moderate activity has been demonstrated for Gram-negative bacteria 
(E. coli, S. enterica) 220–223. Hop extracts contain high amounts of α- and β-acids (humulones 
and lupulones), with β-acids having the strongest antibacterial activity. It is postulated that 
undissociated hop acids incorporate into bacterial cell membranes and passively diffuse into 
  
81 
 
the cell. When the acids then dissociate because of a higher internal pH, the liberated protons 
acidify the cytoplasm, which leads to a dissipation of the transmembrane proton gradient, a 
decrease in proton motive force-driven uptake of nutrients, starvation and eventually to cell 
death 220,224. However, the low reported minimal inhibitory concentration (MIC value) of hop 
acids for C. botulinum suggests that additional antimicrobial mechanisms may be involved in 
their action.  
Unfortunately, limited data are available on the effect of these natural compounds on 
endospores. Our group recently reported on the antibacterial activity of eleven essential oils 
against both vegetative cells and spores of B. cereus 225. All oils except one, i.e. carrot seed EO, 
had a inhibitory effect on B. cereus germination. The only data available on gIICb spores is 
published by Ismaiel & Pierson in 1990, where the effects of clove, thyme, black pepper, 
pimenta, origanum, garlic, onion, and cinnamon oils on growth and germination of one gIICb 
type E strain and two gICb strains were studied 226. In the type E strain, origanum oil was the 
most effective growth inhibitor, causing 98 % inhibition at ≥ 100 ppm. Pimento, clove, thyme 
and cinnamon followed in that order. At 50 ppm, depending on the oil between 20 % and 60 
% growth inhibition was observed, while at 10 ppm no inhibition was observed anymore. The 
results were somewhat different for spore germination. At concentrations ≥ 100 ppm, all oils 
could effectively inhibit germination, with only 4 % germination relative to the control 
without oil. At 50 ppm, all oils still had a strong inhibitory effect (10 % of germination), except 
pimento and clove (40-60 % germination). At 10 ppm, only the oils of garlic and onion were 
still somewhat effective with less than 50 % germination.  
In this chapter, we assessed the inhibitory effects of carvacrol, t-cinnamaldehyde, carrot seed 
EO and hop β-acids on nutrient and non-nutrient induced spore germination (see 2.2.1 and 
2.2.2), using the nontoxigenic derivative from strain NCTC 11219 constructed in Chapter 4. 
Since spore germination necessarily preceeds vegetative cell growth and thus toxin 
production, the inhibition of germination by natural compounds could possibly be used to 
extend the shelf life of refrigerated foods by delaying gIICb multiplication and BoNT toxin 
formation.  
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6.2 Materials and Methods 
6.2.1 Growth conditions, spore production and purification 
For all experiments a nontoxigenic mutant of gIICb strain NCTC 11219 was used, designated 
as NCTC 11219 ∆bont::ermB, or briefly ∆bont (Chapter 4). The growth conditions and the 
media that were used for vegetative growth and sporulation are described in 4.2.1 and 4.2.2. 
The spores were harvested after six days of incubation at 30 °C, washed four times with 0.85 
% sterile saline by centrifugation, concentrated fivefold and stored in saline at 4 °C. Spores 
were handled in ambient atmosphere, while incubation for outgrowth occurred in a Don 
Whitley DG250 anaerobic workstation (initial gas mixture 80 % N2, 10 % CO2, and 10 % H2) 
using overnight deoxygenated media. Vegetative cells were always manipulated in the 
workstation. 
6.2.2 Chemicals and stock solutions  
The germinant mixture, further referred to as the gerMix, that was used to induce nutrient 
germination, was composed of L-alanine (Sigma), L-lactate sodium salt (Acros) and NaHCO3 
(Acros) at final concentrations of 100 mM, 50 mM and 50 mM respectively in 100 mM Tris-
HCl buffer (pH 7.4). The gerMix solution was prepared freshly before use, as a twofold 
concentrated working solution. A 1 M stock solution of dodecylamine (Acros) was freshly 
prepared in ethanol, and further diluted in 100 mM Tris-HCl buffer to 6 mM (= twofold of 
working concentration). Stock solutions of 120 mM CaCl2 (Chem Lab, Zedelgem, Belgium) 
and 120 mM DPA (Acros) were made in 100 mM Tris-HCl, and the pH of the DPA solution 
was readjusted to pH 7.5 with Trizma base (Sigma). The two solutions were then mixed in a 
1:1 volume ratio and eventually further diluted in 100 mM Tris-HCl to achieve final Ca2+-
DPA concentrations of 60 mM, 50 mM, 30 mM and 20 mM. 
Stock solutions of 8 mM carvacrol (Sigma) and 8 mM cinnamaldehyde (Acros) were prepared 
freshly in 2x gerMix or 2x dodecylamine, and further diluted in the same solution. A stabilized 
stock emulsion of 10 % (v/v) carrot seed essential oil (Anthémis Aromatherapie, Oosterstreek, 
The Netherlands) was made in 100 mM Tris-HCl buffer containing 0.2 % agarose and 2x 
gerMix or 2x dodecylamine. The agarose was used to accomplish a stabile emulsion of the oil, 
which was then further diluted in 2x gerMix or 2x dodecylamine to achieve the concentrations 
to be tested. The Beta Bio 45 % solution (Hopsteiner, Mainburg, Germany) contains 45 % 
(w/w) of the natural β-acids fraction of hops extract in propylene glycol. This solution was 
  
83 
 
further diluted in 2x gerMix or 2x dodecylamine to obtain the tested concentrations of the β-
acids.  
6.2.3 MIC on vegetative growth determined by the broth dilution method 
The minimal inhibitory concentration (MIC) for vegetative cells was determined as the 
concentration that inhibits growth within 24 h at 30 °C by measuring optical density (OD). 
Different concentrations of carvacrol, cinnamaldehyde, carrot seed EO and hop β-acids in 
TPGY broth were added in 96-well microtiter plates. Then, stationary phase cultures were 
diluted and added to the compounds to achieve a final concentration of approximately 2.105 
CFU/ml in the wells. Final concentrations of 4 mM, 2 mM, 1 mM, 0.5 mM, 0.25 mM, 0.125 
mM of both carvacrol and cinnamaldehyde were tested (~ 615 to 19 ppm for carvacrol, and 
503 to 16 ppm for cinnamaldehyde). Carrot seed EO was tested at 1 %, 0.5 %, 0.25 % and 0.125 
% (v/v) (~ 10000 ppm to 1250 ppm) and hop β-acids at concentrations 0.001 %, 0.0005 %, 
0.00025 %, 0.0001 %, 0.00005 %, 0.000025 % (~ 10 to 0.25 ppm). Positive (TPGY + cell 
suspension) and negative controls (TPGY) were included. Since a 10 % stock emulsion of 
carrot seed EO was used that contained 0.2 % agarose, the negative control here contained 
the same amount of agarose as 1 % carrot seed EO. The analysis was done with three 
independent cultures, and the MIC was defined as the concentration for which the OD600 value 
was not significantly different from the OD of the negative control, after 24 h incubation at 
30 °C.  
6.2.4 Nutrient and dodecylamine induced germination with/without inhibiting 
compounds 
Spore crops were centrifuged (3400 x g, 10 min, 4 °C), resuspended in 100 mM Tris-HCl and 
heated for 10 min at 65 °C to inactivate any residual vegetative cells and spores that would 
have spontaneously germinated during storage, and also to activate dormant spores for 
germination. Hereafter a sample was taken from the suspension, diluted and plated on  TPGY 
to determine the initial spore count N(t0). The remainder of the heat activated spore 
suspension was subdivided and added in a 1:1 volume ratio to 2x gerMix or 2x dodecylamine, 
with or without the tested inhibitory compounds at 2x concentration, and incubated for 1 h at 
30 °C. Then, one part of the suspension was diluted and plated, designated N(t1-noHT), 
whereas the other part was again heat treated for 10 min at 65 °C before plating, N(t1-HT). 
Because the spores that have germinated within 1 h have lost their heat resistance, the 
difference in counts between N(t1-noHT) and N(t1-HT) corresponds to the amount of 
germinated spores. However, this can only be the case if counts of N(t0) are similar to N(t1-
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noHT), demonstrating that no spore inactivation has taken place during the incubation, but 
only germination. There was never a significant reduction shown when comparing counts 
N(t0) with N(t1-noHT). Therefore, the following formula was used to determine the log 
germination.  
Log germination (log CFU/ml) = log10 (N(t0) / N(t1-HT)) 
Germination by plate counting was assessed after 1 h, because the germination experiment 
was conducted outside the anaerobic cabinet, and a longer incubation period could thus 
inactivate the germinated spores due to oxygen exposure. This would result in a lowered 
count of N(t1-noHT), not comparable anymore with counts of N(t0), making it impossible to 
distinguish inactivation by oxygen from inactivation by the compound.  
All experiments were performed in triplicate with independent spore crops. The log 
germination in gerMix/dodecylamine with addition of a tested compound was determined 
relatively to the log germination in gerMix/dodecylamine alone for every spore crop. The 
germination assays with the hop β-acids were performed by Aurélie De Jong (Laboratorium 
of Food Microbiology, KU Leuven). 
6.2.5 Ca2+-DPA induced germination 
The germination assay was performed as described for nutrient germination, with one small 
alteration. Ca2+-DPA was used at 20 – 60 mM for germination experiments, but since a 
twofold concentrated solution of 120 mM cannot be made because of the limited solubility of 
Ca2+-DPA, the spores were resuspended immediately in 60 mM, 50 mM, 30 mM and 20 mM 
Ca2+-DPA, and the initial heat treatment to activate the spores was done in the presence of 
Ca2+-DPA. 
6.2.6 High pressure induced germination 
Spore crops were centrifuged (3400 x g, 10 min, 4 °C), diluted tenfold and resuspended in 100 
mM Tris-HCl and heated for 10 min at 65 °C. A part of the sample was plated as described 
before, to determine the initial spore count N(t0). Hereafter, the spore suspension was 
subdivided and transferred to 1 ml heat-sealed sterile polyethylene bags that were subjected 
to 200 MPa, 600 MPa, as well as to atmospheric pressure as the control. Pressure treatment 
was performed for 15 min at 30 °C in an eight-vessel HP device (HPIU-10 000, 95/, 1994, 
Resato, Roden, The Netherlands). The temperature of the vessels was controlled by a water 
circuit connected to a cryostat and a mixture of glycols (TR15, Weesp, The Netherlands) was 
used as pressure-transmitting liquid. After the pressure treatment, the spores were incubated 
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aerobically for 4 h at 30 °C at atmospheric pressure to allow a maximal germination response. 
Hereafter, the sample was heat treated (65 °C, 10 min) to determine the fraction of germinated 
spores by plating, with the same formula as described above. 
6.2.7 DPA measurements 
While germination assessment by plate counting was done after 1 h incubation to limit oxygen 
exposure, germination assessment by DPA measurements was done after longer germination 
times to maximize the germination degree. After 4 h of incubation, spores were centrifuged 
(12 000 x g for 5 min) to remove the spore pellet from the germinant solution, whereafter the 
supernatant was diluted tenfold in Tris-HCl buffer and stored at – 20 °C until DPA analysis. 
Because the spore crops are already diluted tenfold at the start of the high pressure 
experiments, the supernatant was not further diluted in this case. DPA measurement was 
based on formation of a fluorescent complex with Tb3+ as described before 227. Hundred µl of 
the spore supernatant from – 20 °C was mixed with an equal amount of 20 mM TbCl3 in a 96-
well black microtiter plate (Greiner Bio-one, Vilvoorde, Belgium). Fluoresence measurements 
were done in a spectrofluorometer (Synergy Mx-biotek, VT, USA) with excitation and 
emission wavelengths of 270 and 545 nm, respectively. Background controls of the buffer, 
gerMix or dodecylamine with/without inhibiting compounds, were taken into account as well. 
The signal of these controls was substracted from the signal of the spore supernatant. Then, 
DPA release was expressed relative to the value obtained for the supernatant of spores that 
were subjected to 98 °C for 30 min, because these spores are assumed to have released their 
entire DPA depot 144. The relative DPA release was determined as the proportion of DPA 
release in the presence of the tested inhibitory compound (together with gerMix or 
dodecylamine) to DPA release without the tested compound. 
6.2.8 Microscopy 
Spore suspensions were immobilized on thin pads of 1 % agarose in Tris-HCl buffer. Pictures 
were taken with a Ti-Eclipse inverted microscope (Nikon, Champigny-sur-Marne, France) 
equipped with a CoolLED pE-100 camera. Images were acquired using NIS-Elements (Nikon) 
and resulting pictures were further handled with open source software ImageJ.  
6.2.9 Statistical analysis 
All experiments were performed with three independent spore crops, and the two-tailed 
unpaired Student's t-test with a significance level of 0.05 was used to statistically assess the 
effect of inhibitors on germination and DPA release.  
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6.3 Results and Discussion 
6.3.1 Germination induced by nutrient and non-nutrient germinants  
It has been shown previously that gIICb spores germinate efficiently in response to L-
alanine/L-lactate/NaHCO3 (≥ 90 % or ≥1 log germination) 122. Therefore, we used this 
combination, further in the text referred to as the gerMix, to test nutrient induced 
germination of NCTC 11219 ∆bont spores. This nontoxic mutant was chosen instead of NCTC 
8266 ∆bont only because it was the first one constructed. Additionally, we analysed non-
nutrient induced germination by exogenous Ca2+-DPA, dodecylamine and high pressure (HP). 
Fig. 6.1 shows germination of NCTC 11219 ∆bont spores by nutrient and non-nutrient 
inducers, based on loss of heat resistance (65 °C/10 min) and DPA release (not for Ca2+-DPA 
induced germination). Exogenous Ca2+-DPA (20, 30, 50 or 60 mM) did not induce 
germination of spores in buffer (at all concentrations tested only 0.1 log germination). Phase-
contrast microscopy confirmed this finding, since only a very minor fraction of spores turned 
phase-dark in the presence of Ca2+-DPA, even after overnight incubation. Also HP treatments 
of 200 MPa and 600 MPa for 15 min did not induce germination at 30 °C (0.0 +/- 0.4 log and 
0.1 +/- 0.3 log germination respectively). Because there was no reduction of counts after HP, 
it can be concluded that no germination or inactivation took place due to the pressure 
treatment. Also in this case, phase-contrast microscopy confirmed the absence of germinated 
spores after the HP treatment. While the DPA release of 200 MPa treated spores (1.1 % +/- 
0.3 %) showed no significant difference with spores incubated at Patm (data not shown), spores 
subjected to 600 MPa released 8.4 +/- 2.1 % of the total DPA, an amount that was statistically 
significant (p < 0.05).  
Efficient germination occurred in response to the gerMix (2.0 +/- 0.5 log CFU/ml) and due 
to the surfactant dodecylamine (4.5 +/- 0.3 log CFU/ml), based on the criterium of heat 
sensitivity. Plating of control samples indicated that neither the gerMix nor dodecylamine 
caused inactivation of the germinated spores within the course of the germination experiment. 
DPA release of spores in gerMix and dodecylamine, was 87.7 +/- 10.0 % and 66.1 +/- 5.0 % 
respectively (Fig. 6.1). 
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Fig 6.1: Spore germination by different potential inducers. Mean percentages +/- standard deviations are shown 
of three experiments using independent spore crops. A) Germination assessed by loss of heat resistance (65 
°C/10 min), after incubation of heat activated spores for 1 h at 30 °C in the gerMix, in dodecylamine  (3 mM) or 
in Ca2+-DPA (60 mM), or after pressure treatment (200 / 600 MPa, 15 min, 30 °C) followed by an additional 4 
h incubation at 30°C. Also 20, 30 and 50 mM Ca2+-DPA were tested but showed no germination induction. B) 
DPA release of spores germinated by the same treatments as in (A), except Ca2+-DPA. Release was measured 
after 4 h at 30 °C and is expressed relative to the total DPA release after treatment for 30 min at 98°C.  
 
Since dodecylamine is a strong surfactant that has bactericidal properties, we also analysed 
the loss of heat resistance after washing away the compound after 4 h, and this reduced the 
amount of spores that are inactivated by heat to 0.9 +/- 0.2 log CFU/ml (not shown in Fig. 
6.1). This suggested that the heat sensitivity of (most or all of) the spores in the presence of 
dodecylamine was not the consequence of genuine spore germination, but of direct spore 
inactivation by dodecylamine facilitated by heat. Also the DPA release of spores exposed to 
dodecylamine increased from 66 % before the heat treatment to 91.6 +/- 2.4 % after the heat 
treatment (the latter is not shown in Fig. 6.1). This is in agreement with earlier observations 
in B. subtilis where DPA release in the presence of dodecylamine also increased with increasing 
temperature 144. Finally, despite the DPA release, the vast majority of spores remained phase-
bright in the presence of dodecylamine, even after a heat treatment. This is in contrast to 
spores incubated in the gerMix, as shown in Fig 6.2, and the results therefore confirm that 
dodecylamine probably does not induce a physiological spore germination process.  
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Fig. 6.2: Phase-contrast microscopy images of spores treated with germinants. The spores were incubated for 4 
h at 30 °C in A) dodecylamine and B) the gerMix, whereafter a heat treatment was performed (65 °C/10 min) 
because it was shown that higher temperatures enhance dodecylamine’s mode of action. Six microscopic fields 
were assessed for each treatment (with around 200 spores per field), and a representative image is shown.  
 
After having identified effective germinants for C. botulinum NCTC 11219, we analysed four 
natural substances for inhibition of these germinants. Although it follows from our previous 
observations that dodecylamine does not induce genuine germination, we included this 
compound in the analysis because it remains of interest to understand how dodecylamine 
induces DPA release and whether this effect could be suppressed by the compounds that were 
tested on nutrient germination. 
6.3.2 MIC on vegetative cells 
The MIC of carvacrol, cinnamaldehyde, carrot seed EO and hop β-acids for vegetative cells of 
C. botulinum NCTC 11219 ∆bont was determined by the broth dilution assay to be 2 mM (308 
ppm), 4 mM (503 ppm), 0.5 v/v % (5000 ppm) and 0.00025 v/v % (2.5 ppm) respectively. 
Therefore, their inhibiting action on germination was further assessed with concentrations 
around their MIC on vegetative cells.  
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6.3.3 Inhibition of nutrient induced germination 
Spore germination in the gerMix was analysed in the presence of different concentrations of 
the compounds (Fig. 6.3). Carvacrol and cinnamaldehyde both inhibited germination, with 
0.05 mM (8 ppm) carvacrol and 0.25 mM (31 ppm) cinnamaldehyde being the lowest tested 
concentrations that have a significant effect (p < 0.05). 
 
Fig. 6.3: Germination in gerMix with carvacrol or cinnamaldehyde (4 mM-0.01 mM) relative to germination in 
gerMix alone. Mean percentages +/- standard deviations of triplicate experiments using independent spore 
crops are shown. Significant differences (p < 0.05) in comparison to the control in gerMix alone are indicated 
with *.  
Fig. 6.4 shows that carrot seed EO significantly inhibits nutrient germination at 
concentrations ≥ 0.005 v/v % (50 ppm), whereas hop β-acids do not inhibit germination at 
concentrations around the MIC for vegetative cells (0.00025 %). The inhibition of spore 
germination of NCTC 11219 by carrot seed EO contrasts with previous findings in our 
research group that this EO does not inhibit B. cereus spore germination 225. Control 
experiments in which spores were incubated with the natural compounds in the absence of 
gerMix showed no germination nor inactivation (data not shown).  
Phase-contrast microscopy allowed to conclude that inhibition by carvacrol, cinnamaldehyde 
and carrot seed EO occurs early in the germination process, since spores remained phase-
bright when these compounds were added to the gerMix, even after 4 h incubation (Fig. 6.5). 
In contrast, hop β-acids did not prevent the spores from turing phase dark, confirming the 
lack of germination inhibition at concentrations around the MIC, as was also shown in Fig. 
6.4. In addition, DPA release was significantly reduced by carvacrol, cinnamaldehyde or carrot 
seed EO (Fig. 6.6). Remarkably, a significant reduced release was also seen in the presence of 
hop β-acids, although the effect was smaller than for the others compounds. Controls were 
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also included where spores were incubated with the compounds without gerMix, showing no 
DPA release. 
 
Fig. 6.4: Spore germination in gerMix in the presence of carrot seed EO (1 %-0.001 %) or hop β-acids (0.001 %-
0.0001 %) relative to germination in gerMix alone. Mean percentages +/- standard deviations of triplicate 
experiments using independent spore crops are shown. Significant differences (p < 0.05) in comparison to the 
control in gerMix alone are indicated with *.  
 
Fig. 6.5: Phase-contrast microscopy of spores incubated at 30 °C in gerMix with/without addition of natural 
compounds. Heat activated spores were resuspended in A) gerMix, B) gerMix with 4 mM carvacrol, C) gerMix 
with 4 mM cinnamaldehyde, D) gerMix with 1 % carrot seed EO, E) gerMix with 0.001 % hop β-acids. After 4 
h, the spores were placed on an agarose pad for visualization. Six fields were assessed per condition (with around 
200 spores per field), and a representative image is shown.  
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Fig. 6.6: DPA release of spores that were incubated for 4 h at 30 °C in gerMix with natural compounds, relative 
to the DPA release in gerMix alone. Heat activated spores were resuspended in gerMix, gerMix with 4 mM 
carvacrol, gerMix with 4 mM cinnaldehyde, gerMix with 1 % carrot seed EO and gerMix with 0.001 % hop β-
acids. Mean percentages +/- standard deviations of triplicate experiments using independent spore crops are 
shown. Significant differences (p < 0.05) in comparison with the control in gerMix alone, are indicated with *.  
Hop β-acids showed no inhibiting effect on heat sensitivity nor on the conversion from phase-
bright to phase-dark, yet they did significantly reduce DPA release. We thus report the 
inhibitory effect of carvacrol, cinnamaldehyde and carrot seed EO on nutrient induced 
germination of NCTC 11219 ∆bont spores. For these compounds, the lowest concentration 
that had a significant effect on germination was much lower than the MIC for vegetative cells 
(Table 6.1).  
Table 6.1: Minimal inhibitory concentration (MIC) of four natural compounds on vegetative cells and on nutrient 
induced spore germination of NCTC 11219 ∆bont.  
Compound MIC on vegetative cells  MIC on nutrient germination * 
Carvacrol 2 mM / 308 ppm  0.05 mM / 8 ppm 
Cinnamaldehyde 4 mM / 503 ppm 0.25 mM / 31 ppm 
Carrot seed EO 0.5 v/v % / 5000 ppm 0.005 v/v % / 50 ppm 
Hop β-acids  0.00025 v/v % / 2.5 ppm No inhibition shown  
  
* The MIC on vegetative cells is determined after 24 h by the broth dilution method, as the lowest concentrati on 
that inhibits vegetative growth, whereas the MIC on nutrient germination is determined after 1 h as the lowest 
concentration that has a significant effect on nutrient induced germination.  
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The MIC on nutrient induced germination of carvacrol, cinnamaldehyde and carrot seed EO 
was respectively 40-, 16- and 100-fold lower than the MIC on vegetative cells. The 
observation for carrot seed EO is of particular interest since it has been reported previously 
by our group that this EO could not inhibit germination of B. cereus, while ten other EOs that 
were tested did have an effect 225. It is still unclear how these natural compounds inhibit 
germination and it would be interesting to investigate this further. Additionally, the bioactive 
compounds in carrot seed EO should be further identified. The oil that is used here consists 
mainly of carotol (66 %) and carotenol (16 %). An antifungal effect has already been described 
for carotol 217, so it would be interesting to use the pure compound in future testing. Finally, 
while the MIC of hop β-acids on vegetative cells is particularly low, no inhibition on 
germination was observed around this concentration range. One possibility could be that the 
hop β-acids are too large molecules to insert or pass the cortex/coat layers. Moreover, it could 
be that higher concentrations are required for an inhibitory effect. Nevertheless, these β-acids 
can be of major importance for the food industry because of their low MIC on vegetative cells.  
6.3.4 Inhibition of dodecylamine induced germination 
The same natural compounds that were tested for inhibition of nutrient induced germination, 
were tested on the apparent germination induced by dodecylamine. First the effect of the 
compounds on the induction of heat sensitivity was assessed. The results for carvacrol and 
cinnamaldehyde are shown in Fig. 6.7 and the results for carrot seed EO and hop β-acids are 
shown in Fig. 6.8. Both cinnamaldehyde and carrot seed EO showed an inhibitory effect in a 
concentration dependent manner, while carvacrol and hop β-acids showed no effect at the 
tested concentrations. The lowest concentrations that had a significant effect were 0.5 mM 
cinnamaldehyde and 0.5 % (v/.v) carrot seed EO (p < 0.05). 
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Fig. 6.7: Apparent spore germination in the presence of dodecylamine with carvacrol or cinnamaldehyde (4 mM-
0.05 mM) relative to apparent germination in the presence of dodecylamine without the compound. Mean 
percentages +/- standard deviations of triplicate experiments using independent spore crops are shown. 
Significant differences (p < 0.05) in comparison to the control in dodecylamine alone are indicated with *.  
 
Fig. 6.8: Apparent spore germination in the presence of dodecylamine with carrot seed EO (1  %-0.01 %) or hop 
β-acids (0.001 %-0.0001 %) relative to apparent germination in the presence of dodecylamine without the 
compound. Mean percentages +/- standard deviations of triplicate experiments using independent spore crops 
are shown. Significant differences (p < 0.05) in comparison to the control in dodecylamine alone are indicated 
with *.  
Furthermore, DPA release induced by dodecylamine was tested with the addition of each of 
the four natural compounds (Fig. 6.9). DPA measurements showed a significant reduction in 
DPA release in dodecylamine with the addition of cinnamaldehyde compared to release of 
spores in the presence of dodecylamine alone. It remains unclear why no reduction in DPA 
release was shown in the presence of carrot seed EO, while a significant effect on loss of heat 
resistance was observed (at concentrations ≥ 0.5 %). The other compounds showed no effect 
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on DPA release due to dodecylamine. Spores only incubated with the compounds (without 
dodecylamine), showed no DPA release.  
 
Fig. 6.9: DPA release of spores that were incubated for 4 h at 30 °C in dodecylamine with addition of natural 
compounds, relative to the DPA release in dodecylamine alone. Spores were resuspended in 3 mM dodecylamine 
with 4 mM carvacrol, 4 mM cinnamaldehyde, 1 % carrot seed EO or 0.001 % hop β-acids. Mean percentages +/- 
standard deviations of triplicate experiments using independent spore crops are shown. Significant reductions (p 
< 0.05) in comparison with the control in dodecylamine alone, are indicated with *.   
 
Since previous observations led us to conclude that dodecylamine does not induce genuine 
germination, we speculated that the effect of cinnamaldehyde could be due to a reaction of its 
electrophilic α,β unsaturated aldehyde group with the primary amino group of the surfactant. 
When cinnamylalcohol, a structural analogue of cinnamaldehyde in which the aldehyde group 
is replaced by an alcohol group was used instead of cinnamaldehyde, no inhibition of 
dodecylamine induced apparent germination was observed (data not shown). This observation 
is in agreement with our hypothesis (although it is not evidence for a chemical reaction), and 
may suggest that the amine group of dodecylamine plays an important role in its effect on 
spores. The latter is in accordance with a previous suggestion that the NH2 head group is 
capable of forming salt bridges with carboxylate anions in the spore cortex, causing the core 
to take up small amounts of water 145. 
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6.4 Conclusion 
In this chapter, different germination inducers were tested on spores of strain NCTC 11219 
∆bont (Fig. 6.1). Exogenous Ca2+-DPA (up to 60 mM) was not able to induce germination. In 
B. subtilis, similar concentrations of Ca2+-DPA trigger germination by activating the cortex 
hydrolase CwlJ, and since gIICb strains do not carry a CwlJ homolog, the failure of Ca2+-DPA 
to induce germination may seem evident. However, Ca2+-DPA germination is not always 
clearly linked to CwlJ, since C. difficile spores do not germinate with Ca2+-DPA although the 
organism encodes a CwlJ homolog (30 % amino acid identity with B. subtilis CwlJ) 143, while 
C. perfringens spores germinate in response to Ca2+-DPA despite the absence of a cwlJ homolog 
in the genome. In addition, HP treatments (200/600 MPa, 15 min, 30 °C) also failed to induce 
germination based on loss of heat resistance, and only the 600 MPa treatment induced a small 
amount of DPA release. This is in accordance with previous reports that showed that HP 
cannot induce gIICb spore germination efficiently at moderate temperatures, and with the 
more general observation that spores of clostridia tend to germinate only weakly or not at all 
following HP treatment 152,160,228,229. 
On the contrary, the nutrient mixture L-alanine/L-lactate/NaHCO3 induced very efficient 
germination whereas the non-nutrient dodecylamine only showed to induce apparent 
germination, based on the heat sensitivity criterium and DPA release. Therefore, the ability 
of four natural antimicrobial compounds to inhibit germination by these two inducers was 
subsequently tested. Although inhibition of nutrient induced germination is most relevant for 
spore control in foods, inhibition of dodecylamine induced germination is of interest as well 
since this inducer follows a different mechanism that is less understood. We showed that 
carvacrol, cinnamaldehyde and carrot seed EO can inhibit nutrient germination of C. botulinum 
spores at concentrations many times lower than the MIC (Table 6.1). This offers an advantage 
for the food industry since these compounds have quite low sensory thresholds, making 
application in foods sometimes difficult 230,231. Further, carrot seed EO and cinnamaldehyde 
were capable of reducing dodecylamine’s effect on heat resistance, although for carrot seed no 
reduction in DPA release was shown. While cinnamaldehyde’s inhibitory effect could maybe 
be explained by a reaction between the electrophilic α,β unsaturated aldehyde group and the 
cationic amine group of dodecylamine, the mechanism of inhibition by carrot seed EO remains 
unclear.  
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Chapter 7* 
Canonical germinant receptor is dispensable for spore 
germination by nutrient or non-nutrient germinants in 
C. botulinum group II strain NCTC 11219  
 
 
 
 
 
 
 
 
 
 
 
* This chapter is based on a manuscript submitted for publication: Clauwers, C., Lood, C., van 
Noort, V. & Michiels, C. Canonical germinant receptor is dispensable for spore germination 
in Clostridium botulinum group II strain NCTC 11219.  
C. Lood and V. Van Noort contributed by conducting bioinformatic analysis of genome 
sequences.  
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7.1 Introduction 
In the natural environment, spore germination is induced when specific nutrients bind to spore 
germinant receptors (GRs) in the spore membrane, thus signalling that conditions are 
favorable for outgrowth (see 2.2.1). This initiates a self-propagating and irreversible cascade 
of events that does not require metabolic energy, starting with the release of monovalent 
cations H+, Na+, K+ and Ca2+-DPA from the spore core, followed by degradation of the spore 
cortex and core rehydration, eventually leading to reinitation of metabolism and outgrowth. 
Core rehydration is a key event in this process that underlies both the loss of the spores’ 
resistance properties and the activation of metabolism 119,127,232. 
The nutrients that trigger germination are species and strain specific and most commonly 
include one or more L-amino acids, purine ribosides and D-sugars 118. GRs designated as Ger 
receptors have been first identified in B. subtilis and later shown to be conserved in spore-
forming bacilli and clostridia, with few exceptions. However, the diversity among Ger 
receptors is large. In B. cereus, where this has been studied in most detail, a recent study defined 
eleven different phylogenetic clusters of Ger receptors, with the number of receptors per 
strain varying from four to ten 233. The number and types of Ger receptors present in a strain 
are believed to reflect the spectrum of germinants that it responds to. In B. subtilis strain 168, 
for example, GerA responds to D-alanine, while GerB and GerK cooperatively respond to a 
germinant mixture of D-alanine, glutamate, fructose and K+. However, the link between the 
germination response and the presence of specific Ger receptors is usually more complex, as 
exemplified by the study of Warda et al. (2017), who failed to establish such a link in seventeen 
B. cereus strains with a variable Ger receptor content 233. This may be due to various reasons, 
including the existence of a functional hierarchy and interactions between different receptors, 
and the fact that receptors may respond to more than one germinant and that their response 
may be influenced by so-called co-germinants 234. Knockout analysis has also indicated that 
Ger receptors of the same type may have a different contribution to the germinant response 
in different bacteria. For example, GerL was linked to L-alanine germination in B. cereus 569, 
but did not affect L-alanine germination in B. cereus ATCC 14579 16,235. Individual knockout 
of all ger operons in B. cereus ATCC 14579 failed to identify a role in germination for three 
(GerK, GerL and GerS) out of the seven Ger receptors, although all operons were transcribed 
during sporulation 16. A similar finding was reported in B. megaterium PV361, where only 
GerK seems to play a major role in germination, while the other four Ger receptors have only 
minor effects 236. Clarification of the structure-function relationship of Ger receptors has also 
been hindered by the difficulty to isolate functional receptors, because they are membrane-
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associated complexes composed of three subunits and associated with other proteins in a so-
called germinosome complex 237,238.  
Ger-type GRs are typically composed of three protein subunits designated A, B and C, that 
are usually encoded in a tricistronic operon. The A protein comprises four to eight predicted 
membrane-spanning domains, as well as large N- and C-terminal hydrophilic domains. The B 
protein contains seven to twelve transmembrane helices, and is structurally related to a 
superfamily of membrane-associated single-component membrane transporters, although the 
sequence similarity is low. The C subunit of the Ger receptor is predicted to be a lipoprotein 
that is anchored to the outer surface of the spore inner membrane 90,119,127. Christie et al. (2008) 
could alter the germinant response of B. megaterium spores by replacing the B subunit of a 
receptor by that of another strain, thus suggesting that this subunit is responsible for 
germinant binding 239. Remarkably, while the available evidence indicates that  all subunits are 
required to form a functional receptor in bacilli, several clostridia, like C. beijerincki, C. 
butyricum, C. asparagiforme, encode only a single A subunit, and it is unclear whether and how 
this subunit is involved in spore germination in these bacteria 127.  
Brunt et al. (2016) recently reported on the diversity of Ger gene clusters in groups I-IV of C. 
botulinum, based on in silico analysis of 148 C. botulinum and 8 C. sporogenes genomes 120. The 
latter were included because of their close relatedness to gICb. Four different ger clusters were 
identified (gerX1-4), which were further divided into subtypes designated with an additional 
letter (see Fig. 2.3). gICb and C. sporogenes strains typically contain three to five different Ger 
receptors, encoded by gerX1a/c/d, gerX2a/b/c and/or gerX3a. In general, spores from these 
strains germinate in response to various amino acids in combination with L-lactate, although 
the latter is not always essential 64,121. The functionality of C. botulinum Ger receptors has been 
experimentally studied in gICb strain ATCC 3502, which has a gerX1a, gerX1d and gerX2b 
cluster, and in C. sporogenes ATCC 15579, which has a gerX1a, gerX1d, gerX2c and gerX3a 
cluster 64. Construction and analysis of insertional knockouts in the A subunit encoding gene 
of each individual ger cluster revealed that both gerX1a and gerX1d were essential for amino 
acid germination in the gICb strain, while gerX2b was completely dispensable. In the C. 
sporogenes strain, in contrast, only gerX1d was essential for germination, while gerX1a was 
dispensable, and gerX2c and gerX3a influenced the rate, but not the extent of germination. No 
indications were found in regard to the germinant specificity of the receptors, since the effect 
of knocking out a receptor was always the same, irrespective of the germinant used (L-ala, L-
cys, L-met, L-ser, L-phe; for all together with L-lactate). In C. sporogenes, four triple knockout 
mutants, each carrying only one intact ger cluster, were also constructed. Only the mutant 
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with an intact gerX1d cluster retained wild type germinant responsiveness, while all other 
mutants failed to germinate. While this study yielded important insights in Ger receptor 
function, it also has an important limitation because the insertional knockout of the A subunit 
gene in a ger cluster does not necessarily abolish expression of the B and C subunits. This is 
certainly the case for the gerX3a cluster, which has a bicistronic organization, with gerB 
transcribed in the opposite direction as gerA and gerC.  
Much like gICb, gIICb spores germinate in response to several amino acids in combination 
with L-lactate, but other than in gICb, L-lactate seems to be essential for germination. In a 
systematic study with three gIICb strains, L-alanine, L-cysteine and L-serine were the amino 
acids that induced the strongest germination response 122. In addition, it was already reported 
earlier that gIICb spores germinated in response to amino acids at pH 9 in absence of lactate, 
as well as the combination of L-alanine with glucose, galactose or maltose at neutral pH 123. 
As opposed to gICb, analysis of gIICb genome sequences indicates that they produce only one 
Ger receptor, encoded by a gerX3b type cluster 120, but the function of this receptor remains 
to be investigated.  
Mutational studies have also been conducted in C. perfringens, which contains a gerX3 like 
locus designated gerK, and a distantly located monocistronic gerAA gene 124,125. It was 
concluded that GerKA, GerAA and GerKB only play auxiliary roles since inactivation of 
either of these proteins had no significant effect on germination. GerKC, on the other hand, 
was required for the response to germinants such as KCl, L-asparagine, or a L-asparagine–
KCl mixture. The finding that the A and B subunits are dispensable in C. perfringens is in 
striking contrast with the situation in B. subtilis 240.  
Despite the wide distribution of Ger-type receptors in sporulating bacteria, there is evidence 
for the existence of other receptor types. Although the genome sequences of at least two 
Clostridium species, C. bartletti and C. difficile, do not contain Ger gene homologs, spore 
germination in these bacteria is also induced by specific germinants, consistent with a 
mechanism involving one or more specific receptors. C. difficile spores do not respond to amino 
acid germinants, but to taurocholate, a characteristic component of bile, which allows the 
spores to recognize their primary niche, the animal gut. Francis et al. (2013) found that several 
C. difficile germination-null mutants had mutations in cspC, which encodes a catalytically 
inactive homolog of the germination protease CspC 126. Interestingly, a mutant that 
germinated in response to chenodeoxycholic acid, which normally is a competitive inhibitor 
of germination, was also found, and this led the authors to propose that CspC acts as the GR 
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for taurocholate in C. difficile 126. Upon germinant binding, CspC is postulated to undergo a 
conformational change that is transmitted to CspB, which would then activate the cortex 
hydrolase SleC by proteolytic cleavage of its pro-region. Several other clostridia, including 
gIICb strains, contain Csp related serine proteases, but their possible role as GRs has not yet 
been studied 127. 
It is clear from the above that the mechanisms of spore germination can vary substantially, 
and that in clostridia in particular, the role of the Ger receptors and the possible existence of 
additional GRs requires further investigation. In gIICb strains, specifically, the presence of 
only a single Ger-type receptor contrasts with the large variety of amino acids that can trigger 
germination. It seems unlikely that GerX3b can act as a specific receptor for all these 
germinants. In the present work, we deleted the entire gerBAC locus encoding the GerX3b in 
gIICb strain NCTC 11219 to analyse its role in germination with different nutrients and the 
non-nutrient dodecylamine. The deletion was accomplished with the use of a pyrE-based gene 
replacement method that we used previously to remove the botulinum neurotoxin gene from 
the same strain (Chapter 4). 
 
7.2 Materials and Methods 
7.2.1 Bacterial strains and growth conditions 
This work was conducted in an atoxigenic ∆bont::ermB and uracil auxotrophic ∆pyrE mutant 
of strain NCTC 11219 (constructed in Chapter 4), further in this chapter shortly named ∆bont 
∆pyr. This strain was used for biosafety reasons, and because of the possibility to use pyrE in 
trans as a negative selection marker for replacement of the gerBAC locus. Clostridial cultures 
were routinely grown at 30 °C in TPGY broth and plated on solid RCM or TPGY agar, 
whereas TYG agar was used in mating (see 4.2.1). Vegetative cultures were manipulated and 
incubated in a Don Whitley DG250 anaerobic workstation using overnight pre-reduced 
media. Spores suspensions were handled in open air, and transferred to the workstation only 
for experiments involving outgrowth. Production and purification of spore crops was done as 
described in 4.2.2.  
E. coli strains were grown in LB or on LB agar at 37 °C. E. coli DH5α was used for cloning 
and maintenance of plasmids, while E. coli CA434 (HB101 containing plasmid R702,185) was 
used as conjugation donor. Media were supplemented with the following antibiotics 
(Applichem): thiamphenicol (Tm, 15 μg/ml in agar, 7.5 μg/ml in broth) and spectinomycin 
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(Sp, 600 μg/ml) for C. botulinum, cycloserine (Cy, 250 μg/ml), chloramphenicol (Cm, 25 μg/ml 
in agar, 12.5 μg/ml in broth) and Sp (100 μg/ml) for E. coli. 5-Fluoroorotic acid (5-FOA, 500 
µg/ml (Manchester Organics) was used in screening for loss of the pyrE-expressing plasmid 
pMTL84151∆gerBAC. 
7.2.2 Plasmid construction 
The plasmid pMTL84151∆gerBAC was constructed to replace the gerBAC locus with the Sp 
resistance marker aad9 in strain ∆bont ∆pyr. All primers used are listed in Table 7.1 and were 
obtained from Integrated DNA Technologies. First, pyrE (675 bp) was amplified from start to 
stop codon with primers pyrE11219_F and pyrE11219_R, restricted with NdeI/SacI and 
placed after the pfdx promotor in pMTL83353, opened with the same enzymes. Hereafter, the 
fragment containing pfdx and pyrE was amplified with primers pMTL83353_F and 
pyrE11219_R, digested with SbfI and SacI and cloned in pMTL84151, restricted with the 
same enzymes. Flanking loci of gerBAC (5’ locus: 932 bp, 3’ locus: 1091) were amplified from 
gDNA of NCTC 11219 using primer pairs ger5’F/ger5’R and ger3’F/ger3’R, respectively. 
The aad9 locus (1009 bp) was amplified from plasmid pMTL83353 with primers aad9_F and 
aad9_R. The amplified 5’ and 3’ loci, the aad9 fragment and pMTL84151 containing pfdx pyrE, 
opened by PCR using primer pair pMTL84151_openF / pMTL84151_openR, were cloned 
together using Gibson assembly, following the suppliers protocol (New England Biolabs, 
Hitchin, UK). The plasmid construct designated pMTL84151∆gerBAC was verified by PCR 
and sequence analysis, and transferred to E. coli CA434 by electroporation.  
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Table 7.2: Oligonucleotides used for cloning and construct verification. Restriction sites are underlined: NdeI 
(CATATG), SacI (GAGCTC) and SbfI (CCTGCAGG). The small letters indicate the overhang region of the 
primer, necessary for annealing fragments via Gibson assembly.  
Name Sequence (5’-3’) 
pyrE11219_F AGGCATATGGAAGCATATAAAAAAGAG 
pyrE11219_R CTTGAGCTCCTACTTAGCACCATATTC 
pMTL83353_F GAGCCTGCAGGATAAAAAAATTGTAG 
pMTL84151_openR ttctggtgatttaactttagCTCCTACTTAGCACCATATTC 
pMTL84151_openF ccgtcgttttacaacgtc 
ger5’F gatgaaattaaaactagaatagatgaatattacaaagaatatggtgctaagtaggagCTAAAGTTAAATCACCAGAAGG 
ger5’R GCACTTTACTTATACATATATCACTAATGAC 
ger3’F ATGAAGGTATAATTTTAAAGATGCTCTAAAATCTC 
ger3’R acgacgttgtaaaacgacggCTAAACATTTCTCTACATCTGC 
aad9_F tctttattttagtcattagtgatatatgtataagtaaagtgcCAATGAATAGGTTTACACTTACTTTAGTT 
aad9_R aataacagagattttagagcatctttaaaattataccttcatAATAAAACAAAAAAATTGAAAAAAGTGTTTCCA
CCA 
∆gerBAC_upF GTTATAGCATGTAAATCAACCACGC 
∆gerBAC_downR TCTTAGCTCCATTAATTTCAGCAC 
  
7.2.3 Construction of the ∆gerBAC deletion mutant  
Plasmid pMTL84151∆gerBAC was introduced into NCTC 11219 ∆bont ∆pyr by conjugation 
(see 4.2.4), using selection on RCM agar with Tm and Cy. Purified transconjugants were 
resistant to Sp and sensitive to 5-FOA, confirming expression of the plasmid aad9 resistance 
marker and pyrE gene, respectively.  
Transconjugants were serially grown in TPGY with Sp, and every round was then plated on 
TPGY with Sp and 5-FOA to select for clones in which double homologous recombination 
with the flanking loci of gerBAC as well as loss of the plasmid had occurred. Multiple attempts 
of plating were needed before resistant colonies appeared. Then, up to 30 colonies could be 
selected out of 200 µl of an overnight culture (i.e. about 107 cells), and plasmid loss was 
confirmed by the loss of Tm resistance of the clones. PCR and sequence analysis with primers 
∆gerBAC_upF / ∆gerBAC_downR, annealing on the chromosome outside the homologous 
fragments, were performed to confirm that gerBAC was deleted and replaced by aad9. The 
mutant was designated NCTC 11219 ∆bont ∆pyr ∆gerBAC::aad9 (in this manuscript further 
described as ∆bont ∆pyr ∆gerBAC). 
7.2.4 Whole genome sequencing 
To further confirm the absence of the gerBAC genes, the ∆bont ∆pyr ∆gerBAC strain and its 
parent ∆bont ∆pyr were subjected to WGS analysis on an Illumina MiSeq sequencer. First, 
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gDNA from both strains was isolated from overnight cultures using the GeneJET Genomic 
DNA purification kit (Thermo Scientific). DNA purity and concentration was assessed by 
Nanodrop analysis, gel electrophoresis and Qubit (Thermo Scientific) analysis. Paired-end 
libraries were constructed using the NEBNext Ultra gDNA library prep protocol with an 
average insert size of 240 bp, and analysed on the Agilent BioAnalyzer (VIB nucleomics core) 
resulting in on average 1.2 million reads per sample. Reads were analysed with Qiagen’s CLC 
Genomics Workbench version 8.5 (http://www.clcbio.com/), and included standard quality 
control, read trimming and filtering (reads < 15 nucleotides were discarded, quality score 
limit = 0.01, ambiguous nucleotides trim limit = 2), and read mapping to C. botulinum NCTC 
11219 reference WGS with accession number JXMR00000000 (using parameters: mismatch 
cost = 2, insertion cost = 3, deletion cost = 3, length fraction = 0.8, similarity fraction = 0.8), 
yielding on average a 43-fold genome coverage for the parental strain and 51-fold coverage 
for the ΔgerBAC mutant.  
7.2.5 Chemicals and stock solutions 
Different germinant mixtures were prepared freshly before use in 100 mM Tris-HCl buffer 
pH 7.4, as twofold concentrated working solutions, from the following chemicals: L-alanine 
(Sigma), L-lactate sodium salt (Acros), NaHCO3 (Acros), L-serine (Acros), L-cysteine (Acros), 
L-threonine (Acros), inosine (Sigma) and D-glucose (Acros). A 1 M stock solution of 
dodecylamine (Acros) was freshly prepared in ethanol, and further diluted in 100 mM Tris-
HCl buffer to 6 mM (= twofold of working concentration).  
7.2.6 Germination assays  
Spore crops were centrifuged (3400 x g, 10 min, 4 °C), resuspended in 100 mM Tris-HCl 
buffer, and heated for 10 min at 65 °C to inactivate any residual vegetative cells and spores 
that would have spontaneously germinated during storage, and also to activate dormant 
spores for germination. Hereafter a sample was taken from the suspension, diluted in Tris-
HCl buffer and plated on TPGY to determine the initial spore count N(t0). The remainder of 
the heat activated spore suspension was mixed with an equal volume ratio of a twofold 
concentrated germinant solution (or buffer as a negative control), and incubated for 4 h at 30 
°C. The suspension was then heated for 10 min at 65 °C and plated on TPGY, to determine 
the counts N(t4-HT). Germination was then expressed using the following formula: 
Log germination (log CFU/ml) = log10 (N(t0) / N(t4-HT)) 
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7.2.7 DPA measurements 
After 4 h of incubation, spores were removed from the germinant solution by centrifugation 
(12 000 x g for 5 min), whereafter the supernatant was used for DPA analysis. Hundred µl of 
the supernatant was mixed with an equal volume of 20 mM TbCl3 in a 96-well black microtiter 
plate (Greiner Bio-one) 227. Fluoresence measurements were done in a spectrofluorometer 
(Synergy Mx-biotek) with excitation and emission wavelengths of 270 and 545 nm, 
respectively. DPA release was expressed relative to the total spore DPA content, which was 
measured after treatment of the spores at 98 °C for 30 min 144 .  
7.2.8 Microscopy 
Spore were immobilized on thin pads of 1 % agarose in Tris-HCl buffer with/without addition 
of germinants. Microscopy pictures were taken with a Ti-Eclipse inverted microscope (Nikon) 
equipped with a CoolLED pE-100 camera. Images were acquired using NIS-Elements (Nikon) 
and resulting pictures were further handled with open source software ImageJ.  
7.2.9 Statistical analysis 
The statistical significance of the extent of germination and DPA release was performed using 
the Student’s T-test with a significance level of 0.05.  
7.2.10 Functional analysis of 152 gIICb strains  
The raw Illumina reads of a diverse set of 152 gIICb strains that have been recently published 
165 (although after Chapter 3 was published) were retrieved from the NCBI Sequence Read 
Archive database (Accession number: SRP059342, no corresponding assembly available). The 
fastq files were processed with BBduk for removal of adapter contamination, trimming (Phred 
score > 28), and size exclusion (read length > 50bp). Each fastq file was subsequently 
inspected with FastQC for quality control 241. The genome of each strain was assembled with 
SPAdes 242, and the quality of the assembly assessed with QUAST 243. Functional annotation 
was done using Prokka 244 with a custom protein database created from strains of the 
Clostridium genus. The protein content of each genome was finally queried using Blastp 
against the GerX3b present in gIICb strain Eklund-B17. 
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7.3 Results  
7.3.1 Construction of the ∆gerBAC deletion mutant  
The deletion of the gerBAC locus was done in strain NCTC 11219 ∆bont ∆pyr of which the 
construction was described in Chapter 4. Besides having the advantage of being nontoxigenic, 
the pyrE deletion renders this strain resistant to 5-FOA, making it possible to use the pyrE 
gene as a negative selection marker. Plasmid pMTL84151∆gerBAC (TmRSpR) was conjugated 
to this strain to allow replacement of gerBAC with aad9. Since pyrE is also expressed on the 
plasmid, it renders the strain 5-FOA-sensitive. Then, plating on RCM with 5-FOA and Sp 
selects for clones in which double homologous recombination as well as loss of the plasmid 
had occurred. PCR analysis confirmed that gerBAC was deleted and replaced by aad9. WGS 
analysis confirmed this, and additionally indicated that the gerBAC locus had not translocated 
elsewhere in the genome, but was completely absent in strain ∆bont ∆pyr ∆gerBAC.  
The spore yield of the ∆gerBAC strain (6.9 +/- 0.6 log cfu/ml; n = 6) was unaffected (p > 0.05) 
compared to that of the parental ∆bont ∆pyr strain (7.2 +/- 0.4 log cfu/ml; n = 6). Colony 
formation from spores of the ∆gerBAC strain was not delayed and the colonies were 
indistinguishable from those of the parent strain. Spore counts, determined after a heat 
treatment, were stable for at least four months at 3 °C.  
7.3.2 The role of GerX3b in germination induced by L-alanine/L-lactate/NaHCO3  
Since the combination of L-alanine with L-lactate and NaHCO3 is a very efficient inducer of 
spore germination in a wide range of gIICb strains 122,123, we first used this germinant mixture 
to analyse the impact of deletion of the GerX3b receptor. Unexpectedly, germination of the 
mutant, as assessed by heat treatment and plating and by DPA release (1.5 +/- 0.6 log 
germination ; 69.3 +/- 10.7 % DPA release), was not significantly different from that of the 
parent strain (1.3 +/- 0.3 log germination ; 83.2 +/- 8.2 % DPA release) (Fig. 7.1). 
Replacement of L-alanine by D-alanine reduced germination of both strains to a background 
level comparable to that observed in the absence of germinants, indicating stereospecificity of 
the L-alanine response. Germination was also monitored by phase-contrast microscopy of 
spores deposited on agar pads. When the L-alanine/L-lactate/NaHCO3 germinant mixture 
was incorporated in the agar, almost half of the spores had already turned phase-dark by the 
time the slide could be viewed, but there was no difference between both strains in the fraction 
of phase-dark spores or in their appearance (Fig. 7.1). When no germinants were included in 
the agar pads, the spores of both strains remained phase-bright. 
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Fig. 7.1: Spore germination of ∆gerBAC spores compared to the parental strain, in L-alanine/L-lactate/NaHCO3  
(all at 50 mM) in 100 mM Tris-HCl buffer (pH 7.4). A) Germination assessed by loss of heat resistance (65 °C/10 
min), after incubation of heat activated spores for 4 h at 30 °C in the germinant mixture. D-alanine (50 mM) was 
used to demonstrate the stereospecific action of germination induction in comparison to L-alanine. Means +/- 
standard deviations are shown of three experiments using independent spore crops. No significant differences 
were found (p > 0.05) between the two strains. B) DPA release of heat activated spores incubated for 4 h at 30 
°C in the germinant mixture, relative to the total DPA content. Mean percentages +/- standard deviations are 
shown of three experiments using independent spore crops. No significant differences were found (p > 0.05) 
between the two strains. C) Spores of the ∆gerBAC mutant visualized with phase-contrast microscopy 5 min (left) 
and 1 h (right) after deposition on an agar pad containing L-alanine/L-lactate/NaHCO3 germinant mixture. A 
considerable fraction of spores had already become phase-dark after 5 min, and spore germination was > 90 % 
after 1 h. A similar result was obtained for the parental strain (picture not shown).  
 
7.3.3 The role of GerX3b in germination induced by other nutrient germinants  
Because deletion of the GerX3 receptor showed no effect on germination induced by L-
alanine/L-lactate/NaHCO3, we further tested other nutrient mixtures previously described 
to germinate gIICb spores (listed in Table 7.2) 122,123. All mixtures were first tested on the 
parental strain and mixtures which induced at least a 0.4 log germination were subsequently 
also used for the ΔgerBAC mutant. Besides L-alanine, both L-serine and L-cysteine in 
combination with L-lactate and NaHCO3 have been previously reported as very efficient 
inducers of germination of gIICb spores. This was confirmed for the spores of our strain, and 
we additionally observed very efficient germination in L-threonine/L-lactate/NaHCO3, as 
well as the combination inosine/L-alanine/NaHCO3, two mixtures previously reported as 
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moderate germination inducers 122,123. Unexpectedly, no statistical differences were found in 
spore germination with any of these germinants between the parental strain and the ΔgerBAC 
mutant (p > 0.05). 
No germination was obtained with glucose/L-alanine/NaHCO3, glycine, and glycine/L-
lactate/NaHCO3, although these were previously reported to induce germination (Table 7.2). 
Ando (1971) reported gIICb spore germination by the single amino acids, L-alanine, L-
cysteine, L-serine at pH 9.0 in the presence of NaHCO3 123. However, we were not able to test 
these mixtures by assessing loss of heat resistance, because ∆bont ∆pyr spores (as well as ∆bont 
spores) already became heat sensitive in carbonate buffer (pH 9.0) without addition of 
nutrients. Because the fraction of phase-dark spores remained negligible, even after overnight 
incubation in the germinant mix, we concluded that these amino acids at pH 9.0 do not induce 
germination in the NCTC 11219 strain. 
7.3.4 The role of GerX3b in dodecylamine induced apparent germination 
Because loss of the putative GerBAC receptor did not affect spore germination by nutrient 
germinants, we next evaluated the effect on apparent spore germination by the non-nutrient 
germinant dodecylamine. Spores in the presence of dodecylamine (3 mM, 4 h at 30 °C) showed 
strongly reduced counts after heat treatment, and there was again no significant difference (P 
> 0.05) between the parental strain and the ∆gerBAC mutant (Table 7.2). In addition, DPA 
release induced by dodecylamine treatment was not different between the ∆gerBAC mutant 
(42.4 +/- 3.2 %) and the parental strain (39.1 +/- 9.6 %) (p > 0.05). Similar low values of DPA 
release have been reported previously for dodecylamine induced germination at relatively low 
temperatures, and higher temperatures stimulated DPA release 34. Furthermore, as was also 
shown in Chapter 6, the dodecylamine-germinated spores did not become fully phase-dark, 
suggesting that dodecylamine treatment does not lead to completion of the germination 
process.  
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Table 7.2: Spore germination of NCTC 11219 strains for 4 h at 30°C in different germinant mixtures that have 
been previously described for gIICb. Germination was determined by plate counting after the germinated spores 
were inactivated by a heat treatment (65°C/10 min). Data for L-alanine/L-lactate/NaHCO3 are from Fig. 7.1. 
Because spores became heat sensitive in carbonate buffer at pH 9.0, the effect of germinants in this buffer was 
observed with phase-contrast microscopy. (ND: not determined) 
   
Nutrient mixture  
in 100 mM Tris-HCl buffer pH 7.4 
Log germination (log CFU/ml) Reference 
 
∆bont ∆pyr ∆bont ∆pyr ∆gerBAC 
 
L-alanine + L-lactate + NaHCO3 (all 50 mM) 1.3 +/- 0.3 1.5 +/- 0.6 122 
L-serine + L-lactate + NaHCO3 (all 50 mM) 2.0 +/- 0.0 2.0 +/- 0.2 122 
L-cysteine + L-lactate + NaHCO3 (all 50 mM) 1.0 +/- 0.1 1.4 +/- 0.5 122 
L-threonine (100 mM) + L-lactate (50 mM) + NaHCO3 (50 mM) 1.3 +/- 0.6 1.0 +/- 0.5 122 
Inosine (20 mM) + L-alanine (25 mM) + NaHCO3 (60 mM) 1.3 +/- 0.4 1.3 +/- 0.4 122,123 
Glucose (20 mM) + L-alanine (25 mM) + NaHCO3 (60 mM) 0.1 +/- 0.2 ND 123 
Glycine (50 mM) 0.1 +/- 0.2 ND 123 
Glycine + L-lactate + NaHCO3 (all 50 mM) 0.1 +/- 0.3 ND 122 
    
Nutrient mixture  
in 100 mM carbonate buffer pH 9.0 
Phase-dark spores after 4 h 
 
 
∆bont ∆pyr ∆bont ∆pyr ∆gerBAC 
 
L-alanine (100 mM) + NaHCO3 (50 mM) < 5%  ND 123 
L-cysteine (100 mM) + NaHCO3 (50 mM) < 5% ND 123 
L-serine (100 mM) + NaHCO3 (50 mM) < 5% ND 123 
L-threonine (100 mM) + NaHCO3 (50 mM) < 5% ND 123 
    
Non-nutrient mixture 
in 100 mM Tris-HCl buffer pH 7.4 
Log germination (log CFU/ml)  
 
∆bont ∆pyr ∆bont ∆pyr ∆gerBAC 
 
Dodecylamine (3 mM)  3.3 +/- 0.6 3.9 +/- 1.1 131,144 
 
7.3.5 Functional analysis 
We assembled previously published reads of 152 gIICb strains. Out of the 152 strains, 17 
strains were removed from the analysis due to poor assembly performance (N50 < 10,000). 
The functional analysis of the 135 remaining strains revealed that across all the strains the 
gerBAC genes are strictly conserved with intact start and stop codons. 
  
  
110 
 
7.4 Discussion  
This work is the first to report on the role of germinant receptors in group II C. botulinum. 
Analysis of WGS of 24 gIICb strains (18 of toxin type E, 4 of toxin type B, and 2 of toxin type 
F) previously indicated the presence of a single locus of the GerX3b type in all these strains 
120. The classical concept of spore germination states that germination is triggered by the 
specific binding of a germinant molecule to a cognate GR protein in the spore membrane. 
However, it is difficult to understand how the single GerX3b receptor in gIICb strains could 
have specific binding sites for the large variety of nutrients that can trigger spore germination 
in this organism. As a first step to unravel the precise role of the GerX3b receptor in 
germination, we therefore undertook to delete the entire gerBAC locus encoding the three 
receptor subunits, using a gene replacement technique that we used previously to delete the 
bont gene (Chapter 4).  
The entire gerBAC locus was successfully deleted and replaced by a spectinomycin resistance 
marker, as confirmed by sequencing of specific PCR amplicons of the region and WGS 
analysis. Much to our surprise, the deletion did not affect germination induction by any of 
four major nutrient germinant mixtures, nor by the non-nutrient dodecylamine. Specifically 
for L-alanine, we demonstrated that the germination response is stereospecific, since D-
alanine (in combination with L-lactate) did not induce germination. This is in line with the 
notion that germinants in gIICb, as in other spore-formers, induce spore germination by 
interaction with a specific receptor. However, our results clearly demonstrate that GerBAC is 
not a functional GR, and thus lead to the conclusion that one or more other, so far unidentified, 
GRs must be responsible for nutrient induced germination.  
One possible alternative receptor are the CspC orthologues in gIICb, since a non catalytically 
active CspC variant was demonstrated to act as GR in C. difficile 126. cspC and cspBA are located 
directly upstream of sleC in C. difficile, and the gene upstream of sleC in C. botulinum NCTC 
11219 also encodes a predicted subtilase family protein, although the similarity to CspC from 
C. difficile is low (32 % amino acid identity over 76 % of the sequence). In addition, this putative 
protease is predicted to contain an intact catalytic triad Asp/Ser/His, as opposed to CspC of 
C. difficile in which two of the three catalytic residues are lost. Additionally, BLAST analysis 
revealed five other gene products in C. botulinum NCTC 11219 showing low but significant 
similarity to CspC of C. difficile R20291. In the genomes of gIICb strains type E Beluga, type 
E Alaska E43 and type B Eklund 17B, the number of CspC orthologues is 5, 6 and 10, 
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respectively. All these predicted proteins are annotated as members of the subtilase family, 
and contain an intact catalytic triad.  
Since our results suggest that GerX3b is not a functional GR, and in the assumption that this 
is the case in all gIICb strains, one would expect the gerBAC genes to have accumulated loss 
of function mutations in some strains. In complement to the 24 WGS analysed by Brunt et al. 
(2016) that appear to have intact gerBAC genes 245, we extended the search space with 135 
gIICb strains and showed that all had intact gerBAC genes. Thus, it appears that maintenance 
of an intact gerBAC locus is important in gIICb. We are not aware that alternative functions 
have been reported for Ger-type receptors in any spore-forming bacteria, and it will therefore 
be interesting to explore such functions in gIICb. On the other hand, the quest for the genuine 
GR in gIICb is open. As discussed above, the CspC-like proteins are possible candidates, and 
their large number in gIICb is compatible with the large variety of germinants in gIICb. 
However, if they show functional redundancy and hierarchy, as is the case for the multiple 
Ger receptors in B. cereus, their functional analysis will be a difficult task. On the other hand, 
the possibility of an entirely novel class of GRs should also be considered, and it seems useful 
therefore to isolate and analyse non-germinating mutants to investigate this possibility.  
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Chapter 8 
SleB is not essential for cortex hydrolysis during 
germination of C. botulinum NCTC 11219 spores 
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8.1 Introduction 
Cortex hydrolysis is an essential step in the completion of spore germination because only 
when the spore cortex PG has been cleaved, the core can fully rehydrate whereafter vegetative 
metabolism can be resumed (see 2.2.1.2). Most Bacillus species have two CLEs (CwlJ and SleB) 
of which either one is sufficient for completion of germination. In contrast, most clostridia 
contain SleB and SleC, and in some species SleM and CwlJ can be additionally present 127. 
Brunt et al. (2016) analysed 24 genomes of gIICb strains and found, next to sleB and sleC, 
additional sleC-like genes designated as sleC2a/b (with sleC2b mostly present in type E strains), 
whereas cwlJ appears to be absent 120. However, the functionality of SleB has been questioned, 
because gIICb strains do not appear to encode a YpeB protein, which in Bacillus is required 
for proper localization and/or function of SleB 139.  
Up to now, only a few studies have been performed on clostridia that investigated the 
functionality of these CLEs. Mutational studies showed that SleC is the essential cortex 
hydrolase in both C. perfringens and C. difficile, which additionally possess SleM and a SleB 
homolog respectively 140,141. Here, we have attempted to study the functionality of SleB and 
SleC in strain NCTC 11219 by knockout mutagenesis. The same strategy was used that has 
been described for deletion of bont/E (Chapter 4 and 5) and deletion of gerBAC (Chapter 7).  
 
8.2 Materials and Methods 
8.2.1 Bacterial strains, growth conditions and spore production 
For construction of the sleB and sleC mutants, we used the atoxigenic and uracil auxotrophic 
mutant C. botulinum NCTC 11219 ∆bont::ermB ∆pyrE (in short referred to as NCTC 11219 
∆bont ∆pyr), of which the construction has been described in Chapter 4. In addition, C. 
botulinum NCTC 8266 ∆bont::ermB ∆pyrE (in short referred to as NCTC 8266 ∆bont ∆pyr) was 
also used for creation of a sleC mutant. Growth media used for clostridial and E. coli cultures 
as well as the preparation of spore crops was performed are described in 4.2.1 and 4.2.2.  
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8.2.2 Plasmid construction  
The plasmids pMTL84151∆sleB and pMTL84151∆sleC were constructed to respectively 
replace the sleB and sleC genes with the Sp resistance marker aad9 in strain 11219 ∆bont ∆pyr. 
Both plasmids are based on pMTL84151∆bont (shown in Fig. 4.1), which was linearized (i) 
with PCR using primers P_openF/P_openR for the sleB construct, and (ii) with restriction 
enzymes KpnI and XhoI for the sleC construct. The linearized plasmid backbone carries the 
catP marker that encodes Cm/Tm resistance as well as pfdx pyrE, that can be used as a negative 
selection marker in the presence of 5-FOA. Further, in this backbone ~ 1 kb up- and 
downstream flanking loci of the target gene (sleB or sleC) were cloned with the aad9 marker 
in between using Gibson Assembly. Table 8.1 shows all primers used for plasmid construction 
and for confirmation of mutants. Primers pairs sleB5’F and sleB5’R, aad9_F/SleB and 
aad9_R/SleB, sleB3’F and sleB3’R were used for construction of pMTL84151∆sleB, and 
primer pairs sleC5’F and sleC5’R, aad9_F/SleC and aad9_R/SleC, sleC3’F and sleC3’R for 
construction of pMTL84151∆sleC.  
The assembled Gibson products were then transferred to E. coli NEB #C2987 (New England 
Biolabs) by chemical transformation (following the Gibson protocol), and transformants were 
selected on LB supplemented with Sp and Cm. After verification of the constructs 
pMTL84151∆sleB and pMTL84151∆sleC by PCR and sequence analysis, the plasmids were 
transferred to E. coli CA434 by electroporation, which was then used as conjugation donor to 
transfer the plasmids to C. botulinum NCTC 11219 ∆bont ∆pyr. 
8.2.3 Conjugation and isolation of ∆sleB and ∆sleC deletion mutants 
Conjugation of plasmids was performed as described previously (see 4.2.4). After conjugation 
of pMTL84151∆sleB or pMTL84151∆sleC to strain NCTC 11219 ∆bont ∆pyr, transconjugants 
were selected on RCM supplemented with Tm and Cy. Purified transconjugants were then 
tested for Sp resistance and 5-FOA sensitivity (verifying expression of the aad9 resistance 
marker and pyrE respectively). 
Subsequently, transconjugants were grown and subcultured daily in TPGY supplemented 
with Sp, and 200 µl of each serial culture was plated on TPGY with Sp and 5-FOA, to select 
for clones in which double homologous recombination with the flanking loci of the target gene 
(sleB or sleC) as well as loss of the plasmid had occurred. Plasmid loss was subsequently 
confirmed by verifying Tm sensitivity.  
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Tabel 8.1: PCR oligonucleotides used for cloning and construct verification. The small letters indicate the 
overhang region of the primer, necessary for annealing fragments via Gibson assembly. 
Name Sequence (5'-3') 
∆sleB 
 
P_openF CCGTCGTTTTACAACGTC 
P_openR CTCCTACTTAGCACCATATTC 
sleB5'F GCCCAAAAAGAGCCTTATATACATAAATTAA 
sleB5'R gttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggATTTGATGAAAATGATGCCAAACTCG 
aad9_F/SleB gtctaataaatataattagattggtcattatttttattaagatttAATAAAACAAAAAAATTGAAAAAAGTGTTTC 
aad9_R/SleB catataaatattaatttatgtatataaggctctttttgggcCAATGAATAGGTTTACACTTACTTTAGTTT 
sleB3'F ctagaatagatgaatattacaaagaatatggtgctaagtaggagGACATAATGCTTATACAAGAAATAATAGG 
sleB3'R AAATCTTAATAAAAATAATGACCAATCTAATTA 
upSleB  TCATATTGTTACACAGGGTCTTATGCTG 
downSleB TGGTTATGATAAATTTTTCAACAG 
sleBinternF ACAATGTTGCTTATGCTCAAGTATTAGGTGAC 
sleBinternR TGCCGTGCTAGGATTATAAAAGAATAATGC 
  
∆sleC 
 
sleC5'F gatgaatattacaaagaatatggtgctaagtaggagctcggtaccTGAAGTTAAAATAGGTAAAAATCAG 
sleC5'R CACTAACTCCTTAATATTTTTCCTACG 
aad9_F/SleC cttatctcatataatattcgtaggaaaaatattaaggagttagtgCAATGAATAGGTTTACACTTACTTTAGTTT 
aad9_R/SleC ggaatataaaaaagcaatgcttcaaacaatttgaagcattgcTTCTAAAATCTGATTACCAATTAGAATG 
sleC3'F GCAATGCTTCAAATTGTTTGAAGC 
sleC3'R aacgacggccagtgccaagcttgcatgtctgcaggcctcgagGTCAGGAATTCAAAGGAATGG 
upSleC  AGTGGGTACTGGAAATCAAGGTG 
downSleC  TCATCTGGAAAAGGTTCTGG 
SleCintern_F  GGTTCCATATAGTGTTTATG 
SleCintern_R  TGCATTACTAGACCATGTAG 
 
8.2.4 Germination assays 
Germination was induced by the gerMix L-alanine/L-lactate/NaHCO3 (all at 50 mM) in 100 
mM Tris-HCl (pH 7.4) and apparent germination by the non-nutrient dodecylamine (3 mM) 
in the same buffer. After 4 h incubation of the spores with the germinants at 30 °C, 
germination was assessed based on loss of heat resistance and DPA release, as respectively 
described in 7.2.6 and 7.2.7. Strain differences in the extent of germination and DPA release 
were statistically analysed using the Student’s T-test with a significance level of 0.05. 
Microscopy pictures were assessed as indicated in 7.2.8.  
 
  
  
117 
 
8.3 Results and Discussion 
8.3.1 Construction of the ∆sleB deletion mutant 
The knockout strategy used was already described in detail for deletion of bont/E and deletion 
of gerBAC (Chapters 4 and 7). After introduction of plasmid pMTL84151∆sleB into strain 
NCTC 11219 ∆bont ∆pyr, three rounds of propagation in TPGY broth with Sp were required 
before 5-FOA/Sp resistant clones could be isolated of which one clone was further confirmed 
to be a ∆bont ∆pyr ∆sleB mutant (in short: ∆sleB). Plasmid loss was confirmed by the Tm 
sensitivity of the clone, whereas PCR and sequence analysis with primers up_sleB/down_sleB, 
annealing outside the homologous loci used in recombination, confirmed the replacement of 
sleB by aad9 in the genome. In addition, a PCR on gDNA of the ΔsleB mutant with primers 
sleBinternF/ sleBinternR located internally of the sleB gene resulted in no PCR product, while 
a PCR product could be formed on ∆bont ∆pyr gDNA. This additionally confirms absence of 
sleB in the ∆bont ∆pyr ∆sleB genome. 
8.3.2 Qualitative evaluation of spore germination of ∆sleB spores 
Spore viability. Freshly harvested spores were plated on TPGY agar after being heat 
activated (65 °C/10 min). No significant differences in counts were found between the ∆bont 
∆pyr parent and the ∆bont ∆pyr ∆sleB mutant (P > 0.05), with the average spore yield being 
7.6 +/- 0.3 log cfu/ml and 8.0 +/- 0.4 log cfu/ml respectively (n=6). The counts of the ∆sleB 
spore suspensions indicate that sporulation is not affected and that the spores are viable and 
can complete germination on rich medium.  
Core rehydration. Microscopy of spores on agar pads was used to observe core rehydration 
during germination, which can only be completed if the cortex has been degraded. Heat 
activated ∆sleB spores turned phase-dark within 1 h in the presence of nutrient germinants 
(L-alanine/L-lactate/NaHCO3), but remained phase-bright without germinants (Fig. 8.1). 
Moreover, the rehydrated ∆sleB spores were swollen in a similar way as the ∆bont ∆pyr spores, 
indicating that the cortex had been degraded. In addition, visual (not quantitative) analysis of 
time-lapse movies showed no difference in the rate of spore germination between the parental 
and ∆sleB strain.  
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Fig. 8.1: Microscopy images of spores of the parental strain, NCTC 11219 ∆bont ∆pyr and the mutant strain, 
NCTC 11219 ∆bont ∆pyr ∆sleB on agar pads without and with germinants (L-alanine/L-lactate/NaHCO3, all at 
50 mM). Pictures were taken 1 h after the spores were placed on the pads. Six microscopic fields were assessed 
for each (with around 200 spores per field), and a representative image is shown. 
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The high spore viability on agar plates and the core rehydration shown by microscopy, 
indicate that SleB is not an essential CLE for completion of cortex hydrolysis in C. botulinum 
NCTC 11219 spores. Possibly SleB plays an auxiliary role in germination, but this should be 
investigated further by the use of kinetic studies and by construction of mutants in which 
multiple CLEs are inactivated together.  
We then investigated whether other germination events are affected due to the sleB deletion.  
8.3.3 Quantitative evaluation of nutrient and dodecylamine induced germination of 
∆sleB spores 
The loss of heat resistance and the release of DPA were assessed in the presence of the gerMix 
and dodecylamine (Fig. 8.2). Germination in the nutrient mixture was reduced (p < 0.05) for 
the ∆sleB spores (0.3 +/- 0.2 log cfu/ml) in comparison with the parental spores (1.4 +/- 0.5 
log cfu/ml), alhough the DPA release was not significantly different between both strains 
(∆sleB: 53.2 +/- 2.0 % ; parent: 63.1 +/- 10.8 %). Furthermore, the apparent germination 
induced by dodecylamine was also significantly different between both strains, with 4.6 +/- 
0.4 log cfu/ml for ∆bont ∆pyr spores and 2.6 +/- 0.7 log cfu/ml for ∆sleB spores (p < 0.05). 
Surprisingly, the DPA release showed an opposite trend, with significantly more release for 
the ∆sleB spores (90.3 +/- 9.4 %) than for the parental spores (58.8 +/- 5.8 %) (p < 0.05). This 
DPA release is measured after incubation for 4 h at 30 °C in the presence of dodecylamine, but 
before the spores have received the 65 °C-treatment to inactivate the germinated fraction. 
When DPA release was measured after heat treatment, the difference between both strains 
disappeared (∆sleB: 96.0 +/- 2.2 % ; parent: 91.5 +/- 2.3 %).  
The observed differences between nutrient induced germination of ∆sleB spores and the 
parental spores, were rather unexpected because the same ∆sleB spores showed to rehydrate 
and swell rapidly on agar pads containing the nutrients (Fig. 8.1). It is unclear why the ∆sleB 
spores in the germination assay, i.e. when incubated in a liquid buffer with germinants, did 
not become heat sensitive, nor phase-dark (observed with microscopy, picture not shown). 
However, it should be noted that we have been confronted with variable germination 
efficiencies before, even for NCTC 11219 ∆bont spores, and in our experience germination 
efficiency can vary significantly between different spore batches and also over storage time, 
with freshly harvested spores often showing only limited germination. In spore batches 
showing poor germination immediately after harvest, the germination degree on agar pads 
always tends to be higher than in liquid, for unknown reasons.  
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Fig. 8.2: Spore germination of the parental strain, NCTC 11219 ∆bont ∆pyr and the mutant strain, NCTC 11219 
∆bont ∆pyr ∆sleB. After incubation of heat activated spores for 4 h at 30 °C in the presence of gerMix (L-
alanine/L-lactate/NaHCO3), dodecylamine and Tris-HCl buffer, germination was assessed based on loss of heat 
resistance (Left) and by DPA release (Right). Mean percentages +/- standard deviations are shown of three 
experiments using independent spore crops. Significant differences (P < 0.05) between the two strains are 
indicated with *.  
  
 
 
 
      
 
 
 
 
 
 
  
 
 
 
For dodecylamine induced apparent germination, it is difficult to conclude on the role of SleB, 
because opposite trends were observed for the loss of heat resistance and DPA release. 
Dodecylamine germination is believed to have an effect on the SpoVA proteins 131 which 
mediate DPA release, but an interaction with SleB has not yet been reported. To confirm the 
involvement of SleB in dodecylamine germination, the genetic complementation of the ∆sleB 
spores will be helpful. Futhermore, a more detailed study on the location of SleB in the spore 
membranes, could presumably give more insight.      
8.3.5 Attempts to construct a ∆sleC deletion mutant  
Although the same knockout strategy was used as for the deletion of bont/E, gerBAC and sleB, 
we were not able to isolate a sleC deletion mutant. The plasmid pMTL84151∆sleC (SpRTmR), 
created for the deletion of sleC, was successfully conjugated to strain NCTC 11219 ∆bont ∆pyr 
and the transconjugants became 5-FOA sensitive as well as Sp/Tm resistant. When these 
transconjugants were propagated in broth (with Sp, without 5-FOA) and subsequently plated 
on TPGY with Sp and 5-FOA, about a dozen of colonies appeared. However, these colonies 
were still Tm resistant, indicating that they had not lost the plasmid (containing pyrE) despite 
being 5-FOA resistant. A total of around 200 clones were picked up from different independent 
experiments, but all were 5-FOA/Sp/Tm resistant. The presence of the plasmid was 
additionally confirmed in some of these clones by PCR using vector primers mcsF/mcsR 
(Table 4.1).  
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After many failed attempts to obtain a NCTC 11219 ∆bont ∆pyr ∆sleC mutant, the same 
strategy was employed in NCTC 8266 ∆bont ∆pyr. The pMTL84151∆sleC plasmid was 
transferred to this strain, and hereafter, six rounds of serial propagation of the transconjugant 
were required before 5-FOA/Sp resistant clones appeared (while in every round, 200 µl of 
culture was plated). Unfortunately, again these clones showed to be Tm resistant and thus 
they were false positives.  
To determine the cause of the 5-FOA resistant phenotype, the pyrE (plasmid-based) genes of 
four 5-FOA/Sp/Tm resistant clones derived from the NCTC 11219 transconjugants and six 
of the NCTC 8266 transconjugants were amplified with PCR (primers mcs_F and checkC_R) 
and sequenced. Surprisingly, no mutations were found in the pyrE genes of these 
transconjugants. Therefore, the pyrF gene (genome-based) was analysed in the same clones 
(primers pyrF_F/pyrF_R) because besides PyrE, also PyrF (an orotidine 5-phosphate 
decarboxylase) plays a role in converting the uracil analogue 5-FOA into a toxic metabolite, 
and thus cells with an inactive PyrF also become 5-FOA resistant. All sequenced clones indeed 
showed mutations in pyrF (Table 8.2). 
Table 8.2: Mutational changes in 5-FOA resistant transconjugants containing pMTL84151∆sleC. Four clones 
were sequenced from strain NCTC 11219 and six clones from NCTC 8266. (fs: frameshift) 
Transconjugant  Mutation Effect on PyrF Number  
NCTC 11219 ∆bont ∆pyr CA  Ala59Glu 3  
 TAAAAAA deletion Asn36fs 1 
NCTC 8266 ∆bont ∆pyr TAAAAAA deletion Asn36fs 2 
 T insertion Tyr80fs 1 
 GC  Cys20Ser 1 
 TG deletion Asp57fs 2 
 
The reason why deletion of sleC did not work is not clear. One possible explanation is that the 
frequency of recombination with the homologous arms flanking the sleC gene was lower than 
it was for the homologous arms flanking the sleB, gerBAC and bont/E genes. Although the 
length of the homologous arms was similar in all cases, the recombination efficiency may also 
depend on the sequence. An alternative explanation is that sleC is an essential gene for 
vegetative cell growth. This might be the case if SleC would be involved in peptidoglycan 
metabolism of the vegetative cells rather than in cortex hydrolysis. One way to test this could 
be to produce SleC recombinantly, and test the activity of the purified enzyme on decoated 
spores and on vegetative cells.   
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8.4 Conclusion 
In this chapter we investigated the functionality of two CLEs in gIICb, SleB and SleC, in spore 
germination. First, a NCTC 11219 ∆bont ∆pyr ∆sleB::aad9 mutant was constructed. The spore 
yield in this mutant was not affected, and the plating efficiency of the spores was a first 
indication that they could still complete germination and grow out on rich medium without 
SleB. Microscopy additionally indicated that ∆sleB spores rapidly turn phase-dark in the 
presence of the germinant mixture L-alanine/L-lactate/NaHCO3, while they remained phase-
bright without these nutrients. No differences were found between ∆sleB spores and the 
parental spores, suggesting that SleB is not essential for cortex hydrolysis.  This is similar to 
C. difficile, in which the inactivation of sleB had no effect on spore germination 141. However, 
our microscopy images have not been quantitatively nor kinetically analysed so an auxiliary 
role of SleB can not be excluded.  
Next, we investigated whether other germination-associated events are affected due to the 
sleB deletion. Germination in the liquid nutrient mixture was significantly reduced for the 
mutant spores, although DPA release was not different in comparison with the parental 
spores. In addition, dodecylamine apparent germination was affected, but because the loss of 
heat resistance and DPA release were apparently contradictory, the results were not 
conclusive. Therefore, these experiments should be repeated in the future, before it can be 
concluded that SleB plays a significant role in the cascade of germination events. Furthermore, 
complementation of the ∆sleB spores will aid to clarify SleB’s functionality.  
Unfortunately, the inactivation of SleC could not be accomplished, because false positive 5-
FOA resistant clones, of which was demonstrated that they had mutations in  pyrF, hindered 
the isolation of the correct sleC mutant. Although the same knockout strategy was used as for 
bont, gerBAC and sleB, it is unclear why the recombination efficiency was too low in this case.   
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Chapter 9  
General conclusions and future perspectives 
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THE ILLNESS BOTULISM IS A SIGNIFICANT PUBLIC HEALTH HAZARD because 
the botulinum neurotoxin (BoNT) that is responsible for the disease is the most potent 
biological substance known to mankind. BoNT causes flaccid paralysis, eventually resulting 
in death when untreated. Because of its extreme potency, the toxin is even considered a 
potential bioterrorism weapon. Therefore, most attention in research has been given to the 
disease and the toxins, while the organism C. botulinum that produces BoNT, has been studied 
less intensively. Nevertheless, because C. botulinum poses a tremendous concern for the food 
industry, food processing and preservation methods have been well established to control 
group I and II C. botulinum (which are mainly associated with human botulism) in foods. While 
group I strains are the main target in canning of low acid foods because of their high spore 
heat resistance, group II strains have a lower spore heat resistance but they can grow at 
temperatures as low as 3.3 °C, making them the pathogen of concern in REPFEDS. In this 
PhD thesis we focused on gIICb strains, and more specifically, on the mechanism of spore 
germination in these strains.   
To avoid the stringent biosafety procedures that apply to working with C. botulinum, we aimed 
to construct nontoxigenic mutants. Although targeted gene inactivation in clostridial species 
has proven to be a rather difficult and inefficient task for a long time, the genetic toolbox for 
knockout mutagenesis has expanded the last few years. Especially the ClosTron insertion 
mutagenesis system has been applied since 2007 in many clostridia, including one gIICb strain 
(Eklund 17B), in which bont was insertionally inactivated. We tried to obtain this nontoxic 
mutant, but according to the US FDA, this strain cannot be regarded as safe because the 
ClosTron insertion could be lost (though this is highly unlikely) and the bont gene be reversed 
to its active state. Therefore export of this strain from the US was prohibited. We thus 
obtained toxic strains, C. botulinum NCTC 11219, NCTC 8266 and NCTC 8550, all producing 
BoNT type E, and attempted to construct our own bont/E deletion mutants.  
FIRST, THE WGS OF THESE THREE STRAINS WERE ASSEMBLED . At the start of 
this PhD thesis, only two WGS were available from type E strains: C. botulinum E1 strain 
Beluga (six contigs) and strain Alaska E43 (whole genome as one contig). We have 
demonstrated in Chapter 3 that NCTC 8266 and NCTC 8550 are highly similar to strain 
Alaska (99 % identity), whereas NCTC 11219 differs more (93 % identity). For that reason, 
we were unable to assemble the latter as a whole genome, but instead four contigs were 
accomplished, applying a combinatorial approach of reference assembly against Alaska E43, de 
novo assembly of non-assembled reads and manual editing. The very close similarity between 
NCTC 8550, NCTC 8266 and Alaska is remarkable, given the fact that they have been isolated 
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in different years and geographical locations (NCTC 8266: Nanaimo, British Colombia (1944); 
NCTC 8550: Institute Pasteur, France (1952); strain Alaska E43: Alaska (year unknown)). It 
raises the question whether accidental strain switching or misnaming may have occurred.  
Construction of deletion mutants in C. botulinum had not yet been accomplished at the start of 
this research, and therefore we took up this challenge and DEVELOPED A NEW 
KNOCKOUT STRATEGY, with which we successfully constructed NCTC 11219 
∆bontE::ermB, in addition to a ClosTron mutant, NCTC 11219 bontE211a::CT (Chapter 4). 
Both mutants were characterized to assure that all phenotypical properties were unaffected, 
except for toxin production. While most characteristics of the mutants showed to be identical 
to the parental strain, also some differences were noted. Heat resistance of the spores at 70 °C 
was slightly lower for both mutants, and growth of the deletion mutant in 2.3 % NaCl was 
faster than for the other strains. In addition, an early onset of sporulation was demonstrated 
for the ClosTron mutant. However, the differences were small and the properties of the 
mutant strains were still well within the normal range for gIICb strains. Therefore, we 
considered the NCTC 11219 ∆bontE::ermB mutant to be a valid safe surrogate to facilitate our 
research and we used this strain to study germination in Chapters 6 to 8.   
Nevertheless, in Chapter 5, we additionally investigated whether one or more of the altered 
properties of the NCTC 11219 mutants were related with the inactivation of BoNT 
production, or due to spontaneous mutations that had occurred during mutant construction. 
Therefore we constructed a bont/E insertion and deletion mutant in another strain, NCTC 
8266, in an identical way as decribed for NCTC 11219, and characterized their properties in 
comparison with the wild type strain. Here, no phenotypical differences were observed for the 
NCTC 8266 deletion mutant, whereas a growth defect at 8 °C and 12 °C was shown for the 
ClosTron mutant. Moreover, WGS ANALYSIS WAS PERFORMED on the ∆bontE::ermB 
and bontE211a::CT mutants of strain NCTC 11219, as well as on NCTC 8266 ∆bontE::ermB. 
Unexpectedly, the analysis showed a lot of mutations including three large deletions (18 kb, 
51 kb, 20 kb) in the NCTC 11219 deletion mutant, while this was not the case for the NCTC 
8266 deletion mutant, in which only three mutations were found (besides one mutation that 
was introduced on purpose). The higher mutational rate in NCTC 11219 in comparison to 
NCTC 8266, could possibly be related with the higher amount of prophage regions (Chapter 
3). Such regions are known to be less stable and it is exactly in these regions that the large 
deletions occurred. Because the gene replacement strategy comprises many different steps 
(deletion of pyrE, double recombination with flanking loci of bont/E, restoration of pyrE), the 
probability of adventitious mutations to occur is relatively high, and it is recommended to 
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conduct WGS analysis to document these mutations and verify that no important gene 
functions have been affected. In addition to the NCTC 11219 deletion mutant, we concluded 
that also the NCTC 8266 deletion mutant is very useful for challenge testing. However, it 
should always be kept in mind that both mutants might react differently from the wild type 
in not tested situations. These strains will make challenge testing more accessible for food 
producing companies, and several companies have already expressed an interest. However, 
more nontoxigenic strains should be constructed, because challenge testing optimally requires 
use of a strain cocktail of gIICb type B, E and F strains to account for sufficient strain-to-
strain variability. 
The early onset of sporulation of NCTC 11219 bontE211a::CT could possibly be linked to a 
mutated diguanylate cyclase, since this was the only mutation found in this strain. These 
enzymes are involved in the synthesis of the secondary messenger c-di-GMP, which plays a 
role in the regulation of various lifestyle changes in different bacteria. However, a link with 
sporulation has only been demonstrated very recently by Fagerlund et al. (2016), who showed 
that the inactivation of a diguanylate cyclase resulted in a 2.5-fold higher sporulation 
efficiency after twenty hours of growth in B. thuringiensis 202. In comparison, the sporulation 
efficiency reported in Chapter 4 for the NCTC 11219 ClosTron mutant was increased about 
hundredfold compared to the wild type strain after ten hours of growth. This is a remarkable 
finding, and the role of c-di-GMP in sporulation onset in gIICb should be confirmed and 
further studied. By directed evolution experiments, we have already attempted to obtain 
spontaneous mutants of the wild type strain that showed a significant advanced sporulation 
onset, but unfortunately this was not successful. Further attempts using modified selection 
regimens should be tested, and if such early sporulation mutants can be isolated that show one 
or more mutation(s) in diguanylate cyclase encoding genes, this could corroborate our finding 
that c-di-GMP signaling is involved in sporulation. Furthermore, it would be useful to 
construct a diguanylate cyclase knockout, for example by using ClosTron mutagenesis. 
However, because of the large number of GGDEF-domain containing proteins, which are 
believed to encode for diguanylate cyclases, in gIICb strains (six in both NCTC 11219 and 
NCTC 8266), their functional analysis could be a difficult task because they may be 
functionally redundant. Nonetheless, further research on this topic could provide an 
interesting novel insight in the complex developmental program of bacterial sporulation.  
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IN CHAPTERS 6 TO 8, WE FOCUSED ON SPORE GERMINATION IN GIICB.  
INDUCTION OF GERMINATION by different germinants, and inhibition of germination 
by some natural preservative compounds was studied in NCTC 11219 ∆bontE::ermB spores 
(Chapter 6). While germination induced by nutrients and by high pressure (HP) had been 
described previously in a few studies, germination induced by the non-nutrients exogenous 
Ca2+-DPA and dodecylamine had not yet been reported in gIICb. We showed that Ca2+-DPA 
(20 – 60 mM) was not effective for germination induction. This was somehow to be expected 
since it is known that Ca2+-DPA activates the cortex hydrolase CwlJ and gIICb strains do not 
carry a CwlJ homolog. Nevertheless, Ca2+-DPA germination is not always clearly linked to 
CwlJ, since C. difficile spores do not germinate with Ca2+-DPA although they encode a CwlJ 
homolog 143, while C. perfringens spores germinate in response to Ca2+-DPA despite the 
absence of a cwlJ homolog in the genome. Our result suggests that the CLE enzymes in gIICb 
are not activated by exogenous Ca2+-DPA.  
In addition, HP treatments (200/600 MPa, 15 min, 30 °C) did not induce germination based 
on loss of heat resistance. Nevertheless, HP treatment at 600 MPa induced a small amount of  
DPA release, and this may indicate a direct or indirect effect on the SpoVA proteins which are 
believed to mediate DPA release. Our results confirm an earlier report that HP cannot induce 
gIICb spore germination efficiently at moderate temperatures 229. Since HP treatments and 
exogenous Ca2+-DPA induce germination in bacilli and at least in some clostridia, our results 
show that the germination mechanism can be significantly different between genera and even 
between species, and with this we highlight the need for specific studies in gIICb strains.  
Also in Chapter 6, we found that the gerMix (L-alanine/L-lactate/NaHCO3) and the 
surfactant dodecylamine were very effective germinants for NCTC 11219 ∆bontE::ermB 
spores, although the mechanisms of germination differed between the two. In both cases, 
spores lost their heat resistance and released their DPA, but only the nutrient germinated 
spores rehydrated and swelled fully. In contrast, spores incubated with dodecylamine 
remained phase-bright and can therefore not reinitiate metabolism. A similar observation has 
been reported for other spore-formers. In B. subtilis and C. perfringens, dodecylamine 
germinated spores only partly lost their refractility, and in C. difficile only minimal cortex lysis 
was demonstrated upon dodecylamine germination 125,143,144. Although dodecylamine 
germination probably does not proceed via the normal germination cascade, it is an interesting 
phenomenon that can learn us more about how the spore core is maintained in a dehydrated 
state, and how this state can be breached. Dodecylamine, especially at higher temperatures, is 
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a highly efficient sporicidal and it is currently applied in the product VIRUSOLVE+ (Virusafe, 
Mansfield, England).  
We further studied THE INHIBITORY ACTION ON GERMINATION of four natural 
antimicrobial compounds. Most studies on the use of natural antimicrobials as food 
preservatives have focused on inhibition of vegetative bacteria. However, since spore 
germination always preceeds outgrowth, inhibition of spore germination can also potentially 
contribute to an increased shelf life and improved safety of foods. In addition, since spore 
germination is an unique physiological process, its inhibition is likely to rely on different 
mechanisms than the inhibition of vegetative cell growth, and it can be anticipated that there 
is not necessarily a correlation between the capacity of a compound to inhibit vegetative 
growth and spore germination. In this work, we investigated the effect of carvacrol, 
cinnamaldehyde, carrot seed EO and hop β-acids on gIICb spore germination. For carvacrol, 
cinnamaldehyde and carrot seed EO, the lowest concentration that had an inhibitory effect on 
nutrient induced spore germination was respectively 40-, 16- and 100-fold lower than the 
MIC for vegetative cell growth. The inhibitory action of carrot seed EO is in contrast to the 
situation in B. cereus, where the oil showed no effect while ten other EOs did 225. Besides our 
present work, there is only one other study, published almost thirty years ago, reporting on 
the impact of EOs on spore germination on gIICb. In this work, origanum and cinnamon EO 
(of which carvacrol and cinnamaldehyde are the active compounds, respectively) had a strong 
inhibitory effect at 50 ppm but not at 10 ppm 226. In strain NCTC 11219, we still demonstrated 
a significant inhibitory effect (< 50 % relative log germination) at respectively 8 ppm and 31 
ppm of the pure compounds, carvacrol and cinnamaldehyde. It should be noted that the older 
study determined germination by counting the fraction of phase dark spores with microscopy, 
whereas we determined germination by plate counting. 
Hop β-acids, in contrast, were unable to inhibit germination even at concentrations equal to 
the MIC for vegetative growth. It will be interesting to see if higher concentrations, in the 
range where carvacrol and cinnamaldehyde inhibit germination,  will have an effect. 
Nevertheless, the extraordinary low MIC value (2.5 ppm) on gIICb vegetative cells makes the 
hop β-acids promising antibacterials for food preservation. According to the manufacturer 
Hopsteiner, 5-10 ppm are effective as an antibacterial agent against many Gram-positives 
(Bacillus, Listeria, Brochrotrix). In literature, MIC values of 1 ppm were found for L. 
monocytogenes and 3 ppm for H. pylori 246,247. 
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The low concentrations at which the EO compounds inhibit gIICb spore germination are 
potentially interesting from an applications point of view, for example in pasteurized foods 
with a long refrigerated shelf life, where gIICb is the major pathogen of concern. The potential 
of EO compounds is currently limited because they often cause unacceptable sensory 
deviations at the concentrations needed to inhibit vegetative bacterial growth in foods.  
IN CHAPTER 7, WE INACTIVATED GERX3B, the only GR that has been identified in 
the genome of gIICb strains. This was achieved by the same knockout strategy that was 
employed for bont/E deletion. The presence of only a single receptor contrasts with the large 
variety of germinants that trigger germination in gIICb and it seemed unlikely that GerX3b 
could act as a specific receptor for all these germinants. Surprisingly, deletion of the entire 
gerBAC locus, which was confirmed by PCR and whole genome sequencing, had no effect on 
nutrient induced germination. Different nutrient mixtures were tested, but no differences in 
germination were seen in comparison with the parental strain (Fig. 7.1 and Table 7.2). Also 
dodecylamine apparent germination was unaffected by the gerBAC knockout. This is in 
striking contrast with mutational studies in C. perfringens, which contains a gerK locus that 
has a similar bicistronic organization to gerX3 (in addition to a monocistronic gerAA located 
rather far away from gerK). Those studies concluded that GerKC is the main receptor protein 
involved in nutrient germination. GerK of C. perfringens was also involved in dodecylamine 
induced germination, which in bacilli is independent of Ger receptors 124.  
Our work is the first study of Ger receptors in gIICb and the lack of a role of GerX3b in 
germination clearly requires further investigation. A first question is whether GerX3b has 
any role at all. The finding that the genes are conserved and intact in all 159 available genome 
sequences of gIICb strains suggests an important function. So far we have focussed on spore 
germination of the ∆gerBAC mutant, but it may be useful to extend the analysis to see if any 
other properties are affected. Secondly, the quest for the genuine GR(s) in gIICb is now open. 
The CspC-like proteins are possible candidates, in analogy with C. difficile, and their large 
number in gIICb strains is compatible with the large variety of germinants. On the other hand, 
the possibility of an entirely novel class of receptors should also be considered,  and therefore 
it will be useful to isolate and analyse non-germinating mutants. At the moment, the 
optimization of a protocol for random transposon mutagenesis in gIICb is in progress in our 
lab.  
FINALLY, CHAPTER 8 ZOOMED IN ON THE CLES. The C. botulinum type E strains 
that were used in this study contain a putative sleC and sleB gene, but also an additional sleC-
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like gene designated as sleC2b and a sleM-like gene, although the latter is not annotated as a 
CLE but as a muramidase 120,127. In C. perfringens, SleM is believed to degrade PG-fragments 
generated by SleC during germination. In this PhD, we focused on the functionality of SleC 
and SleB by the use of knockout mutagenesis. A sleB deletion mutant was successfully 
constructed and microscopy images demonstrated that spores lacking SleB were still able to 
degrade the cortex and complete germination on germinant-containing agar pads. However, 
opposite results were obtained in the quantitative germination assays in liquid germinant 
solution, in which the germination of ∆sleB spores could not be induced. A clear conclusion 
could also not be made concerning the role of SleB in apparent germination by dodecylamine, 
because the loss of heat resistance and the DPA release were in conflict. Therefore, while it is 
clear that SleB is not essential for germination, the experiments are currently insufficiently 
reliable and reproducible to completely rule out a minor or more subtle role. Further work 
should be done to make the germination assays (including the production of spore crops) more 
reproducible. It will also help to include a genetically complemented ∆sleB strain.  
Although four deletion mutants could be constructed in this thesis by the same strategy, a 
∆sleC mutant could not be successfully accomplished because false positive 5-FOA resistant 
clones (having mutations in pyrF) hampered the isolation of the correct mutant. It remains 
unclear why the frequency of double homologous recombination together with the loss of the 
deletion plasmid in this case was lower than the frequency of mutations to occur in pyrF. 
However, the problem highlights the importance to improve the strategy or to develop an 
alternative deletion strategy in the future. To this end, the optimization of the highly efficient 
genome-editing tool, the CRISPR-Cas sytem (CRISPR-Cas system (clustered regularly 
interspaced short palindromic repeat–CRISPR-associated protein), is currently ongoing in 
our lab. The strategy has recently been used in various clostridia (C. beijerinckii, C. 
pasteurianum, C. cellulolyticum and C. acetobutylicum 248–250) and it has been proposed as a simple 
and effective solution to overcome several barriers in Clostridium mutant construction. In the 
future, we aim to apply this system in gIICb strains to construct more mutants in germination 
genes.  
TO CONCLUDE, the founding of a completely new research line in our lab was a first 
significant achievement, since only a few research groups study gIICb strains worldwide 
because of the difficulty to manipulate this organism. This PhD work has contributed to the 
development of genetic tools for gIICb, and has also provided some novel insights in spore 
germination in this group of organisms. By the use of a newly developed knockout strategy, 
we were the first to delete the neurotoxin gene in gIICb, thus providing nontoxigenic strains 
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that greatly facilitate fundamental and applied research in this organism. Using the same 
deletion method, knockout mutants were created of the germination genes gerBAC and sleB, 
to gain more insight into their role in spore germination of gIICb. Despite the importance of 
gIICb strains as the main target pathogen for many refrigerated foods, it is remarkable how 
little is known about the germination mechanism of these strains. A better understanding of 
this mechanism is not only important to improve the acccuracy of predictive models that are 
used to assess food safety from production to consumption, it may also allow the development 
of novel control strategies, since germination is an essential step in the progression of toxin  
production. Although B. subtilis has served for many years as the model organism to study 
germination, recent findings in several Clostridium spp. have demonstrated significant 
differences. Our work in gIICb has also led to a remarkable and unprecedented finding, i.e. 
that the only canonical Ger receptor present in gIICb (GerX3) is not involved in nutrient 
induced germination, although this had been widely assumed by many authors. Our finding 
leads to the important conclusion that spore germination in gIICb must rely on other 
germinant receptors, possibly of an entirely novel type. With this, the conclusion of this work 
offers an exciting prospect for further work to unravel the germinant receptors and other 
aspects of the spore germination mechanism in this important pathogen. 
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